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ABSTRACT  
 
BACKGROUND AND AIMS  
Cerebral palsy (CP) is the most common physical disability of childhood 
occurring in 1 in 500 live births in developed countries. Although CP starts in 
infancy because of a lesion in the developing brain, it is usually not 
diagnosed until about 19 months. The problem with late detection has meant 
that early neurorehabilitation is not accessed until motor impairment is 
evident. Consequently the dose of active intervention during the critical 
period for brain plasticity is often inadequate. Little evidence exists for the 
effectiveness of early intervention (EI) protocols for infants with CP. In 
particular, interventions that take a motor learning approach and focus on 
the task and environment as well as the child, are rarely used. The aim of this 
research was to evaluate the effectiveness of a motor learning intervention on 
infants at high risk of CP who were identified early in infancy. 
METHODS 
A literature review was conducted to explore current practice and evidence 
regarding how and when CP is diagnosed. Then a systematic review and 
meta-analysis was carried out to evaluate the effectiveness of environmental 
enrichment interventions on the motor outcomes of infants with CP. A 
prospective study assessed the feasibility of detecting CP in an Australian 
context using the General Movements Assessment (GMA).  
An EI enrichment programme “GAME” (Goals, Activity and Motor 
Enrichment) was then developed based on contemporary motor learning 
theory and within the framework of family centred practice. GAME was 
tested in a feasibility 12-week pilot (n=13) and then in a larger (n=30) 
randomised controlled trial (RCT).  
RESULTS 
 Meta-analysis of five studies demonstrated a small positive effect 
(SMD=0.39) for environmental enrichment interventions compared to 
standard care. Accuracy for detecting CP using the GMA was 98% 
(sensitivity) and 94% (specificity). Results of both RCTs demonstrated an 
advantage in motor outcomes for infants in GAME at all time points on both 
norm referenced and criterion referenced outcome measures. 
 
! ! 5!
 
CONCLUSION 
Early identification of infants with CP is possible using evidence based tools. 
Motor outcomes for infants with CP can be advanced by early and specific 
motor learning interventions offered in an enriched home environment. 
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Chapter 1: INTRODUCTION  
1.1. The problem: How to optimise the motor development of very young 
infants with or at the highest risk of cerebral palsy 
1.1.1 Cerebral Palsy 
Cerebral palsy (CP) is the most common physical disability of childhood 
affecting 34,000 Australians with approximately 700 new cases diagnosed each 
year. The current definition of CP is “a group of disorders of the development of 
movement and posture, which are attributed to non-progressive lesions of the 
developing fetal or infant brain” (1). The motor impairments of CP are variable 
and range from a mild to severe and may be unilateral or bilateral, affecting all 
limbs, the trunk and neck. Consequently the activity limitations of CP are also 
variable and the condition is considered highly heterogeneous.  The 
heterogeneity of CP is suggested in the definition (“group of disorders”) and is 
evident in the variation in antecedents, motor ability, the predominant motor 
patterns of CP, and the presence of secondary impairments that are frequently 
co-occurring in CP.  
The Gross Motor Function Classification System (GMFCS) is a universally used 
system that classifies CP according to level of motor function (2). Children in 
levels I and II walk independently and according to CP Register data account 
for 60% of all CP (3). Children at level III ambulate with assistive devices and 
often become non- ambulators in adolescence (4). Those classified as levels IV 
and V are wheelchair dependent where independence in operating a wheelchair 
and the ability to weight-bear for transferring are often the separating factors 
between levels.  Children in levels GMFCS IV and V account for 30 % of all CP 
(3). Manual ability has also been classified for children over four years of age 
with the Manual Ability Classification Scale (5) 
CP can also be described by the predominant type of movement disorder, with 
spasticity the most common form (85-90%) followed by dyskinetic CP (4-7%) (6). 
Many people have a mixed presentation with either spasticity or dyskinesia as 
the predominant disorder. 
! 16!
In addition to motor difficulties, a diverse range of secondary impairments often 
accompanies CP. A recent systematic review found that 3 in 4 people with CP 
experience pain, 1 in 4 are non-verbal, over 40% have a cognitive impairment 
and 1 in 4 have a vision impairment (7). In addition secondary impairments may 
arise as a result of the “natural history” of CP leading to debilitating 
contractures and joint deformity and a functional decline in motor ability (4). 
 
1.1.2 Therapeutic Interventions for CP 
Rehabilitation interventions are the standard of care for children with CP, and 
available interventions broadly fall into 3 categories; (i) those that aim to 
improve function; (ii) those that aim to prevent secondary impairments from 
occurring; and (iii) those that provide compensation by adapting the 
environment around the child (6). A number of systematic reviews demonstrate 
that high quality evidence exists for some interventions that aim to improve 
motor function in children with CP including constraint induced movement 
therapy (CIMT), bimanual training, goal directed training and goal oriented 
home programmes (8). However there are still many interventions with poor 
supporting evidence that are part of the standard care of children with CP. The 
lack of evidence is in part due to difficulties in conducting studies of high 
methodological quality with children of heterogeneous conditions. Indeed many 
of the intervention studies that have been show to be effective are of more 
homogenous samples, for example hemiplegia (9). The heterogeneity of CP is 
increasingly thought to be a significant contributor to the difficulties 
encountered when studying interventions for this diverse group of people (10).  
1.1.3 Motor Trajectories in CP 
Typically developing children display a relatively predictable sequence of motor 
milestone acquisition although there is some variation in age of attainment (11). 
During the first year of life infants learn to sit, crawl on hands and knees, stand 
with assistance and about 50% walk unassisted by their first birthday. 
Concurrently, infants are developing increasingly complex reach and grasp 
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behaviours and by 12 months are able to use both hands to reach for, transfer 
and grasp and release objects 
The heterogeneity of CP in terms of motor function has been well described in a 
landmark study in 2002, the Ontario Motor Growth Study. Individual scores on 
the Gross Motor Function Measure were mapped against age and stratified by 
GMFCS levels to create motor development curves for CP (12). These curves are 
useful for predicting likely mobility outcome and are widely used as a tool to 
discuss prognosis with families as well as plan realistic rehabilitation goals. The 
study and resulting gross motor curves demonstrated that children with CP 
achieve 90% of their gross motor development potential by age 5 across all 
GMFCS levels, after which a plateauing effect occurs. Children at GMFCS level 
V reach this point before 3 years of age (Figure 1).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  Steepest portion of CP Motor Curves (Figure used by permission 
from JAMA 
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 As would be expected, the steepest portion of the curves occur between 0 - 2 
years although in this large cohort study only 68 of the 657 children (10%) were 
between one and two years of age. Infants under one are not reported in this 
study. In other words, very little is known about the motor trajectory of infants 
with CP before the age of two. Tabulated reference percentiles are available for 
children from two years demonstrating the great variance even within GMFCS 
levels (13). There are no equivalent curves for infants and toddlers. 
Infants with brain lesions usually have slower motor development than their 
age matched peers due to the impaired development of sensorimotor pathways 
and their target structures (motoneurons and muscle) (14). The location and 
extent of the brain lesion is one of several factors that predict outcome severity 
in children with CP. White matter injuries (WMI) are the most common type of 
injury accounting for up to 46% of all CP (15). About two thirds of infants with 
WMI will have milder motor impairments (GMFCS I-II) with hemiplegia and 
diplegia the more common motor distribution types. Cystic periventricular 
leukomalacia (cPVL) is often associated with non-ambulant CP especially when 
it is bilaterally distributed and occupies more than 5% of the hemispheres (16). 
Grey matter lesions occur in about 25% with hemiplegia the most common 
outcome (17). Hypoxic Ischaemic Encephalopathy  (HIE) can lead to mild or 
severe outcomes with injuries to the basal ganglia and thalamus often leading to 
dyskinetic CP affecting all limbs. Where injury only involves the white matter 
motor disability may be milder (18). Similarly maldevelopment of the brain can 
result in severe motor and cognitive disability or mild motor dysfunction (19). 
Although the degree and location of damage to the motor areas of the brain is 
predictive of outcome, associated impairments such as cortical vision 
impairment, cognitive delay and uncontrolled epilepsy also impact on motor 
development and function.  
1.1.4 Early Intervention evidence in CP 
Not only is little known about the motor trajectories of infants with CP, the early 
intervention literature for CP is also problematic. Good evidence exists for the 
effectiveness of interventions for older children with CP that take a goal-
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oriented and motor learning approach to therapy (8). Studies in both children 
with CP and adults with acquired brain injury have demonstrated that the 
repeated practice of task – specific activities leads to improvements in gross 
motor function and performance of daily activities (20-22). Evidence in the field 
of early intervention in CP is far less convincing. A recent search of the 
Cochrane Database of Systematic Reviews and Physiotherapy Evidence 
Database (PEDro) over the last 10 years identified 6 systematic reviews (23-28) 
evaluating child-focused early intervention programmes for infants 0 - 2 at high 
risk of CP (Table 1). Of these systematic reviews four focus only on preterm 
infants, and only two specifically evaluate the impact of early intervention on 
infants with CP. One of these is paper 2 of this thesis (28). A great deal of 
variability exists in programmes typically offered to high risk infants and 
although cognitive and social gains have been shown in studies of preterm 
infants, motor gains are generally not found. Even cognitive gains are generally 
not maintained after intervention ceases (27).  
The main types of interventions that have been studied in infants for the 
purpose of advancing motor development vary and include 
Neurodevelopmental Therapy (NDT) (29), general developmental stimulation, 
developmental skills approach (30) and conductive education (31). To date there 
is little evidence to show that motor outcomes can be influenced significantly by 
any of these approaches over and above what is expected from natural 
development (32). 
TABLE 1: Systematic reviews evaluating child focused interventions in children 
0-2 years (2005-2015) 
 
CITATION 
 
POPULATION 
 
INCLUDED 
INTERVENTIONS 
 
MOTOR 
OUTCOMES 
 
NON-MOTOR 
OUTCOMES 
Benzies et al; 
2013(23) 
 
 
SR and MA 
Preterm Various 
programmes that 
included parents 
Not reported Significant 
positive 
maternal 
depression, 
! 20!
anxiety and 
self efficacy 
Blauw-
Hospers et al; 
200524 
Preterm 
At risk of 
disability 
CP 
Various 
programmes 
aiming to 
improve motor 
development 
Mixed results 
NDT 
ineffective 
Specific and 
general 
programmes 
might have 
beneficial 
effects 
depending on 
age of infant 
 
Mixed results 
Fernandez et 
al; 201225 
Preterm 
infants 
Physiotherapy 
intervention 
programmes 
Mixed results; 
studies 
heterogeneous 
Not reported 
Schulzke et 
al; 201426 
SR and MA 
 
Preterm 
infants 
Physical activity 
programmes 
Not reported Positive effect 
on weight gain 
and linear 
growth 
 
 
Spittle et al; 
201227 
SR and MA 
Preterm Various child 
oriented 
programmes 
Small effect in 
short term 
Significant 
positive 
cognitive 
Morgan et al; 
201328 
 
SR and MA 
(Paper 2 of this 
thesis) 
CP/high risk 
of CP 
Programmes 
including an 
environmental 
enrichment 
component 
Small positive 
effect at end 
of treatment 
period 
Not reported 
SR= systematic review; MA=meta-analysis 
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1.1.5. Diagnosing CP 
One of the key reasons for the paucity of EI trials for infants with CP relates to 
age of detection of CP. A problem with many EI trials aiming to recruit infants 
with CP is that they unintentionally end up with a mixed group including some 
participants with mild motor dysfunction, some with normal outcomes and only 
a few with CP. For example, although premature infants are regarded as “high-
risk” only 10% or less will go on to have CP making it difficult to generalise 
findings from the high number of studies of this population (3). Underpowered 
trials for CP are the consequence of late detection. 
Although CP results from an injury to the developing brain (i.e. occurs in 
infancy) a formal diagnosis is often not made until the second year of life. In 
Australia the average of diagnosis is 17 months for children who were 
monitored closely after birth as well as for those who present with motor delay 
during late infancy (unpublished data from Australian Cerebral Palsy Register). 
Only infants with a history of neonatal encephalopathy are diagnosed earlier, at 
an average of 13 months. Confirming a diagnosis of CP is typically a complex 
process. When infants are closely monitored because of neonatal risk factors 
such as prematurity or encephalopathy, motor delays might be noted earlier 
although a “wait and see” approach is often preferred (6). The chance that an 
identified brain injury might not lead to the activity limitations necessary for a 
CP diagnosis leads practitioners to be cautious. For children with no apparent 
risk factors, investigations typically begin when it becomes apparent that motor 
milestones are not being reached, in particular sitting or standing. However as 
many standardised motor tests are not specifically predictive of CP (33) and 
some “tell-tale” motor signs such as spasticity do not appear until the second 
year, it can still be some time before an official diagnosis is given. Before making 
a diagnosis, medical professionals wish to rule out other potential conditions 
(34) and ensure the condition is not progressive. Brain imaging is widely used to 
document the presence and extent of injury and increasingly sophisticated tools 
are under development (35). However, clinical research also documents 
outcomes that do not seem to “match” imaging findings (36) and up to 15% of 
children with CP have normal neuroimaging. Nevertheless, a number of 
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systematic reviews have demonstrated that certain defined patterns of injury in 
the grey and or white matter nearly always lead to CP indicating the importance 
of appropriately timed neuroimaging in the diagnostic process (15,16,18,37). 
Prechtl’s Qualitative Assessment of General Movements (GMA) (38) a 
diagnostic observational tool, has been shown to be predictive of neurological 
outcome, particularly CP, in high- risk preterm and term-born infants. Spittle 
and colleagues demonstrated a correlation between abnormal GMs and 
abnormal white matter and suggest that a combination of GMs assessment and 
structural MRI in high-risk infants is a logical approach to early detection of CP 
(39). Despite numerous publications and high quality systematic reviews this 
approach to early detection is still not commonly used (38). Published 
algorithms for diagnosing CP do not include GMA and recommend 
neuroimaging when tone is assessed as high (34). The combined use of GMA 
and appropriately timed neuroimaging is a potential solution to the problem of 
late detection. 
Standard of care for infants at high risk of CP includes in the first instance, 
frequent monitoring, and early intervention (EI) if motor delay appears to be 
worsening. Accessing EI however, can be dependent on a confirmed diagnosis 
or a sufficient description of “at risk “ status. There is a growing body of 
research indicating that this period of time is the critical window of infant brain 
development. An increasing amount of neuroscience literature demonstrates 
that perinatal damage to the developing corticospinal tract is worsened by 
inactivity (41). Martin and colleagues found in a cat model of CP, that activity 
based therapies delivered early, re-established corticospinal connections and led 
to improved control of the affected limbs (42). In humans the first 18 months of 
life are considered critical for development of the corticospinal tracts (42, 43). 
Theoretically, infants with brain injuries affecting the motor regions of the brain 
ought to respond best to active interventions applied as early within this critical 
window as is possible.  
The tendency for late diagnosis, coupled with service dependent diagnostic 
criteria, creates a problem for timely access to interventions that aim to optimise 
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the neural organisation occurring during this time period. Additionally once 
infants are referred, the model and type of service provision to these children is 
variable. A recent intervention study in the US found that the variation in 
standard care for high risk infants varied enormously with more than 50% of 
participants in the study unable to access physical therapy intervention before 
12 months of age (44).  
We hypothesised late detection and thus low dose early intervention was 
standard of care (described in chapter 7) in our region. In a survey of NICUs in 
Sydney in 2011, prior to the implementation of GMA in most NICUs, we found 
that the average amount of EI received by an infant at high risk of CP in the first 
year of life was only 14.2 hours (survey questions and table of outcomes listed in 
appendix 1). Moreover, the inclusion criteria for follow up post discharge varied 
from site to site. Some had no standard follow up for infants with HIE for 
example, whereas others followed all infants with HIE until early childhood. It 
seems likely that a proportion of infants at high risk of CP might be “slipping 
through the cracks” despite the existence of follow up services. 
1.1.6 Neuroplasticity and motor function 
It is the intrinsic ability of the brain to change and organise itself that provides 
the scientific background to the purported benefits of rehabilitation. 
Neuroplasticity has been the subject of both basic science and clinical research 
for several decades. Demonstrable changes in structure, function and 
connections at the molecular and cellular level provide scientists and clinicians 
with confirmation that injuries to the brain are not static and that exploiting 
these mechanisms might be the solution to recovery. The search for 
interventions to harness neuroplasticity mechanisms is ongoing in many fields 
(45). A number of studies have investigated the place of pharmacological 
interventions in animal models (46) or repetitive Transcranial Magnetic 
Stimulation in changing the levels of excitability in the corticospinal tract (47). 
Clinically feasible rehabilitation protocols aim to harness activity - dependent 
plasticity mechanisms by providing repetitive experience to retrain functional 
skills lost as a result of injury. Adult stroke studies have demonstrated changes 
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in neural organisation as a result of motor training, for example studies of CIMT 
have demonstrated structural neuroplastic change (48). Researchers and 
clinicians in the rehabilitation field want to know the type and intensity of 
clinically feasible strategies that can be used to promote optimal neural 
organisation. Allied health professionals providing interventions to infants with 
CP urgently need evidence based protocols that are grounded in neuroscience. 
At the same time as advances in neuroscience have been progressing, the focus 
of developmental research has shifted from a neuro-maturational framework, 
sometimes referred to as “disembodied development”, to one of an interaction 
of multiple dynamic systems or “embodied development” (49, 50). In these 
contemporary frameworks purposeful motor behaviours are understood to 
emerge from a convergence of child-specific (biomechanical and physiological), 
task-specific and environmental constraints and processes.  A variety of novel 
and ground-breaking experiments have shaped our understanding of how 
normal motor development progresses and ought to form the basis of motor 
intervention programmes. Some of these findings are listed below:  
1. Biomechanical factors influence motor development at a very young 
age. Thelen demonstrated over 30 years ago that the loss of the stepping 
reflex was attributed not to increasing supraspinal inhibition, the 
prevailing assumption of the day, but increasing body mass rendering 
the infant’s leg muscles too “weak” to lift the legs against gravity (51). 
Thus “practice” of stepping maintained muscle strength and led to earlier 
walking and retention of the stepping reflex, an observation that had 
previously been attributed solely to the effects of neuromaturation (52). 
2. Infants who are developing typically learn by trial and error and 
display high levels of variability in movement solutions for achieving a 
motor goal (53). 
3. Task constraints influence the emergence of motor skills. Studies by 
Fetters and colleagues showed that by simply changing the weight of a 
mobile positioned for kicking, both the frequency and pattern of kicking 
behaviours could be altered in infants as young as 4 months of age (54). 
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4. Environmental factors influence the rate and trajectory of motor 
development. Child rearing practices across different cultures (55) and 
parent training of specific motor activities have been shown to advance 
the emergence of motor skills (56-57). 
5. Intensity of practice is a determining factor in the rate of motor 
development. A study examining the characteristics of the emergence of 
walking postulated that the amount, variability of and distribution of 
practice were crucial factors in the successful development of walking 
(56). Repetition is a key principle of motor learning. 
“Dynamic systems” provide the theoretical background to evidence based 
motor learning interventions for children with CP including goal - directed 
training (GDT) or functional training (59). This approach uses mutually agreed 
upon, meaningful goals to shape the intervention plan. Then aspects of the 
desired goal are considered in relation to child-specific (for example muscle 
strength), task specific (task analysis is used to “break down” the task into 
components), and environment specific characteristics. Frequent repetitive task 
practice is a key component of this intervention and a coaching framework may 
be used with children of suitable age and cognition (60). To date, the application 
of GDT has demonstrated positive results in older children with cerebral palsy 
and adults with acquired brain injury however there have been no published 
studies using this approach in young infants with CP. Goal oriented 
interventions for infants at high risk of CP that utilise principles of motor 
learning could be a potential solution for advancing the motor trajectories of 
these children during the critical neuroplastic window. 
1.1.7 Enriched environments  
The study of Enriched Environments  (EE) has been proven to enhance 
neuroplasticity in animal studies and in adults with neurological disorders. 
Gains documented include improved memory and motor recovery (61). 
Environmental enrichment is arguably a potential rehabilitation “solution” for 
those with brain injuries and studies of the contribution of EEs to recovery after 
adult stroke are underway (62). While animal studies use consistent animal 
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housing set-ups, it is more difficult to describe the “essential ingredients” of an 
enriched environment in human rehabilitation settings. It seems in the human 
context more is known about deprivation and its negative consequences than is 
known about enrichment (63). Multiple studies of “at risk” children, most 
notably premature infants and those from low socioeconomic groups, have 
examined the value of enrichment in enhancing outcomes. These studies 
demonstrate significant benefits in cognitive and behavioural development via 
the enrichment of either home or day care environments, or from a variety of 
early intervention programmes that aim to enhance the child’s learning 
environment (64, 27).  
The home environment has for many years been recognised as a key-
contributing factor to favourable outcomes for children at risk. The International 
Classification of Function and Disability (ICF) also highlights the importance of 
environmental factors in influencing activity and participation of children with 
disabilities (65). Maternal mental and physical health and confidence, sleep, 
child rearing practices, socioeconomic factors (66) and support networks are all 
regarded as important contributors to child health and development (67). In 
fact, the home environment is considered so crucial that service delivery 
frameworks that are family centred are now considered standard of care in early 
intervention and child rehabilitation programmes (68). Family Centred Practice 
recognises the family as the constant in the child’s life and that families are 
invaluable partners to health professionals. Family centred care aims to enhance 
the competencies of the family in their care giving role.  
Early Intervention programs for infants who are at risk of poor developmental 
outcomes aim to enrich the child’s environment. These programmes tend to be 
home based, educational in nature and rely on the parents/carers to provide the 
interventions with the support of various professionals (69,70). Recent 
systematic reviews have demonstrated that although home -based early 
intervention programs for infants regarded as “at risk” are the norm, a positive 
impact on motor development is yet to be clearly demonstrated (24,27).  
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1.2 Research Questions 
The thesis brings together a series of papers investigating the feasibility of 
detection of CP early in infancy and the effectiveness of environmental 
enrichment and early motor learning interventions on the motor outcomes of 
young infants at high risk of CP. This research addresses the following 
questions: 
• Is it possible to detect CP early in an Australian context? 
• If it is possible to detect CP early, then at what age can it be detected and 
what are the best tools to accurately identify CP in infancy? 
• How effective is early intervention for improving motor outcomes of 
infants with CP? 
• Does environmental enrichment influence the motor outcomes in infants 
with CP? 
• Can motor learning interventions effective in older children with CP be 
implemented for infants with CP or who are at very high risk of CP? 
• Does a home-based, goal oriented rehabilitation approach that educates 
and supports parents to practice motor tasks with their baby lead to 
improved outcomes for infants with CP? 
 
1.3 Aims of research 
In response to the research questions, the aims of this thesis are: 
1. To review the literature regarding the early detection of CP 
2. To review the evidence for the effectiveness of interventions aimed at 
enriching the environment of infants with CP or at high risk of CP 
3. To assess the sensitivity and specificity of the General Movements 
Assessment for detecting CP in infants 3-4 months of age in an Australian 
context 
4. To develop and describe the content of a goal oriented motor learning 
intervention that combines environmental enrichment, intensive motor 
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training and parent education called GAME (Goals Activity and Motor 
Enrichment) 
5. To test the feasibility of early detection of CP using the GMA to recruit 
infants to a pilot RCT of GAME intervention and to test the outcomes of 
GAME after 12 weeks of intervention compared to usual care 
6. To test the efficacy of GAME in a larger RCT on motor outcomes in the 
short and longer term 
 
1.4 Outline of studies  
An outline of the studies and how they fit together in this thesis is portrayed in 
Figure 2. In the first 2 studies the problem and consequences of late diagnosis of 
CP is discussed. The paucity of evidence for the effects of EI for infants with CP 
is a product of a lack of a systematic approach to early detection and the dearth 
of intervention protocols based on basic science and of effective rehabilitation 
strategies that work in older children with CP.  
 
 
 
 
 
 
 
 
 
 
Figure 2: Diagrammatic representation of the studies 
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The solution to this problem is the subject of the remaining studies. Study 3 
represents the result of a knowledge translation project that was coordinated to 
embed the use of the GMA into clinical practice. A rater network was 
established and infant assessment and outcome data collected across 5 
recruitment sites. The sensitivity and specificity of the GMA for detecting CP in 
this Australian rater network is detailed.  
Studies 4-6 describe the aims, methods and results of a novel EI approach for 
infants at high risk of CP. The intervention, GAME (Goals – Activity – Motor- 
Enrichment), is described and tested in both a small (phase 1) pilot study and 
then in a larger (phase 2) RCT. 
The final chapter draws together the findings and limitations of the study and 
discusses future directions for research in the field. 
Study 1: (Chapter 2) 
Aim 1: To review the literature regarding the early detection of CP 
A literature review was conducted to describe the risk profile of CP in 
neonates and to identify the assessment tools with the highest predictive 
capacity to detect CP in infancy. 
Results 1: High level evidence exists that CP can be detected early 
Study 2: (Chapter 3) 
Aim 2: To review the evidence for the effectiveness of interventions aimed at 
enriching the environment of infants with CP or at high risk of CP 
A systematic review was undertaken to summarise the evidence of the 
effectiveness of environmental enrichment interventions in infants with 
CP. In the absence of a formal definition of environmental enrichment for 
humans, a working definition based on animal literature is proposed. A 
meta-analysis combines data from five studies that compared 
environmental enrichment interventions with standard care. 
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Results 2: A small positive effect on motor outcomes exists for the benefits of 
interventions including environmental enrichment compared to standard care. 
Study 3. (Chapter 4) 
Aim 3: To assess the sensitivity and specificity of the General Movements 
Assessment for detecting CP in infants 3-4 months of age in an Australian 
context.  
A knowledge translation project was conducted to enable early detection 
of CP. A targeted training programme in Prechtl’s Qualitative 
Assessment of General Movements in Sydney’s Neonatal Intensive Care 
Units was undertaken. Data collected from five sites over a 30-month 
period was analysed to determine if sensitivity and specificity of 
detecting CP in 3-4 month old infants was comparable to internationally 
published rates. 
Results 3: Diagnostic accuracy for detecting CP using the GMA was comparable 
to international rated with a sensitivity of 98% and specificity of 94%. 
Study 4. (Chapter 5) 
Aim 4: To develop and describe the content of a goal oriented motor learning 
intervention that combines environmental enrichment, intensive motor training 
and parent education called GAME (Goals Activity and Motor Enrichment) 
A clinical protocol for a goal-directed, intensive motor training 
intervention (labelled GAME) in infants was devised, based on published 
literature.  
Results 4: After it was tested in a small pilot (study 5) the protocol for a larger 
RCT (study 6) was developed and published. 
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Study Five: (Chapter 6) 
Aim 5: To test the feasibility of early detection of CP using the GMA to recruit 
infants to a pilot RCT of GAME intervention and to test the outcomes of GAME 
after 12 weeks of intervention compared to usual care. 
The GAME protocol was tested in a small pilot study. This pilot aimed to 
test both the feasibility of the recruitment and randomisation strategies as 
well as the acceptability of the intervention to parents. Outcome data 
from the pilot study were used to conduct a power analysis for the 
randomised controlled trial, to ensure the study had adequate sample 
size to detect change if present. 
Results 5: Twelve weeks of GAME intervention resulted in favourable motor 
outcomes compared to standard care. The intervention was clinically feasible to 
do and recruitment and randomisation procedures were acceptable to all 
stakeholders. 
Study Six (Chapter 7) 
Aim 6: To test the efficacy of GAME in a larger RCT on motor outcomes in the 
short and longer term 
A single blind randomised controlled trial (RCT) with 2 groups was used 
to evaluate whether improved motor outcomes in infants with (CP) result 
from GAME OR standard care. Results are reported after 16 weeks of 
intervention and at one year. 
Results 6: Between-group differences favouring GAME intervention were found 
in motor skills after 16 weeks of intervention. Furthermore, at 12 months 
corrected age, GAME participants had significantly higher motor function and 
cognition scores compared to standard care. 
1.5 Significance of the research 
In Australia, 700 new cases of CP are diagnosed each year. By 2050 there are 
expected to be over 47, 000 people living with CP in Australia. CP is more 
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common in any year than the most common types of cancer, stroke and road 
traffic accidents and is in the top five most costly conditions on a per capita 
basis of 15 conditions studied by Access Economics in recent years (68). The cost 
of CP was estimated at 1.47 billion in 2007, and 43% of this cost is borne by 
individuals with CP and their friends and families, and is almost certainly an 
underestimate. The recent introduction of the National Disability Insurance 
Scheme in Australia will see costs for services for people with CP continue to 
rise with more of the financial burden falling to government. Evidence based 
interventions are important not only to minimise the impact of CP on the quality 
of life for children and their families but also to assist government and policy 
makers to allocate resources and efforts to programmes shown to be effective. 
The findings of this research have the potential to improve the outcomes of 
these children by reducing the age of detection of CP thus allowing early access 
to intervention. This study is unique because previous interventions with this 
population either (a) started late i.e. outside the optimal neuroplastic window, 
because of a “wait and see” method of diagnosis; or (b) utilised a normalisation 
of movement approach for example, Neurodevelopmental therapy (NDT), 
which have been shown to be ineffective. This research makes a unique 
contribution to advancing knowledge about early intervention for infants at 
high risk of CP because it instead tests the effectiveness of proven effective 
interventions in older children in this younger population. Since motor learning 
interventions have not been tested in very young infants it is still unknown if 
severity of impairment can be minimised by taking advantage of neuroplastic 
mechanisms very early in life using activity based protocols such as those 
contained in this research programme.  
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APPENDIX 1: 
Survey questions: 
1. When an infant is discharged from the NICU is high risk of CP discussed? 
2. What is the routine follow up plan? Is it related to birthweight, medical 
conditions or gestational age? 
3. At what ages are they followed up and by whom? 
4. What assessments do they have and at what ages? 
5.Are they referred to allied health? Who/where/why? What is frequency of 
intervetnion? 
7. What is the usual age for a definitive diagnosis of CP to be given 
NIC
U 
Follow-up 
inclusion 
criteria 
Diagnostic 
window 
Follow 
up  
time 
points  
Timing of 
allied  
health 
referrals 
Intensity of 
allied health 
interventions 
if referred 
1 Gestational age: 
< 30 weeks  
Growth 
restriction: <37 
weeks + on 3rd 
centile  
Neuro: HIE OR 
other 
neurological 
concern 
 
Inpatient: 
Initial 
discussion of 
“high risk”  
Follow up: 
Final 
diagnosis by 
12 months at 
latest 
6 weeks 
4, 8 and 
12 
months 
3, 5 and 8 
years 
Varies: 
Often 4 or 
8 months 
as 
determine
d by clinic 
staff 
Can vary 
from follow 
up to 
monthly or 
fortnightly 
for infants; 
less intense if 
older 
2 Gestational age: 
<32 weeks  
Growth 
restriction: 
sometimes 
Other: complex 
Inpatient: 
Risk 
discussed 
prior to 
discharge 
Follow up: 
4, 8 and 
12 
months 
Up to 3 
years if < 
29 weeks 
Varies:  At 
any follow 
up time 
point as 
assessed 
by NICU 
Individualise
d; no 
parameters 
given 
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medical needs  Final 
diagnosis by 
paediatrician 
between 1-3 
years 
allied 
health staff 
3 Gestational age: 
<29 weeks,  
Weight: <1000g,  
Neuro: Grade 3 
or 4 IVH, PVL, 
seizures, 
meningitis  
Other: 
protracted 
hyperglycaemia 
Inpatient: 
Risk 
discussed 
more than 
once  
Follow up: 
Final 
diagnosis 
ranges from 4 
months 
(severe CP) - 
2 years (mild 
CP) 
4, 8 
and12 
months 
2 and 5 
years if 
<750 
gram or 
<27 
weeks 
Varies – at 
discharge 
in some 
cases or at 
any follow 
up time 
points if 
abnormal 
or delayed 
developme
nt noted 
Monthly to 
fortnightly 
for infants 
Less frequent 
for toddlers 
4 Any baby at risk 
of 
developmental 
delay who is not 
followed up by 
another service 
(eg cardiac 
follow up) 
Inpatient: 
Discussion 
based on test 
results re 
“high risk”  
Follow up: 
Final 
diagnosis 
given 
between 6 
months- 3 
years 
4 and 12 
months 
and 3 
years 
 
If 
concerne
d also 8 
and 18 
months 
Varies – at 
discharge 
in some 
cases or at 
any follow 
up time 
points if 
abnormal 
or delayed 
developme
nt noted 
Monthly on 
average 
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5 Gestational age: 
<29 weeks,  
Weight: <1000g,  
Neuro: grade 3 
or 4 IVH or 
specific risk 
factors such as 
seizures 
 
Inpatient: 
General 
discussion of 
“High risk” 
category 
Follow up:  
Final 
diagnosis 6-
12 months or 
later if mild 
1,3,4,6,8,1
2 and 18 
months 
(physio)  
1, 2, 5 
and 8 
years 
(medical) 
Physiother
apy for all 
high-risk 
group, 
seen at the 
hospital. 
 
Monthly – 
every 2 
months 
however 
more intense 
block of 
weekly to 
fortnightly 
may be 
offered for a 
short period 
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This first paper provides a narrative review of the difficulties of 
diagnosing CP and gives a rationale regarding the importance of the 
early detection of CP. The paper outlines the difficulties of applying 
diagnostic labelling to a condition known as an “umbrella term” in the 
absence of readily available biomarkers.  
The concept of “high risk of CP” is discussed with reference to premature 
infants, term infants with neonatal encephalopathy and term infants with 
no apparent risk factors who later go on to be diagnosed with CP. Data 
indicated that it is possible to find and therefore study these infants early 
to advance the early intervention evidence base. 
The assessment tools with the highest predictive power for CP are 
summarised, enabling recommendations to be made that aim to: 
 
1. Enable earlier and accurate diagnosis of CP for high-risk infants 
2. Provide an evidence based care pathway for children born 
preterm or term and at high risk of CP 
3. Facilitate earlier referral to early intervention during critical 
periods of child development 
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Cerebral palsy (CP) is the most severe physical disability within the
spectrum of developmental delay. CP is an umbrella term describing a
group of motor disorders, accompanied by many associated impairments.
The disability is a result of injuries to the developing brain occurring any
time from the first trimester of pregnancy through to early childhood.
However, for the great majority, their full etiological causal pathway
remains unclear. It is important to discriminate as early as possible
between: (a) mild or nonspecific motor delay, (b) developmental coordi-
nation disorder, (c) syndromes, (d) metabolic and progressive conditions,
and (e) CP with its various motor types and distributions. The most prom-
ising predictive tool for CP is the general movements assessment, which
assesses the quality of spontaneous movements of infants in the first 4
months of life. We propose a change in diagnostic practice. We recom-
mend a shift away from referral for intervention following a formal (most
often late) description of CP, to one of referral for intervention
which occurs immediately once an infant is considered “at risk” of CP.
VC 2013 Wiley Periodicals, Inc. Dev Disabil Res Rev 2011;17:114–129.
Key words: cerebral palsy; early diagnosis; general movements;
perinatal risk factors; neonatal risk factors; brain injury
INTRODUCTION
G
lobal developmental delay is an umbrella term that
describes two or more delays in the area of speech
and language, social and emotional, cognitive and
motor development. Children with cerebral palsy (CP) often
fall under the umbrella of global developmental delay, but CP
cannot be considered “delay,” as children do not “grow out
of it.” Health professionals need to understand what clinical
features distinguish CP from other motor disorders, so the
most effective interventions can be commenced earlier. The
American Academy of Pediatrics have developed a policy for
the surveillance and screening of developmental disorders
(Council on Children with disabilities et al., 2006), however
this paper focusses specifically on CP. The objectives of this
review are fivefold:
1. Describe the nature of CP and what makes it different to
other motor or learning disorders.
2. Outline the prevalence of CP.
3. Determine who is at high risk of CP, what are the predictors
and early signs?
4. Identify tools that help clinicians to accurately predict CP.
5. Present an evidence based algorithmic approach to recogniz-
ing CP and developing intervention plans.
In the early months of life, global developmental delay
and CP present similarly, if delayed, acquisition of develop-
mental milestones is the only comparator. It is the movement
disorders (e.g., spasticity and dystonia), the level of functional
impairment, and the associated impairments that set CP apart
from other milder motor disorders or learning disorders such
as developmental coordination disorder (DCD). DCD is less
severe and 25 times more common than CP affecting !5–6%
the population and current practice is not to diagnose before
the age of 5. As a result, the diagnosis of CP is often delayed
while the possibility of DCD is explored.
DCD is primarily a learning problem where children
can achieve normal movement patterns and skills but have
problems with learning and planning the movements. CP
conversely is a physical disorder, where children are not able
to achieve the normal movement patterns and the primary
problem is motoric not learning, although deficits in learning
may compound the motor problem.
DCD is used to refer to children who fulfill a certain
criteria; poor motor performance which significantly interferes
with activities of daily living which are not explained by any
medical, neurological, or psychosocial condition. Thus a child
with CP whose motor disability is neurological cannot have a
diagnosis of DCD [Blank et al., 2011]. The physical disability
of CP is life-long whilst DCD is more apparent in the win-
dow where the child is learning key motor skills for example,
catching a ball, dressing independently, and handwriting.
WHAT IS CEREBRAL PALSY?
CP is an umbrella term which “describes a group of dis-
orders of the development of movement and posture, causing
activity limitations, which are attributed to nonprogressive dis-
turbances that occurred in the developing fetal or infant brain.
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The motor disorders of CP are often
accompanied by disturbances of sensa-
tion, cognition, communication,
perception, and/or behavior, and/or by
a seizure disorder” [Bax et al., 2005].
This most recent definition acknowl-
edges the complexity of the condition
and the impact of the associated
impairments.
What are the Fundamental Facts
We Know About Cerebral Palsy?
Classification of cerebral palsy guides inter-
vention decision making
CP is a heterogeneous condition,
and to elucidate prognosis and guide
selection of the most appropriate inter-
ventions (e.g., constraint induced
movement therapy for hemiplegia and
selective dorsal rhizotomy for diplegia)
three major classifications are applied;
motor-type, topography, and function.
Clinicians often remark that a child may
have two or three different descriptions
of their CP within one medical file, evi-
dencing the poor reliability of these
traditional classification systems. Tables
1 and 2 outline the traditional motor
types and topographies of CP and the
proportions of a CP population with
each type. In this paper, we refer to the
Australian Cerebral Palsy Register
(ACPR) when reporting rates and for
international comparisons the Swedish
Register and a study by Reid et al.
[2011a] where registers throughout the
world are compared.
To solve the problem of low inter-
rater (and sometimes intra-rater) reliability
when identifying topographical subtype,
the Surveillance of Cerebral Palsy Europe
[SCPE, 2000] has recommended that tra-
ditional topographies be combined into
two easily definable topographies: Unilat-
eral (one side of the body), Bilateral (both
sides of the body). The ACPR instead
applies a limb by limb coding using the
Australian Spasticity Assessment Scale
(ASAS) [Love, 2007]. The ASAS scores
the muscles’ response to rapid passive
movement without the subjectivity and
wording ambiguities of the modified Tar-
dieu and Ashworth scales [Mutlu et al.,
2008]. Nonspastic motor types are also
coded, resulting in a “stick figure dia-
gram” of motor impairment, which
provides an objective picture of the CP.
Figure 1 presents the CP description
form. The descriptive form is also clini-
cally useful for treatment decision-
making, such as pharmacological options
and contracture management. The ASAS
is currently undergoing further reliability
studies, but it is freely available for
use along with the description of CP
form: http://www.kemh.health.wa.gov.au/
services/register_developmental_anomalies/
documents/CP%20Description%20Form%
20-%20WARDA%20website.pdf.
The gold standard tool for reliably
describing motor function in CP is the
gross motor function classification sys-
tem (GMFCS) [Palisano et al., 1997].
GMFCS provides a common language
that conjures up a “picture” of a child
with CP. GMFCS is a five level classifi-
cation system of gross motor function
in people with CP. The classification is
based on the person’s ability to self ini-
tiate movement with a focus on sitting,
transferring, and mobilizing [Palisano
et al., 1997]. Different classification
descriptions exist at different age
groups. Table 3 summarizes the system
for 2–4-year olds, to coincide with the
most common time of recognition and
the proportion in a CP population with
each level of GMFCS.
It should be noted that whilst the
GMFCS classification can be applied to
infants, about 40% change classification
levels by age 2. After 2 years, the classifi-
cation system is stable and thus GMFCS
reassessment is recommended after age 2
[Gorter et al., 2008]. This is clinically
and diagnostically very important,
because parents are anxious to learn early
about the severity of their child’s condi-
tion for future planning but in reality the
most accurate description of function and
severity can only be given at 2 years.
The presence of associated impairments and
functional limitations affects the child’s
outcome
For many children with CP, it is
not just a physical disability. When
seeking to prognosticate the severity of
Table 1. Classification by Motor Type
ACPRa 1
Reid, 2011a
Spasticty: Overactive muscles that display a velocity-dependent
resistance to stretch. Spasticity can cause secondary
impairments such as loss of muscle length, joint
dislocation and pain.
85 – 91%
Dyskinesia: Dyskinesia is either athetosis or dystonia. Athetoid CP is
hypotonic with hyperkinesia characterized by involun-
tary writhing-stormy movement and can
co-occur with chorea. In contrast, dystonic CP is
hypokinetic, involving involuntary, abnormal twisting
postures or repetitive movements with hypertonia.
Tone is typically fluctuating.
4 – 7%
Ataxia: Ataxia results in tremors with a shaky quality. Ataxic
CP involves a loss of muscular coordination where
movements have abnormal force, rhythm, and accuracy.
4 – 6%
Hypotonia: Pure, generalized hypotonia (decreased muscle tone) is the
least common CP motor-type. Some argue that pure
hypotonia should not even be considered a cerebral palsy
sub-type.
2%
aAustralian Cerebral Palsy Register.
Table 2. Classification by Topography
ACPRa
Hemiplegia: Hemiplegia/monoplegia is the involvement of one side of the
body. The upper limb is usually more affected than the
lower limb. Strong early hand preference or hand disregard
is sometimes the first sign of a problem.
38%
Diplegia: Diplegia is where both the legs are affected and are more
affected than the upper limbs.
36%
Quadriplegia
(Tetraplegia)
Quadriplegia refers to the presence of spasticity in all four
limbs; where the affect on the arms is equal or more than
the legs. Trunk and oro-facial involvement is also to be
expected. In rare cases, one limb is spared and this is
referred to as triplegia.
26%
aAustralian Cerebral Palsy Register.
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CP and determine intervention plans,
assessment of associated impairments
must also occur. The likelihood and se-
verity of associated impairments increase
with the severity of motor impairment
[Himmelmann et al., 2006; Odding
et al., 2006]. Some have reported that
associated impairments impact more on
function and quality of life than the
motor impairment [Himmelmann and
Uvebrant, 2011]. A meta-analysis of CP
registers calculated the overall rates of
associated impairments and functional
limitations in the CP population to be:
three in four are in pain; one in two
have an intellectual disability; one in
three cannot walk; one in three have a
hip displacement; one in four cannot
talk; one in four have epilepsy; one in
four have a behavior disorder; one in
four have bladder control problems; one
in five have a sleep disorder; one in five
dribble; 1 in 10 are blind; 1 in 15 are
tube fed; and 1 in 25 are deaf [Novak
et al., in press]. Many will have a num-
ber of these impairments, and the
presence of these impairments compli-
cates therapy, decreases health status and
quality of life for the individual and
their family, and increases costs for the
family and to society. The associated
impairments of CP will now be dis-
cussed briefly.
Epilepsy. Epilepsy can potentially
severely limit the quality of life for the
person with CP and their family, and
adults with CP and epilepsy are less likely
to find employment [Michelsen et al.,
2005]. Epilepsy occurs in 30% of individ-
uals with CP [Arnaud et al., 2008;
ACPR Group, 2009]. In 2% of individu-
als with CP, their epilepsy will be
resolved by the time they turn 5 years of
age [ACPR Group, 2009]. For those
whose seizures are not resolved, epilepsy
is a lifelong condition. Rates of epilepsy
are higher in those with: spasticity born
at term (48%) compared with preterm
(28%); bilateral CP (34–87%) compared
with unilateral (23%); and those with
intellectual impairment (61%) compared
with no intellectual impairment (19%)
[Carlsson et al., 2003; Wichers et al.,
2005; Himmelmann et al., 2006].
Intellectual impairment. Intellectual
impairment can be defined by low gen-
eral intellectual functioning as measured
by IQ scores, in combination with diffi-
culties with adaptive behavior, all
manifesting before the age of 18. Practi-
cally, this means that people with an
intellectual impairment have memory
deficits, difficulty reasoning, learning
new skills, attending and organizing in-
formation. 50% of individuals with CP
have an intellectual impairment and
between 20 and 30% [Jarvis et al., 2005;
McManus et al., 2006] have a severe in-
tellectual impairment. Formal assessment
of intellect is essential (but at times diffi-
cult) for an individual with CP.
Communication. Communication dis-
ability can have a major impact on the
individual with CP and their family.
Impairment in this domain can impact
on both understanding of language and
expression. For individuals who have
severe communication impairment,
social isolation and poor self-esteem can
result. Between 20 and 30% of people
with CP are nonverbal which means
that systems to support other forms of
communication are required [Arnaud
et al., 2008; ACPR Group, 2009;
Andersen et al., 2010; Parkes et al.,
2010]. They are more likely to be non-
verbal if they are non-ambulatory
(GMFCS IV-V, 57%) compared to
those who are able to walk (GMFCS I-
III, 4%) [Shevell et al., 2009]. Augment-
ative and alternative communication
(AAC) systems, which can range from
low/light technology systems such as
signing or use of alphabet charts to high
technology systems such as speech
generating devices, may be used to
communicate. It is a fundamental
human right to have the opportunity to
communicate; however, high technol-
ogy AAC systems are expensive,
requiring wait listing and for some indi-
viduals will mean that they are unable
to access systems that would support
them to communicate.
Vision. Vision impairments can range
from mild requiring glasses, to func-
tionally blind. About 5–12% of
individuals with CP have a severe
impairment, or are functionally blind
[McManus et al., 2006; ACPR Group,
2009]. Another 30% will have a mild to
moderate vision impairment.
Hearing. Hearing impairments can also
range from a mild impairment to bilat-
eral deafness. Bilateral deafness occurs
in 2% of people with CP while other
hearing impairments occur in a further
10% [Surman et al., 2006; ACPR
Group, 2009]. Assessment of vision and
hearing in children with CP should be
thorough and done early, as it can
impact greatly on their ability to learn
and achieve milestones.
Other. Other impairments strongly
associated with CP are hip dislocation
(8%), displacement (27–35%) [Hagglund
et al., 2005; Soo et al., 2006] and spine
deformities, sleep disorders (23%)
[Newman et al., 2006], pain (70%)
[Jahnsen et al., 2004; Arnaud et al.,
2008], eating (8% tube fed) [Shevell
et al., 2009; Sigurdardottir and Vik,
2011], excessive drooling (22%) [Parkes
et al., 2010], bladder and bowel control
complaints (24%) [Roijen et al., 2001],
and behavior difficulties (26%) [Parkes
et al., 2008]. These less well-understood
impairments are more likely to occur
with bilateral CP and intellectual
impairment.
CP is the most common physical disability
in childhood with prevalence unchanged for
60 years
The overall prevalence of CP is
!0.2% of the population (i.e., 1 in 500)
in developed countries. As can be seen
by a projected age distribution of one
state in Australia (Fig. 2), even though
the injury responsible for CP occurs in
the developing brain, it is a lifelong
condition, with most patients having a
normal life expectancy. In reality, CP is
not just a condition of childhood.
The true incidence of CP cannot
be estimated as there are a proportion of
infants who die in the intrapartum, neo-
natal and infant period, who had brain
lesions that may or may not have met
Table 3. Classification by Gross Motor Function at 2-4 Years
ACPRa
Level I: Floor sits independently, hands-free. Walks without
assistive devices.
32%
Level II: Floor sits independently, hands-free with balance
affected. Walks using an assistive mobility device.
27%
Level III: Floor sits using w-sitting. Walks short distances indoors
using a hand-held mobility device with assistance.
12%
Level IV: Floor sits when placed, uses hands for balance. Rolls,
creeps or crawls for short distances.
14%
Level V: Unable to sit independently. No form of independent
mobility.
15%
aProportion in Australia with each level of GMFCS.
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the criteria for CP. It has been suggested
therefore that the closest rate to inci-
dence (for CP) is prevalence of neonatal
survivors (NNS). Western Australia
(WA) is one register that reports in this
manner, and is also one of the longest
running CP Registers in the world. CP
is mandatorily reported in WA, there-
fore it is assumed that this register has as
close to a total population cohort as is
possible. WA’s CP rates reported in
2006 are 2.78/1,000 NNS increasing to
3.9/1,000 when post-neonatal CP is
taken into account [Blair and Watson,
2006; Watson et al., 2006]. NNS are
important when rates are reported by
gestational age stratum. The lower the
gestational age stratum, the more rates
differ between NNS and live births. It is
particularly important for those at the
youngest gestational ages. When report-
ing rates in the birth years 2005 and
2006 for those born between 20 and 27
weeks in WA, the rate per 1,000 NNS
was 72 (95% CI 32–110) compared to
live births 51 (95% CI 24–79) [Watson,
2012, personal communication]. If neo-
natal deaths are not taken into account,
live births give a misleading lower rate.
In term births (371 weeks), where the
rate of intrapartum/neonatal death is
proportionally much less, the difference
between NNS 1.7 (95% CI 1.4–2.1)
and live births 1.7 (95% CI 1.4–2.0)
becomes inconsequential. Despite this
denominator being the most accurate,
for comparison live births are the most
widely used denominator.
Estimates of prevalence through-
out the world vary depending on the
methodology of “count,” percentage
ascertained and variations in selection
criteria. CP Registers have identified
rates ranging between 1.4 and 2.77/
1,000 live births; surveillance programs
range between 2.1 and 3.6/1,000 live
births; and cross-sectional surveys range
between 1.05 and 4.1/1,000 live births.
The two largest data sets, the ACPR
and the SCPE both have an overall
birth prevalence of 2/1,000 live births.
In developing countries, it is thought
that incidence is higher as the public
health measures that help prevent some
CP cases are not freely available in
developing countries [Blair and Watson,
2006]. All data sets across the world
agree there is a higher proportion of
boys diagnosed with CP. Although CP
is found across all socio-economic
classes, there is a clear association
between low birth weight and low
socio-economic status, and in normal
birth weight ranges, rates of CP are
2.42/1,000 live births for those in the
lowest socio-economic groups, com-
pared to 1.29/1,000 for the most
affluent groups.
The overall rate of 2/1,000 has
been fairly stable over the last 60 years
in contrast to the dramatic falls in peri-
natal mortality rates. However, there
have been some trends in gestational
age stratum, shown in Figure 3. Rates
in the extremely and very low
Figure 1 Cerebral palsy description form. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.].
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gestational groups rose during the
1980s, but are now trending down.
Moderately premature infants’ rates
have decreased slightly, while in term
infants the rates are unchanged [Blair
et al., 2001; Watson et al., 2006].
Because the majority (>73%) of infants
are born over 32 weeks gestational age,
the increases and decreases in the
extremely and very preterm groups
have made little difference to the over-
all rate.
Identification of infants “at-risk of cerebral
palsy” is possible; assessment and screening
should follow
Since there are no identifiable
biomarkers to accurately predict CP,
and clinical risk factors only identify
subpopulations of infants at risk [McA-
dams and Juul, 2011], understanding
the term “causal pathways” is impor-
tant. CP atiologies are described in
terms of causal pathways, as there is
very rarely one specific cause of brain
damage severe enough to cause CP.
Much research has been published that
attempts to discern the risk factors that
lie on one or more causal pathways to
CP. What researchers are beginning to
realize is how little is known about
how these risk factors interact on causal
pathways. Risk factors can be described
according to when they occur or when
they are identified. The following
examples have been identified for CP:
! Prior to conception: Previous gynecolog-
ical history of stillbirths/multiple miscar-
riages/neonatal death/premature birth,
family history of CP and other genetic
predispositions, maternal diagnoses, for
example, intellectual impairment, epi-
lepsy and low socioeconomic status.
! Early pregnancy: Infection, birth defects,
multiple births, male gender, and other
genetic predispositions.
! During pregnancy: Maternal disease, for
example, thyroid disorders, pregnancy
complications, for example, preeclampsia
and bleeds in the second and third trimes-
ter, infection and inflammation,
intrauterine growth restriction (IUGR),
placental abnormalities and other precur-
sors to premature birth.
! Around the time of birth and the neonatal
period: An acute intrapartum hypoxic
event, stroke, seizures, hypoglycemia, jaun-
dice, and infection.
! Postnatal period: Infections, accidental
and nonaccidental injuries, stroke both
spontaneous and following surgery.
The rate of CP in neonatal survi-
vors varies significantly with level of
risk at birth. To describe the risk of
developing CP, infants have been sepa-
rated into three distinct groups shown
in Figure 4: (1) premature infants (30–
40% of all CP); (2) term born infants
who shortly after birth have neonatal
encephalopathy (NE), a clinically
defined syndrome of disordered neona-
tal brain function (15–20% of all CP);
and (3) term born “healthy” infants,
who do not require special care in the
neonatal period (40–50% of all CP) and
do not appear to have identifiable risk
factors at birth [Badawi et al., 2005;
Wu et al., 2006; McIntyre et al., 2011].
Premature infants. When considering
which babies are at risk of CP, preterm
infants commonly come to mind. The
risk of CP increases as gestational age
Figure 2 Estimated number of people living with CP in New South Wales, Australia. [Color figure can be viewed in the online issue, which is avail-
able at wileyonlinelibrary.com.]
Figure 3 Gestational age specific rates/1,000 live births in WA, 1980–2006. [Color figure can
be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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decreases, therefore babies born at 36
weeks’ gestation are at much lower risk
than those born at 24 weeks. As a
result, rates in premature infants range
between 3 and 80/1,000 neonatal survi-
vors, reflecting the wide variation in
levels of risk across premature gesta-
tions. Premature infants constitute up to
40% of infants who develop CP [Kirby
et al., 2011]. So why are premature
infants at increased risk of CP, and
which ones are at the highest risk?
The group of preterm infants can
be separated according to gestational
age, with the first subgroup being
extreme prematurity, generally consid-
ered less than 28 weeks’ gestation.
There is much data in the literature
which depicts the outcomes of
extremely premature infants and much
research has been conducted in this age
group [Hoon and Faria, 2010; Reid
et al., 2011b]. In the 1970s and 1980s,
the frequency of CP in this gestational
age group increased. This was attributed
to the increasing survival of extremely
preterm infants and their predilection to
germinal matrix hemorrhage and peri-
ventricular leukomalacia (PVL) [Stanley
and Watson, 1992; Hagberg et al.,
1996]. Evidence from population-based
samples in Europe, Australia and the
United States, and analyses from CP
Registers in Australia and Europe
describing trends in prevalence, sub-
types, and severity, suggest that this rise
in frequency of CP in extremely pre-
term infants has reached its peak and is
now decreasing [SCPE, 2000; Reid
et al., 2011b; Watson, 2012, personal
communication]. Up to 10% of
extremely preterm infants (variations in
reports exist from as low as 3–10%) and
up to 5% of infants between 28 and 31
weeks gestation will be described as
having CP [Himpens et al., 2008; Wat-
son, 2012, personal communication].
Practice point. Mothers whose labor is
imminent (and prior to 30 weeks gesta-
tion) should now be offered magnesium
sulphate for neuroprotection of their
child. Meta analyses have shown that
CP can be reduced by 30% for infants
under 30 weeks gestation [Crowther
et al., 2002].
CP Registers in Europe report
that this trend for decreasing rates con-
tinues into the group of late preterm
infants (32–36 weeks’ gestation or
1,500–2,499 g) [Andersen et al., 2011].
The overall prevalence of CP in these
children had dropped from 12.2 per
1,000 live births in 1983 to 4.5 per
1,000 in 1997. There is conflicting evi-
dence in Australia, with the rate being
maintained at between 5 and 7/1,000
live births since the early 1980s [Wat-
son et al., 2006].
Cerebral lesions in particular
PVL, intraventricular hemorrhage
(IVH) and intracranial hemorrhage
(ICH) grade III and IV, are the most
important predictors of CP in very pre-
term infants [Tran et al., 2005; Beaino
et al., 2010; Himpens et al., 2010]. In
particular, PVL lesions in the corona
radiata above the posterior limb of the
internal capsule (PLIC) observed in cor-
onal sections have been used to
accurately predict motor prognosis
[Nanba et al., 2007]. The presence of
lesions in this region was highly predic-
tive of CP (GMFCS 1 or higher) with
sensitivity 100% and specificity 97%. A
study by Himpens et al. [2010] that
investigated the predictive value of
ultrasound in brain injury found that
deep grey matter lesions are a signifi-
cant predictor for severe versus mild
and moderate CP (OR 5 6), and that
cerebral infarction and hemorrhage
grade IV are strong predictors of unilat-
eral spastic CP versus bilateral spastic
CP (OR 5 49 and 24, respectively, P
< 0.001).
Recently, there has been increas-
ing interest in and evidence regarding
the possible effects of intrauterine infec-
tion or inflammation early in the
postnatal course, leading to CP. Carlo
et al. [2011] recently argued that a late
prenatal and/or early neonatal exposure
to inflammation may predispose infants
to neurodevelopmental impairment.
Wu and Colford [2000] also found that
clinical chorioamnionitis was associated
with an increase in CP in preterm
infants (OR 5 1.9) and term infants
(OR 5 4.7).
Transient hypothyroxinaemia,
bronchopulmonary dysplasia (BPD),
and necrotizing enterocolitis have also
been associated with premature birth
and a later description of CP. A recent
study of 1,047 preterm infants (<28
weeks) demonstrated that while all
infants with BPD had a higher risk of
CP those who were mechanically ven-
tilated until 36 weeks PMA had at least
a fourfold increased risk of CP [Van
Marter et al., 2011]. In addition, pre-
term infants who have had surgery to
repair a patent ductus arteriosus, or
who required home oxygen have also
been identified as at increased risk of
CP [Tran et al., 2005].
Practice point. Infants born premature
are at high risk of CP if they have
abnormal cerebral imaging and a more
complex course. These infants should
receive a general movements (GM)
assessment before term equivalent age,
and be referred to active surveillance
and early intervention when they leave
the hospital. (see Pathway A Figure 5,
to be discussed in the following
section).
Term infants with and without neonatal
encephalopathy
The overall rate of CP for term
infants has been consistently 1.4–1.7/
1,000 live births over the past 30 years
[Watson et al., 2006; Himmelmann
et al., 2010]. Multiple births born at
term are at four times the risk of CP
than singletons born at term. The risk
rises again for surviving twins after the
death of a cotwin [Pharoah, 2006].
Risk factors associated with the devel-
opment of CP in the term population
also include congenital malformations,
maternal age over 35 years, chorioam-
nionitis, preeclampsia, placental
abnormalities, meconium aspiration
syndrome, IUGR, transient metabolic
abnormalities, respiratory distress syn-
drome, neonatal infections and seizures.
[Shankaran, 2008; McIntyre et al.,
2012]. One of the most well known
risk factors for term-born infants is NE.
The second piece of the pie (Fig.
4), with a well-recognized predilection
to develop CP are term or near term
infants with NE. For term born infants
with NE, the rate of CP is between
100 and 125/1,000 neonatal survivors,
and those born with severe NE are at
the highest risk of CP of all infants.
Infants with moderate to severe (Sarnat
Stage 2 or 3) NE account for one in
four cases of term CP [Badawi et al.,
2005]. Kurinczuk et al. [2010] report
an incidence of NE between 2.5 and
3.5 per 1,000 live births and that !30%
of cases in developed countries are asso-
ciated with evidence of an acute
intrapartum hypoxic event. These
include sentinel birth events that are
also rare but important risk factors for
CP in term infants, such as placental
abruption, cord prolapse, severe intra-
partum hemorrhage, severe shoulder
dystocia, and a tight nuchal cord. It is
estimated that up to 8% of CP is attrib-
utable to an acute intrapartum event
with moderate to severe NE [Blair and
Stanley, 1997].
Practice point. Infants with moderate to
severe NE following an acute intrapar-
tum event benefit from hypothermia.
This intervention prevents CP in one
out of eight of those treated [Jacobs and
Tarnow-Mordi, 2010]. A number of
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adjuvant therapies to help those that do
not respond to cooling alone are cur-
rently in animal model and phase 1
neonatal studies, for example, erythro-
poietin, melatonin, xenon, and
topiramate [Gonzalez and Ferriero,
2009].
In term infants with moderate to
severe NE, imaging showing basal gan-
glia/thalamus injury has a positive
predictive value for CP of 88% [de
Vries et al., 2011]. In a study of 173
term infants with NE, the basal ganglia/
thalamus pattern of injury was associ-
ated with the most severe motor and
cognitive outcomes at 30 months
[Miller et al., 2005].
Practice point. Term infants with mod-
erate to severe NE and a basal ganglia/
thalamus injury should be automatically
described as “At high risk,” and go
straight to Pathway B (Figure 5). They
should receive a GMs Assessment, be
referred to active surveillance and early
intervention when they leave the
hospital.
The remaining infants with NE
that go on to be described as having
CP have antenatal risks such as IUGR,
intrauterine infection, metabolic abnor-
malities, syndromes, and birth defects
[Badawi et al., 1998; Kurinczuk et al.,
2010]. Perinatal arterial stroke occurs in
!1.7/100,000 live births. In the new-
born period, it can also result in NE,
but the majority of these infants present
after the immediate neonatal period
with seizures or hemiparesis. Mothers
with preeclampsia and infants who have
IUGR are at risk of perinatal arterial
stroke [Shankaran, 2008]. Stroke with
abnormalities involving the cerebral
peduncle are also highly predictive of
CP PPV 78% [de Vries et al., 2011].
Practice point. Infants with a cerebral
birth defect, or stroke with involvement
of the cerebral peduncle should be
identified as “at risk” of CP and should
join Pathway B (Figure 5) at
“assessment for CP.”
The risk of developing CP in term
infants who have received routine care at
birth, the third group of infants who go
on to develop CP, is !1/1,000 neonatal
survivors and these infants are at the low-
est risk. However, they represent 45% of
all infants with CP and numerically com-
prise the largest group (Fig. 4). Why do
these apparently “neurologically normal”
children at birth develop CP, and can we
identify them earlier so they can have
access to active surveillance and early
intervention?
From a total population case con-
trol study in Western Australia,
McIntyre et al. [2011] compared the
clinical descriptions of 295 term infants
with CP with 442 term control infants
none of which required special care.
They identified six independent predic-
tors of CP in the neonatal period:
abnormal fontanelle OR 4.4 (95% CI
0.8–23); abnormal tone OR 7.3 (95%
CI 2–26.8); birth defects identifiable in
the newborn period OR 5.2 (95% CI
2.4–10); ventilatory assistance restricted
to the labor room only OR 2.9 (95%
CI 2.2–12); abnormal consciousness
referred to irritability and lethargy, but
none were comatosed OR 3.7 (95% CI
2–7); and in the small group with
abnormal temperature regulation tem-
perature was down or fluctuating, not
high OR 4.1 (95% CI 1.2–14). A num-
ber of these predictors are reminiscent
of criteria for mild NE, and the pres-
ence of two or more of these factors
yielded a high specificity (99%), but
low sensitivity (14%) for CP. This is
not surprising considering the unknown
etiology of this group of infants. Of this
low risk group who had CP, 58% did
not have any of these neonatal factors,
yet 60% of these infants had moderate
to severe CP.
This is not the first time a finding
like this has been reported. The
National Collaborative Perinatal Project
reported that most children with CP
did not derive from groups at high risk
(low Apgar scores, or the presence of
neonatal signs). About 43% were exam-
ined and classified as “neurologically
normal” in the neonatal period and
concluded that a large proportion of
CP cases remain unexplained [Nelson
and Ellenberg, 1986; Ellenberg and
Nelson, 1988]. Earlier still, in 1970,
Eva Alberman attempted to model
what were at that time the three most
important risks around birth: (1) parity
>4; (2) abnormal method of delivery—
breech, face or shoulder delivery, inter-
nal version, or delivery by an untrained
person; and (3) neonatal illness in the
1st week of life—convulsions, cyanotic
attacks, cerebral signs, hypothermia,
jaundice, Rh incompatibility, or serious
illness. Infants were at the highest risk
of disability when all three of these risks
were apparent. They were only a small
group (0.1% of total births), but more
importantly only 0.2% of those with a
disability. When any combination of
these three risks were used, 13.2% of all
live births were classified as at risk, and
this identified 26.3% of all those with a
disability. A striking finding was that
74% of all those with CP, severe mental
handicap, hearing, and sight impair-
ments could not be identified using this
model.
Very little has changed for those
born at term without any noticeable signs
during the neonatal period since the first
studies of these cohorts in the 1950s. For
these infants, failure to reach major
motor milestones, such as rolling, sitting
or standing, have often been the catalyst
for the commencement of developmen-
tal assessments and interventions. Given
that the window for milestone attain-
ment in typically developing children is
quite broad [WHO Multicenter Growth
Reference Study Group, 2006], this usu-
ally leads to a “wait and see” approach
where infants receive no intervention
during their period of rapid neural devel-
opment. In view of the fact that every
second child with CP will be born at
term and requires no special care in the
neonatal period, it is imperative that
frontline health professionals such as
pediatricians, general practitioners and
allied health practitioners have a best
practice pathway to follow when a parent
Figure 4 Rate of CP in NeoNatal Survivors. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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presents with a child who falls into this
category.
Practice point. When parents bring
their term born child (3 months to 3
years of age) that did not require special
care when born to a health professional
with concerns regarding motor devel-
opment or abnormal posturing they
should go straight to Pathway B at
“screen for CP.” We propose that a
tiered approach as developed by Rose-
nbaum et al. [2009] should be adopted.
They recommend using the ages and
stages questionnaire 1 three extra ques-
tions for parents. Consideration should
also be given to risk factors during
pregnancy and signs of mild NE in the
neonatal period. When an abnormal
result is derived, Pathway B (Figure 5)
should be followed to “assessment for
CP” through standardized motor
assessments.
The description of cerebral palsy is tradition-
ally given late but can be given earlier
This review is timely as “it is
now universally accepted that the ear-
liest possible diagnosis and treatment (of
CP) are essential to prevent, or at least
minimize, the handicapping effects of a
disability and to make the most of the
assets a child possesses” [Alberman and
Goldstein, 1970]. Yet, paradoxically, 40
years later families are not automatically
receiving early intervention while they
“wait and see” whether their child will
“catch up” from simply a slower motor
developmental trajectory or if their
child actually has CP or DCD or an in-
tellectual impairment with associated
motor difficulties.
Figure 5 Recommended assessment for identification of infants at risk of CP.
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CP registers indicate the average
age for a description of CP to be given
is 19 months, but the range is wide.
For those with severe motor impair-
ment the description of CP can be
given as early as 1 week but may take
up to 3 years, and less surprisingly for
those with mild or moderate motor
impairment the description of CP is
given anywhere between 1 week and 5
years of age [Watson et al., 2006]. The
burgeoning body of recent neuroplas-
ticity literature suggests that intensive,
repetitive, task-specific intervention for
CP ought to commence very early
while the brain is most plastic (i.e., in
the first 2 years of life), which is almost
never the case when the family is taking
part in “wait and see” monitoring prior
to description.
Good evidence shows that earlier
detection of CP is both possible and
accurate and, more importantly, diag-
nostic-specific early intervention is
therefore possible. Rather than waiting
for a formal description of CP to be
given, infants should be identified as “at
high risk of CP” when they are high
risk, and therefore commence diagnos-
tic-specific early intervention straight
away. For those who are not at high
risk but have early signs, they should be
regularly comprehensively assessed to
ensure access to the most appropriate
early intervention.
Why is Cerebral Palsy Missed and
Why is the Description so Difficult
for Doctors to Make?
Health professionals hesitate to use
the terminology CP early for a number
of reasons, but importantly the condition
is not a diagnosis; it is a “clinical
description.” There are no biological
markers or definitive tests for CP. The
Figure 5 (Continued)
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term does not infer etiology, and it has
no prognostic value as severity and asso-
ciated impairments are incredibly
variable. However, 86% of parents know
something is wrong with their child
before a description of CP is given [Baird
et al., 2000]. Leading up to this point in
time, most parents experience being told
by their medical team that the plan is to
“wait and see.” When health professio-
nals use the term “wait and see,” the
intention is to use this time to rule out
other diagnoses, delay the delivery of
bad news or provide time for the child
to grow out of it.
Rule out other diagnoses
Doctors first rule out other diag-
noses that may explain the symptoms.
This is an important step as there are
other conditions that mimic the early
signs of CP which can have important
treatment implications, such as: neuro-
degenerative conditions (e.g., Ataxia
Telangiectasia); metabolic syndromes
(e.g., Glutaric acidemia); and genetic
conditions (e.g., Trisomy 18, Angelman
Syndrome, Cornelia de Lange syn-
drome) [Badawi et al., 1998].
Delay the delivery of bad news
Doctors sometimes delay the
delivery of bad news while exploring
the possibility of a less severe, more
common disorder such as DCD. Differ-
ential diagnosis is critical as it informs
the selection of intervention strategies
suited to the specific condition. For
example, effective intervention for
Figure 5 (Continued)
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DCD involves cognitive approaches
best suited to school-aged children,
whereas CP intervention uses a variety
of pharmacological, motor, social and
cognitive intervention approaches that
can commence early in life. It is there-
fore important that children with CP
are differentiated earlier in order to get
the right interventions early.
Provide opportunity to grow out of it
Doctors sometimes delay the
delivery of bad news to provide enough
time for the possibility that the child
may “grow out of it.” However for
those few whose motor signs resolve,
commonly they transpire to have an in-
tellectual impairment or behavioral
problems [Nelson and Ellenberg, 1981].
The brain injury responsible for
CP may be suspected or even con-
firmed in the neonatal period, but the
diagnosis for many does not occur until
the motor impairments and activity lim-
itations inherent in the definition are
observable. This lag time is not useful
to families or to the child.
“. . .. . .I am very worried about my
son, he is 5 months old, and over the last
month I have noticed he seems to go
into strange positions, I especially notice
it each time I pick him up. I went to the
GP, who agreed and thought I should
see a pediatrician. I went to the pediatri-
cian who agreed they were unusual and
said let us see how he is when he is 10
months old. That is too long to wait! So I
went to another pediatrician who agreed
again, it was abnormal, so now I am
booked to go to a physiotherapist for fur-
ther tests, and after that they will decide
what to do” but I do not know what to
do now. . .” (Personal communication,
February 4, 2012, parent discussion with
first author over the phone).
System barriers to description are
also potentially at work. For example,
for any mother and her newborn,
obstetricians hold vital information
about maternal-fetal health. If the baby
is premature or ill, care is immediately
transferred to neonatal specialists, where
the primary patient is now the infant,
not the mother, and some of the rele-
vant preconception and pregnancy
history about risk factors for CP may
not be passed on. When the infant is
well and discharged from hospital, care
is likely to be transferred to a commu-
nity based general practitioner or
pediatrician who may lack access to the
relevant maternal-fetal and/or neonatal
medical history. The pediatrician may
then be assessing a healthy baby that
may just appear slightly “delayed,” and
it is not until later in infancy that the
gravity of the problem may be evident,
precipitating a late diagnosis.
What are the Most Important
Things that can be Done in Clinical
Practice to Describe Cerebral Palsy
Earlier?
We propose a new clinical path-
way that is designed to circumvent the
existing screening and diagnostic barriers
by tying together the relevant evidence
needed to make an earlier diagnosis and
commence earlier intervention (see
Pathways A and B). These pathways
have been developed using GRADE
level evidence [Guyatt et al., 2008] and
“traffic lights” to signify the effective-
ness of the interventions [Novak and
McIntyre, 2010]. Green equals “go,”
(high quality evidence to support
the use of the intervention, therefore
use this approach). Yellow equals
“measure” (low quality or conflicting
evidence supporting the effectiveness of
the intervention). Red equals “stop”
(high quality evidence indicating inef-
fective interventions) [Novak and
McIntyre, 2010].
The serious nature of these stand-
ard care limitations has led us to
conclude that “waiting and seeing” is
potentially harmful to children with CP
and their families. We therefore have
identified solutions to three of the
major problems relating to the late di-
agnosis of CP, which are timely and
possible for the health system to redress:
New clinical diagnostic and intervention
pathways
When the system fails to recog-
nize a child with CP very early due to
using the “wait and see” monitoring
mode, this decision essentially ensures
that infants receive limited or no diag-
nostic-specific intervention within the
critical window of brain development.
The window of brain development,
where the brain is actively sprouting
and pruning in response to activity, is
often misspent in children with CP. In
Pathways A and B, we review the evi-
dence for early intervention possibilities
in CP. The evidence tells us quite
clearly that general early intervention
and parent interventions, designed to
enhance in-home care characterized by
positive interactions, categorically
improve a child’s cognition with the
Figure 6
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best effect seen in children of low
socio-economic status. However, more
recent neuroplasticity evidence suggests
that a skill-based, high-intensity practice
approach to early intervention is
required to impact on motor outcomes,
as is the case in most adult brain inju-
ries. These newer types of motor
learning approaches, which are effective
in older children with CP, require
urgent study within the CP infant pop-
ulation. It is therefore the responsibility
of the health professional who observes
major risk factors or a motor delay to
investigate further, diagnose “at risk of
CP” early, and refer to early interven-
tion at a minimum to optimize their
cognitive function. We outline a way
to do this via systematic use of risk fac-
tor history taking, neurobehavioral
predictive tools, in addition to MRI
(Pathways A and B).
Promotion of a climate for new research that
will improve outcomes
Late description of CP is creating
a major problem for recruitment of
infants to promising early rehabilitative
and potentially curative studies. Lack of
diagnosis is impeding the advancement
of regenerative medicine, early inter-
vention and other well-recognized
treatments for CP yet to be tested in
the earlier years, for example, medical
interventions for tone management,
reflux, and epilepsy. When a health
professional identifies an infant at high
risk for CP, coupled with referral to
early intervention trials, it will help to
accelerate future discoveries for these
children and change the landscape of
the diagnosis and prognosis.
Promotion of good family mental health and
resilience for the long-term
If late description is not helping
infants or research, are we helping
parents by sheltering them from bad
news? A population study conducted in
Britain found that parental dissatisfac-
tion with delayed diagnosis of CP is
associated with higher rates of parental
depression [Baird et al., 2000]. So it
would appear that sparing parents from
bad news is unhelpful. Therefore early
recognition and provision of early pre-
ventative mental health support for
families may help parents manage the
inevitable stress, which could help
improve family outcomes long-term.
The concept of “at risk” is not a
new one. During the 1960s in the
United Kingdom, there were “at risk”
registers, with the usual accompanying
debate over their value and cost effec-
tiveness. It was deemed not practicable
to have universal screening of all chil-
dren, but it was felt essential that all
children at risk be monitored. In a letter
to the Lancet in 1967 defending the
concept, Dr Ronald Mac Keith and col-
leagues wrote, “by the criterion of
identifying handicaps which are in some
cases undoubtedly, and in other cases
probably, benefited by having treatment
started without delay, developmental
and neurological assessment from the
age of 5 months is neither difficult nor
inefficient” [Mac Keith et al., 1967].
The concept itself was deemed by most
to be a sound one. The problem at this
time was the “at risk” criteria used was
identifying up to 60% of all live births
in an area. The goal of these programs
was to screen 10–20% of all births to
identify the majority of the invisible
handicaps that is, those that would oth-
erwise not be identified until the 4th
and 5th years of life. We recommend
that the “wait and see” period is
reframed to the “wait and be” period,
where children are diagnosed “at risk of
CP” early and are immediately referred
to diagnostic-specific early intervention.
What Tools can be Used to
Accurately Predict and Identify
Early Signs of Cerebral Palsy?
Imaging
Practice point. All children with a pre-
sumed or suspected brain injury should
have magnetic resonance imaging (MRI).
Neuroimaging is used as an inte-
gral part of the diagnostic process
[Krageloh-Mann and Horber, 2007].
MRI is the gold-standard neuroimaging
technique for elucidating the pathoge-
nesis of CP: white matter damage of
immaturity (WMDI) including PVL,
lesions of the deep grey matter, malfor-
mations, focal infarcts, and cortical and
subcortical lesions [Bax et al., 2006].
Cranial ultrasound (CUS) is a safe and
inexpensive alternative used in the neo-
natal intensive care unit (NICU) to
detect structural changes in the new-
born brain. However, MRI has higher
sensitivity and specificity than CUS as a
predictor of CP in very low birth
weight (VLBW) infants [Mirmiran
et al., 2004]. Despite strong correlations
between clinical findings and MRI, 12–
14% of children with CP will have nor-
mal MRIs [Bax, 2006; Krageloh-Mann
and Horber, 2007] and therefore MRI
should not be used in isolation for mak-
ing the description of CP.
Newer techniques and technolo-
gies are being developed which are
likely to advance the role of imaging in
the diagnostic process and treatment
selection process. Advanced neuroimag-
ing techniques such as diffusion
weighted imaging (DWI) and diffusion
tensor imaging (DTI) have been uti-
lized to more specifically identify
diffuse or subtle white matter injuries
[Hoon and Faria, 2010]. Magnetic reso-
nance spectroscopy (MRS), provides
measures of brain biochemistry and is
proving an effective tool in understand-
ing prognosis in NE and preterm
infants [Ancora et al., 2010; Van Kooij
et al., 2012]. Large deformation diffeo-
morphic metric mapping (LDDMM),
where a 3D atlas of the brain is pro-
duced, shows great promise for
illuminating the structural brain abnor-
malities that occur in CP with the
potential for informing selection,
design, and measurement of rehabilita-
tion interventions [Faria et al., 2011].
General neuromotor and developmental
assessments
Many neuromotor and develop-
mental assessments with sound
psychometric properties exist for infants
and young children. For diagnostic pur-
poses, tools with predictive properties
are the most worthwhile. However,
there has been a historical preference by
pediatricians and neonatal follow-up
teams to use discriminative tools that
assess a combination of: abnormal mus-
cle tone of the trunk and extremities;
the presence of primitive reflexes; the
quality and quantity of voluntary move-
ment (e.g., milestone acquisition); and
the presence of involuntary movement.
The problem with this persistent prac-
tice is that these tools are only useful
for discriminating between infants who
are developing typically from those
who are not. Determining who is typi-
cally developing and who is not is even
more complicated in premature infants
because they have their own develop-
mental trajectory [Heineman and
Hadders-Algra, 2008; Spittle et al.,
2008a]. Routinely used neuro observa-
tions and standardized developmental
tests were not designed to specifically
detect the presence of CP and thus fur-
ther compound the complexity of the
CP diagnostic process. They may be
helpful to some diagnosticians but will
lack adequate specificity for most.
Ideally the aim of monitoring
ought to be to differentiate why some
children are not developing normally,
to enable diagnostic-appropriate best-
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available evidence-based intervention to
be provided. This paper will now focus
on the evidence for the best available
tools for predicting and recognizing
CP, distinct from tools better suited to
suspecting global developmental delay
(GDD). Clinometric reviews indicate
that different tools need to be used at
different ages to describe and detect CP
and that a combination of tools is best
practice [Heineman and Hadders-Algra,
2008; Spittle et al., 2008a].
Practice point. A combination of risk
factor history taking, neurological ex-
amination that includes assessment of
quality of movement, volitional move-
ment and neuroimaging are required. A
health professional with clinical exper-
tise and experience in motor
development should interpret and eval-
uate the findings generated by these
assessments (Figure 6).
Tools predictive of cerebral palsy
Qualitative assessment of general movements
[Einspieler et al., 2004)]. Of all the
tools available to predict CP, GMs is
consistently the most predictive, with
specificity and sensitivity rates higher
than MRI [Burger and Louw, 2009].
The GMs assessment measures the qual-
ity of spontaneous movements with the
infant lying supine. Scoring is done by
trained assessors via observation of
video footage and can be used from the
preterm period until 20 weeks post
term age (PTA). Two distinct time
periods for assessment exist; the writh-
ing period (up to 9 weeks PTA) and
the fidgety period (from 9 to 20 weeks
PTA). In both periods, the infant is
scored with “normal” or “abnormal”
GMs. Abnormal GMs are then further
classified. In the writhing period,
abnormal GMs known as “cramped
synchronized” have been shown to be
highly predictive of CP (sensitivity
5100%; specificity 5 40%; PPV59.4%;
NPV5 100% [Spittle et al., 2009]. If
the abnormal GM of “cramped syn-
chronized” is followed by the abnormal
GM “absent fidgety” (in the fidgety pe-
riod) this has consistently shown the
highest predictive value for CP (Darsa-
klis and Snider, 2011).
A recent systematic review of 17
studies demonstrated the accuracy of
the GMs assessment in predicting neu-
rodevelopmental outcomes in infants up
to 2 years with a sensitivity !92% and
specificity !82% [Burger, 2009]. The
GMs assessment has been found to be
superior to ultrasound findings in pre-
dicting CP [Einspieler et al., 2004]
When correlated with MRI findings,
namely white matter injury, the GMs
assessment (specifically “absent fidgety”)
has been shown to accurately predict
CP 100% of the time in very preterm
infants [Spittle et al., 2008a] Evidence
of the predictive value of GMs in full
term infants with hypoxic ischemic
encephalopathy (HIE) has also been
demonstrated [Prechtl et al., 1993].
Importantly, the GMs assessment has
good clinical utility because it is quick,
inexpensive, and noninvasive. Rater
training is provided by the GMs trust.
Hammersmith infant neurological assessment
[Haataja et al., 1999]. The Hammer-
smith assessment is based on the
Dubowitz and Dubowitz [1981] assess-
ment of the newborn and is a simple
method of examining infants between 2
and 24 months of age. There are three
parts to the examination: neurologic
signs, developmental milestones, and
behavior. In the first section, the neu-
rologic exam, an optimality score is
obtained from the assessment of cranial
nerve function, posture, quality and
quantity of movement, tone, and
reflexes and reactions. The second and
third sections do not form part of the
overall score but give important addi-
tional information regarding
developmental progress. Recent studies
have demonstrated the predictive value
of the Hammersmith infant neurological
assessment (HINE) for CP. A large
study [Pizzardi et al., 2008] of 658
infants who were either preterm or
term with NE were prospectively stud-
ied from birth until 12 months
corrected age. ROC curve analysis was
used to test the predictive power of the
HINE. Global HINE scores showed
high prediction of CP at all ages (ROC
curve areas above 0.9), but most impor-
tantly movement quality and quantity
test items had even higher predictive
power.
A retrospective study of 70 infants
diagnosed at 2 years with CP observed
a strong (r 5 282) negative correlation
between HINE scores at 3–6 months of
age and levels of GMFCS [Romeo
et al., 2008a]. Infants in GMFCS levels
3–5 scored below 40, whereas those in
levels 1–2 scored between 40 and 60.
Combined use of the HINE and GMs
at 3 months PTA can be used to
describe an infant as at “high risk” of
CP [Romeo et al., 2008b].
Practice point. Routine follow-up for
preterm and sick infants should be
scheduled at three-months and six-
months corrected, not the conventional
four-months, to enable medical teams
to use the best predictive tools to help
make the description of CP earlier.
Practice point. When examining infants,
do not discount CP when spasticity or
dyskinesia is not identified. A period of
time lapses between the original damage
to the developing brain, whether in
utero or during early infancy/child-
hood, and the appearance of
impairments. It is well known that the
brain, which begins development in
utero, continues to develop during
childhood. Thus a child’s neural devel-
opment is “age-specific,” so brain
dysfunction will manifest according to
the brain’s development at that age
[Hadders-Algra, 2004]. Compared with
a mature brain which responds to injury
with specific and localized signs, a
young infant may present with general-
ized and nonspecific signs (e.g.,
hypotonia) [Kuban and Leviton, 1994;
Hadders-Algra, 2004]. It is proposed
that further brain development in an
infant, including myelination of axons
and maturation of basal ganglia neurons,
must occur before spasticity and dyski-
nesia can manifest [Kuban and Leviton,
1994]. The infant with hypotonia may
thus “develop” spasticity and dyskinesia
by the age of 1 or 2 years, as the com-
plexity of neural functions increases
[Kuban and Leviton, 1994; Hadders-
Algra, 2004].
Movement assessment of infants [Chandler
et al., 1980]. The movement assess-
ment of infants (MAI) is a criterion-
referenced scale that evaluates neuro-
motor dysfunction in high risk infants
at 4, 6, 8, and 12 months of age. The
assessment is carried out by a therapist
and takes 30–60 min to complete,
requiring a manual but no specialized
equipment. The MAI assesses tone,
primitive reflexes, equilibrium reactions,
and volitional movement. The test has
been shown to be twice as sensitive as
the Bayley scales of infant development
in detecting early signs of CP [Harris,
1987]. Studies of predictive values at 4
and 8 months of age report sensitivity
rates ranging from 73.5 to 96.0 and
specificity of 62.7–78.2 [Spittle et al.,
2008b]. A recent investigation of the
predictive validity of the MAI at 6
months of age demonstrated a signifi-
cant correlation between MAI scores
and Bayley scales of infant development
at 12 months, although sensitivity and
specificity for CP were not reported
[Metgud et al., 2011].
Other useful assessments. Several other
neuromotor assessments, such as the test
126 DEV DISABIL RES REV " CEREBRAL PALSY—DON’T DELAY "MCINTYRE ET AL
of infant motor performance (TIMP)
[Campbell, 2005], The neuro-sensory
motor development assessment
(NSMDA) [Burns et al., 1989], and the
Alberta infant motor scale (AIMS)
[Piper and Darrah, 1994], are appropri-
ately used to discriminate infants with
abnormal motor function from those
typically developing. All have sound
psychometrics. Of these tools, the
TIMP has been shown to be sensitive
to change in response to intervention
[Campbell et al., 1995].
Assessment summary.
! High risk infants should be routinely
assessed using the GMs preferably three
times; during early admission, around
term corrected (if preterm) and at 9–14
weeks (corrected for gestational age).
! “High risk of CP” designation should
be given to infants at 9–14 weeks (cor-
rected) with a combination of absent
fidgety GMs and white matter injury
on MRI.
! After 20 weeks (corrected), use the
HINE or MAI.
! MRI is the best imaging tool to eluci-
date the pathogenesis of CP and should
be offered to all infants who have
abnormal findings.
! Use the CP description form to
describe motor type and severity to
inform intervention planning.
CONCLUSION
Until recently, CP was considered
unpreventable, incurable, and almost
untreatable. However, preventive efforts
including: rubella vaccination, iodine
supplementation in areas of severe iron
deficiency, anti-D vaccination, prevent-
ing methyl–mercury contamination,
reducing the number of embryos trans-
ferred in invitro fertilization (IVF) (in
Australia), and enforcing laws for seat
belts and fencing around swimming
pools have been successful prevention
strategies. Recently, magnesium sulfate
and hypothermic intervention have also
started to prevent a small proportion of
CP. Both of these interventions occur
very early and require health professio-
nals to be mindful of CP as a potential
outcome that could be prevented or
cured. With advances in medical, public
health, and allied health research, the
likelihood of further breakthroughs are
probable.
Further research is required to
determine why infants born at term, not
at “high risk” of CP in the newborn pe-
riod go on to develop CP. Health
professionals need to be aware that 45%
of all CP falls into this category. There-
fore we recommend prompt response to
parental concerns with screening and
assessments as outlined, followed by im-
mediate referral for intervention for
those infants then considered “at risk.”
Premature and term infants with
brain injury identified on MRI are at
high risk of CP. We have identified
pathways which make recognizing “at
high risk” of CP easier for health pro-
fessionals. We propose a change in
diagnostic practice, a shift away from
referral for intervention following a for-
mal (most often late) description to one
of referral when an infant is “at high
risk” of CP. This will provide the op-
portunity for targeted research in early
intervention, thus providing optimal
outcomes for children with CP.
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Early intervention (EI) has been espoused as the standard of care for children 
at high risk of neurodevelopmental disability since the 1990s with the 
introduction of the “Individuals with Disabilities Education Improvement 
Act (IDEA)” in the USA. The aims of EI are broad and are based on the 
principles of neuroscience, which highlight the importance of intervening in 
the early years to optimise neuroplasticity mechanisms. For infants with 
brain lesions, the role of experience - dependent plasticity is significant.  
 
This paper explores the effect of a known “active ingredient” for recovery in 
animal studies – environmental enrichment. The evidence for the effect of 
environmental enrichment in programmes designed for infants and very 
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studies combined to demonstrate a small positive effect of environmentally 
enriching interventions on infant motor outcomes.  
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Enriched Environments and Motor Outcomes in
Cerebral Palsy: Systematic Review and Meta-analysis
abstract
BACKGROUND AND OBJECTIVES: Neuroplasticity evidence from ani-
mals favors an early enriched environment for promoting optimal
brain injury recovery. In infants, systematic reviews show environ-
mental enrichment (EE) improves cognitive outcomes but the effect
on motor skills is less understood. The objective of this review was to
appraise the effectiveness evidence about EE for improving the motor
outcomes of infants at high risk of cerebral palsy (CP).
METHODS: A systematic review was conducted. Cochrane Central Reg-
ister of Controlled Trials (PubMed), Cumulative Index to Nursing and
Allied Health Literature, Education Resource Information Center, SocINDEX,
and PsycINFO databases were searched for literature meeting inclu-
sion criteria: randomized controlled trials; high risk of /diagnosis of
CP; .25% participants #2 years; parent or infant interventions post-
discharge; and motor outcomes reported. Data were extracted using
the Cochrane protocol regarding participants, intervention character-
istics, and outcomes. Methodological quality was assessed using risk
of bias assessment and GRADE.
RESULTS: A total of 226 studies were identiﬁed. After removing dupli-
cates and unrelated studies, 16 full-text articles were reviewed, of
which 7 studies met inclusion criteria. The risk of bias varied
between studies with the more recent studies demonstrating the
lowest risk. Enrichment interventions varied in type and focus,
making comparisons difﬁcult. A meta-analysis was conducted of
studies that compared enrichment to standard care (n = 5), and
totaled 150 infants. A small positive effect for enrichment was
found; standardized mean difference 0.39 (95% conﬁdence interval
0.05–0.72; I2 = 3%; P = .02)
CONCLUSIONS: EE looks promising for CP, and therefore high-quality
studies with well-deﬁned EE strategies are urgently required.
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Children with cerebral palsy (CP) reach
∼90% of their gross motor potential by
age 5 and even younger for the more
severely impaired,1 so effective inter-
ventions for optimizing early motor
development are vital. As with typically
developing children, the ﬁrst 2 years
are critically important for cognitive
and motor development2 because the
brain is experiencing continuous
spontaneous plasticity. Pediatricians,
who are responsible for making the
diagnosis of CP and referral to re-
habilitation, therefore require up-to-
date evidence about effective early
interventions for children with CP.
The value of enriched environments in
enhancing brain recovery at both
structural andchemical levels hasbeen
repeatedly demonstrated in animal
studies.3,4 Effects of enrichment in-
clude improved memory and motor
function.4 Replication of animal data
ﬁndings within humans is still un-
dergoing experimentation, with one of
the early challenges being how to de-
ﬁne an “enriched human environ-
ment.” No single agreed deﬁnition of
environmental enrichment (EE) in hu-
man infants exists. In animal studies,
an EE is deﬁned as an environment that
facilitates enhanced cognitive, motor,
and sensory stimulation.4 Although
there are no agreed parameters for
enrichment, these animal housing
conditions typically include high levels
of complexity and variability with ar-
rangement of toys, platforms, and
tunnels being changed every few days
to promote motor learning and mem-
ory. Researchers have postulated that
it is the voluntary and challenge
aspects of these environments that are
crucial. Animals are not forced to per-
form activities; rather their engage-
ment with the environment is active
and playful.5 The motor opportunities
afforded by EE are a critical success
factor. An intriguing theoretical ques-
tion is whether an EE where an animal
can practice a task and engage in any
amount of physical exercise can be
actually distinguished from speciﬁc
motor training, as with humans. Some
animal researchers consider training
a discrete intervention, whereas oth-
ers include training as a “rehabilitative
enrichment” component of the EE.6 Ei-
ther way, EEs offer opportunity for
motor learning and “training,” and for
the purposes of this article we con-
sidered training inclusive of environ-
mental adaptations to enhance training,
as 1 form of motor-speciﬁc enrichment.7
Because no agreed deﬁnition exists,
the ﬁndings of this review must be
interpreted with attentiveness to the
deﬁnition we posed from literature.
Animal EE ideas are difﬁcult to replicate
within human experiments because
humans experience an individualized
level of complexityandvariabilitywithin
their daily lives. In addition, unlike
animals, human infants cannot volun-
tarily access their environment be-
cause motor maturation occurs later;
for example, ambulation is not present
at birth. Consequently infants are de-
pendent on their parents for access to
both generalized andmotor-speciﬁc EE.
Muchmore is knownabout the negative
impact of deprivation on child develop-
ment, inferring that EE and activity-
dependent plasticity are vital.8–11 Well-
understood examples include the
following: (1) institutionalized children
within deprived environments display
intellectual quotients 20 points lower
than peers,12,13 which is reversible when
EE is applied within orphanages13; (2)
children living in chronic poverty ex-
perience slower growth, worse health,
and lower intellectual ability unless EE
protective factors are in place (eg,
parental responsivity and acceptance,
availability of learning materials, safe
play areas, and a variety of experi-
ences)14; (3) typically developing chil-
dren experience delayed sitting skills
from parents conscientiously following
the Sudden Infant Death Syndrome
“back to sleep” program, which deprives
children of experiences in prone, but is
fortunately remediable15; and (4) typi-
cally developing children experience
delayed walking from regular use of
infant walkers, whereas Jamaican
infants walk earlier owing to parental
handling techniques.16,17 It should be
noted that these latter examples have
only a short-term inﬂuence on motor
development in typically developing
children, and it is not known if these
environmental inﬂuences beneﬁt or
disadvantage infants with motor dis-
orders in any way. Motor-enrichment
interventions have recently been tri-
aled in preterm and typically de-
veloping infants. Reaching training
delivered by caregivers to their pre-
term infants was able to partially
ameliorate the delayed reaching skills
often observed in the preterm pop-
ulation.18 Similarly, training parents to
practice speciﬁc motor tasks with
typically developing infants acceler-
ated the rate of motor development in
both the short and long term.19,20
In the small amount of literature about
the beneﬁts of EE for infants at risk for
brain injury, we know that premature
infants demonstrate neurobehavioral
beneﬁts from sensory-speciﬁc EE ac-
tivities, such asmassage21 andmusic.22
Developmental care interventions for
premature infants have been shown to
deliver modest short-term gains, but
with some trials showing no beneﬁt at
all.23 Some programs, such as The
Newborn Individualized Developmental
Care and Assessment Program, a sen-
sory-speciﬁc EE and cue-based inter-
vention for high-risk infants, has been
shown to positively inﬂuence brain
function and motor development.24
Generic EE via early interventions, such
as the Head Start program,25 provide
cognitive beneﬁts short-term, espe-
cially for infants from lower socioeco-
nomic backgrounds whose risk of
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environmental deprivation is higher.
Similarly, systematic reviews show fa-
vorable short-term cognitive beneﬁts
from generic EE programs offered to
premature infants.26,27 Because only
∼8% to 15% of premature infants will
go on to have CP,28 it is not clear whether
interventions aimed at preterm infants
will have clear beneﬁts for infants with
CP. In contrast, “traditional” physical
and occupational therapy early-
intervention approaches, such as neu-
rodevelopmental treatment (NDT), have
not been shown to be effective in im-
proving motor outcomes in infants or
older children with CP, despite the
theoretical possibility of providing
sensory-enrichment cues for learning
motor skills.29,30
Given that optimization of neuro-
plasticity is the aim of all rehabilitation,
it is important for those who deliver
early-intervention services to under-
stand the parental and EE-intervention
role that in turn is informed by knowing
the important components of EE for
infants with brain injury. Indeed, the
importance of the role of parents in
providing optimal home environments
for at-risk infants,31 as well as arrang-
ing opportunities for motor training,
have been highlighted in recent
reviews.32
Because interventionists use the term
EE without deﬁnitional or procedural
precision, it is important tobeclear that
not all therapy interventions are
enriching. In some standard care
interventions, manual handling tech-
niques are applied with the child’s role
being largely passive. This contravenes
animal EE deﬁnitions, in which active
exploration of complex and variable
environments is required. For the
purposes of this review and in the ab-
sence of an agreed infant EE deﬁnition,
we proposed an operational deﬁnition
of infant EE, consistent with the animal
literature (Fig 1). Infant EEs are inter-
ventions that aim to enrich at least 1 of
the motor, cognitive, sensory, or social
aspects of the infant’s environment for
the purposes of promoting learning.
Examples include interventions aiming
to enhance parent-infant interaction,
educate parents about assisting their
child’s skill development, provide op-
portunities for active motor learning
(self-generated motor activity) by
adapting the physical and play envi-
ronment, or provide comprehensive
programs aimed at enrichment across
a number of domains.
The purpose of this study was to sys-
tematically review the evidence for the
effectiveness of EE interventions (either
generic EE or motor-speciﬁc EE; eg,
motor training) for infants at very high
risk of CP, which explicitly sought to
improve motor outcomes.
METHODS
The method used was a systematic
review and meta-analysis with report-
ing according to the Preferred
Reporting Items forSystematicReviews
and Meta-Analyses statement.33 A
comprehensive search was conducted
of the following databases between
May and August 2011 and updated in
FIGURE 1
Environmental enrichment—infancy.
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May 2012: The Cochrane Library, in-
cluding the Cochrane Database of Sys-
tematic Reviews and the Cochrane
Central Register of Controlled Trials
(inclusive of PubMed); the Cumulative
Index to Nursing and Allied Health Lit-
erature; PsycINFO; Education Resource
Information Center; and SocINDEX.
Types of Studies
Included studies were randomized
controlled trials (RCTs). Systematic
reviews were also retrieved but not
appraised as per conventions. Con-
trolledstudiesandstudies in languages
other than English were excluded.
Types of Participants
Participants were either infants with
a conﬁrmed diagnosis of CP of any
subtype or severity, or infants desig-
nated “at high risk” of CP using the best
predictive tools available, namely, ab-
normal general movements (absent
ﬁdgety) or abnormal brain imaging
(cranial ultrasound or magnetic reso-
nance imaging). Studies were included
in which 25% of participants were 2
years of age or younger at the time of
study enrollment.
Types of Interventions
EE Interventions
EE interventionsof interestwere those in
which the infant’s environment was
enriched via parent training or coach-
ing in parent-infant interaction or in
various stimulation activities, speciﬁ-
cally those for motor learning; or where
the physical environment was modiﬁed,
adapted, or constructed to enable mo-
tor skill attainment; or where therapists
provided intense, targeted motor skill
practice aimed at enhancing plasticity.
Interventions that solely focused on
enriching parent well-being for im-
proving parent outcomes but not for
improving child motor outcomes were
excluded. The effects of regular parental
caregiving were not speciﬁcally teased
out for either the EE or comparison
group, because if effective for pro-
moting motor development, we would
expect as a function of randomization
that positive parental caregiving was
evenly distributed between both
groups. Studies of “NDT plus” were in-
cluded in the EE categorization if, and
only if, the added elements of the in-
tervention (ie, the “plus” component)
clearly involved EE.
Comparison Interventions
Comparison interventions were those
deemed “standard care” as provided by
physiotherapists and included tradi-
tional approaches, such as NDTor Vojta.
NDT and Vojta were not considered
enrichment interventions by our deﬁ-
nition, because NDT and Vojta, despite
modernization, continue to fundamen-
tally focus on passive therapist-delivered
facilitation and inhibition (therapeutic
handling).34 In contrast, EE approaches
deliberately minimize handling to pro-
mote active child-generated muscle
activation and movement. Interven-
tions that included handling or posi-
tioning embedding into daily routines
were regarded as largely passive
interventions and were thus treated as
non-EE interventions from standard
care, on the basis that these treatment
ideas originated from NDT.
Types of Outcome Measures
Outcome measures of interest were
those that assessed progress in motor
skill acquisition at any time point after
intervention and as either a primary or
secondary measure. To improve ho-
mogeneity, meta-analysis was con-
ducted using only data collected at time
points immediately at the end of the
intervention period.
Search Terms
The following Population, Intervention,
Comparison, Outcomesearch termswere
used: P = cerebral palsy OR neonatal
stroke OR intraventricular hemorrhage
OR brain injury OR hypoxic ischemic
encephalopathy OR newborn encepha-
lopathy OR periventricular leukomala-
cia (PVL); I = environment OR enriched
environment OR enhanced environ-
ment OR home environment OR nurture
OR parenting OR parent training OR
parent coaching OR caregiving OR
shaping OR stimulation OR intensive
task practice; C = nil; O = motor de-
velopment OR motor skills OR motor
learning OR motor outcome. Filters
applied during the searching were
“infants 0–23 months” and articles in
English. Abstracts from conferences
and dissertations were excluded. Ad-
ditional hand searching was conducted
from reference lists and ﬁeld expert
recommendations.
Selection of Studies
Two authors (C.M. and I.N.) indepen-
dently screened all titles and abstracts,
identiﬁed articles, and excluded irrel-
evant citations. Full-text articles of all
potentially relevant articles were
obtained and assessed for eligibility.
Ninety-ﬁve percent agreement was
reached; disagreement was resolved
through discussion and consensus. The
criteria for study exclusion are docu-
mented in Fig 2.
Data Extraction and Management
A data extraction tool based on the
Cochrane guidelines35 was used by 2
authors (C.M. and I.N.). The following
data were extracted: study design; in-
clusion and exclusion criteria; partici-
pant characteristics, including the
diagnosis of CP or “high risk of CP”;
number of participants; age and gen-
der of participants; characteristics
of the intervention and comparison
interventions, including treatment ap-
proaches and duration, frequency, and
intensity of intervention; details of
cointerventions plus compliance with
treatment protocol; motor outcomes;
methods used to measure change in
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motor function; mean scores and SDs
of outcomes; and direction of effect for
motor outcome. We contacted authors
of included studies when there was
incomplete reporting of data. All
authors contacted were able to provide
the missing data requested.
Quality of Studies and Risk of Bias
The methodological quality of the in-
cluded studies was assessed by using
the Cochrane risk of bias recom-
mendations from the Cochrane Hand-
book for Systematic Reviews of
Interventions35 and is summarized in
Table 2.
Analyses
Meta-analysis was conducted for the
studies that were clinically homoge-
neous. Data were analyzed by using
Review Manager 5 (RevMan; Computer
program Version 5.1. Copenhagen: The
Nordic Cochrane Centre, The Cochrane
Collaboration, 2012). The I2 statistic
was used to quantify the heterogeneity
of outcomes and informed decisions
about whether to pool data. Meta-
analyses were conducted by using
a random-effects model to conserva-
tively account for the data heteroge-
neity. The mean differences in motor
outcomes were pooled for each study
to provide a summary estimate of the
effectiveness of EE interventions. For all
continuous outcomes with different
units, effects were expressed as stan-
dardized mean differences and 95%
conﬁdence intervals.
RESULTS
The electronic searches, citation
tracking, and reference list searches
elicited 226 references after 9 dupli-
cates were removed. After screening
titles and abstracts, 16 studies were
identiﬁed, and after inspecting the full-
text articles, 7 studiesmet full inclusion
criteria. Reasons for exclusion are
summarized in Fig 2.
Included Studies
Across the 7 included studies there
were a total of 328 participants
(Table 1). Three studies36–38 inves-
tigated the effects of EE interventions
(as per our deﬁnition) on very young
hospitalized infants with brain injuries
and at high risk of CP and followed
their progress post discharge. The
remaining 4 studies39–42 investigated
EE interventions (as per our deﬁnition)
in children older than 1 year with
a conﬁrmed diagnosis of CP. The fea-
tures of EE interventions varied con-
siderably among the studies. Six
studies provided part of the EE in-
tervention via parent training or
coaching. This included ways of inter-
acting with their infant,36–38 strategies
for modifying the physical environment
for motor task practice, and providing
frequent opportunities for task prac-
tice.39,40,42 Only 1 study did not actively
train parents but encouraged them to
“use newly acquired skills when the
therapist was not present.”41p306
Methodological Quality and Risk of
Bias in Included Studies
The methodological quality and risk of
bias in the 7 included studies were
variable, with a tendency for the more
recent studies to be of the highest
quality and at the lowest risk of bias
(Table 2). Three studies used adequate
methods for generating the randomi-
zation sequence but 4 were unclear.
Three studies used adequate methods
to conceal allocation. Blinding of par-
ticipants and therapists was not pos-
sible in any of the studies because of
the “hands-on” and thus visible nature
of the intervention. Five of the studies
used assessors who were blinded to
group allocation and 4 studies had
FIGURE 2
Flow diagram. aArticles may have been excluded for failing to meet .1 inclusion criterion.
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adequate follow-up. Only 1 study se-
lectively reported outcomes and 5
studieswere free of other bias because
they provided full statistical reporting.
Effects of Interventions on Motor
Outcomes
Five of 7 included studies compared an
EE intervention with standard care and
were clinically homogeneous for meta-
analysis (ie, comparedEEwith standard
care, and used the Bayley Psychomotor
Developmental Index [PDI] [4/5] trials).
Standard care was not clearly de-
scribed in terms of the treatment
approaches in use or the intensity of
intervention provided. Two of the 7
studies compared 2different typesof EE
interventions (as per our deﬁnition)
head to head.39,42 In the study by Law
et al,39 both the context-focused group
and the child-focused group enlisted
intensive task practice as an EE feature.
What differentiated the groups was
that the context-focused intervention
also included parent training and en-
vironmental adaptations to promote
functional skill attainment. Likewise,
Wallen et al42 compared modiﬁed
constraint-induced movement therapy
(CIMT) with an intensive occupational
therapy approach in which both groups
received intensive task practice and
parent training aimed at EE.
The 5 studies that compared EE with
standard care were included in the
meta-analysis. Data imputed into the
analyses were motor outcomes cap-
tured at the immediate cessation of
treatment. Motor outcome data were
pooled from 4 studies using the Bayley
PDI43 and 1 study using the Quality of
Upper Extremity Skills Test (QUEST).44
For the study by Nelson et al,37 only the
values reported on infants with a cen-
tral nervous system injury were in-
cluded within the meta-analyses, which
was possible because these ﬁgures
were reported separately from infants
without central nervous system injury.
Data from the 6-month point were used
from the Palmer et al40 study because
infants in the experimental group re-
ceived the enrichment intervention
only during the ﬁrst 6 months and then
after this they were prescribed main-
tenance NDT for the next 6 months.
QUEST values for the Taub et al41 trial
were used, as this was the only motor
outcome measure used in this trial for
which appropriate psychometrics
were available. These values were re-
trieved from the Cochrane Review by
Hoare et al.45 When combined, the 5
studies included a total of 150 partic-
ipants. The standard mean difference
was 0.39 (95% conﬁdence interval
0.05–0.72; I2 = 3%; P = .02), indicat-
ing a small positive effect favoring
enrichment over standard care (Fig 3:
forest plot).
DISCUSSION
Theaimof this systematic reviewwas to
determine the effect of EE intervention
programs on the motor outcomes of
infants who were 2 years and younger
with a high risk or diagnosis of CP,
compared with standard care. This is
the ﬁrst systematic review and meta-
analysis that has attempted to deﬁne
and measure the effect of EE on motor
development of infants with CP. Pre-
vious systematic reviews have focused
more broadly on motor and cognitive
outcomes in preterm populations27 or
those at risk for a broader range of
developmental disorders.46,47 In these
previous studies, favorable cognitive
outcomes programs have been con-
sistently demonstrated for a range of
early-intervention programs, but mo-
tor outcomes rarely improve. Five
studies with sufﬁcient homogeneity for
meta-analysis were found, which in-
dicated good-quality evidence for
a very small but favorable beneﬁt from
enrichment interventions in improving
motor outcomes for infants with CP.
The studies were all RCTs (ie, high lev-
els of evidence, of medium-high quality,
and varying levels of risk of bias). The
entire body of evidence for EE improv-
ing motor outcomes in infants with
CP was graded as moderate quality
(ie, further research is likely to have an
important impact on our conﬁdence in
the estimate of effect and may change
the estimate).48 Nevertheless, our study
makes a newand unique contribution to
TABLE 2 Cochrane Risk of Bias Assessment
Study 1 2 3 4 5 6 7
Badr et al36 (2006) ? ? — + — + —
Law et al39 (2011) + + — + + + +
Nelson et al37 (2001) ? ? — — — + +
Ohgi et al38 (2004) + — — + + + +
Palmer et al40 (1988) ? ? — + + + +
Taub et al41 (2004) ? + — — — — —
Wallen et al42 (2011) + + — + + + +
The Cochrane Risk of Bias assessment domains addressed are the following: (1) random sequence generation; (2) allocation
concealment; (3)blinding of participants and personnel; (4) blinding of outcome assessment; (5) incomplete outcome data;
(6) selective reporting; (7) other bias. +, low risk of bias;—, high risk of bias; ?, unclear.
FIGURE 3
Forest plot.
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the literature by highlighting ways to
improve motor outcomes at an early
age. Unfortunately, it was not possible
to draw conclusions about the con-
tributions of the varying components of
EE because of the high levels of in-
tervention and participant heterogene-
ity among the studies. The studies
varied in severity of motor impairment,
initial degree of risk for CP, the type of EE
used, the intervention duration, the in-
volvement of parents, and the motor
assessments used. The meta-analysis
appears, however, to indicate that en-
richment is beneﬁcial, despite differ-
ences in child attributes and “favorable”
parent characteristics, as conceivably
any differences would have been dis-
tributed evenly across EE and non-EE
groups owing to randomization.
The 2 studies that commenced with
newborns were unable to demonstrate
favorable motor outcomes for the ex-
perimental groups. Although reasons
were explored in each publication, we
also concluded that these studies were
inadvertently underpowered because
only a small proportion of participants
ultimatelyendedupwithaCPdiagnosis.
In other words, because most of the
participants in both groups were
healthy or mildly affected, intervention
would be unlikely to affect their results.
Infants who have normal or milder
motor impairments will unmistakably
score better on norm-referenced tools,
such as the Bayley PDI, than will infants
with CP. Potentially grouping motor-
impaired infants with those whose de-
lay is simply related to prematurity
does not allow identiﬁcation of aspects
of the interventions that may have been
effective for the different diagnoses. In
addition, it has been suggested in
earlier reviews that norm-referenced
tools, such as the Bayley PDI, may not
be sensitive enough to measure
change in infants with CP.46 The 3 infant
studies used different inclusion crite-
ria for deﬁning risk of CP, which is likely
to further explain the nil ﬁndings. For
example, Badr et al36 curiously ex-
cluded a subgroup of infants with the
highest risk for CP (eg, Grade IV in-
traventricular hemorrhage with PVL),
but the remaining study group still had
some risk factors for CP.
Not surprisingly, only a small percent-
age of infantswere thendiagnosedwith
CP at follow-up. Nelson et al37 reported
a ﬁnal CP diagnostic rate of 44% to 67%,
dissolving the study power. None of the
studies included infants younger than
12 months who had not been sick in the
neonatal period. This is an interesting
ﬁnding, and supports the authors’ ex-
perience that almost half of infants at
risk for CP are not being referred for
therapy services until closer to their
ﬁrst birthday.28 Another identiﬁed lim-
itation in 2 of the infant studies (Nelson
et al,37 Ohgi et al38), was that the
authors ceased intervention before, or
at 6 months of age, before the average
age at which CP is commonly diag-
nosed. It is therefore unclear whether
ongoing intervention of different types
(ie, EE versus no EE) would have
changed the results, as the complexity
of motor demands increases over time
and children with CP tend to fall farther
and farther behind.
Several studies had tobe excluded from
this review, because they did not meet
the inclusioncriteriaofasampleathigh
risk of CP; most notably, an RCT that
compared the parent coaching in-
tervention “Coping with and Caring for
Infants with Special Needs” (COPCA),
with standard care. In the COPCA study,
there were no differences between the
groups with respect to motor out-
comes, which should have perhaps
been expected given that ,25% of
participants were eventually diag-
nosed with CP. Thus, for the most part,
authors were comparing healthy
infants with healthy infants. Post hoc
analysis of infants with CP revealed
a positive correlation between PEDI
scores and elements of the COPCA ap-
proach.49,50
In the subsequent years since many of
these clinical trials have been con-
ducted, the ﬁeld has learned a great
deal more about how to precisely
identify infants who aremost at risk for
CP. It is now possible to identify those
infants at risk for CP with a high degree
of accuracy using the General Move-
ments Assessment plus imaging.51,52
Abnormal general movements (“ab-
sent ﬁdgety”) at 3 months corrected
age predicts CP with a sensitivity of
$92% (speciﬁcity $82%).53 In light of
our study ﬁndings, using best practice
tools to identify those infants at risk for
CP and to tease them apart from those
at risk for general delay is very im-
portant, as EE interventions can be
speciﬁcally targeted at motor de-
velopment if this is expected to be
impaired. Also, earlier intervention in-
stituted at a time of greater brain
growth and plasticity is likely to be
associated with a stronger beneﬁcial
effect.
Of the 4 studies that included infants
with a conﬁrmed CP diagnosis, the se-
verity of the motor impairment varied,
which is known to be a covariate for
explaining study ﬁndings.54 Only 1 study
(Law et al39) included children from all
Gross Motor Function Classiﬁcation
System (GMFCS) levels. The Taub et al41
and Wallen et al42 studies included only
children with hemiplegia (usually
GMFCS I–II) and Palmer et al40 applied
their enrichment intervention to a sub-
group of children with diplegic CP. Al-
though the Palmer et al40 study
predates the invention of GMFCS, it is
clear from the description of the par-
ticipants that almost all infants had
motor skills that fall into GMFCS I to III
categories (ie, were certain to be am-
bulatory). Broadly speaking, the inter-
ventions described in these 4 studies
all involved motor task practice cus-
tomized to the child, delivered by
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a professional (therapist or teacher)
and reinforced by tailored home prac-
tice. Interestingly, these 4 of the 7
studies were the studies that showed
a positive trend favoring EE.
The studyby Lawet al39 that compared 2
different EE interventions head-to-head
found both approaches were equally
effective. Law et al’s39 ﬁndings are
consistent with other studies of func-
tional therapy or task-based training EE
approaches known to be effective in
older children.55,56 In line with the In-
ternational Classiﬁcation of Function-
ing, Disability, and Health, functional
therapy or task-based training EE
approaches deliberately consider the
impact of the environmental context in
the design and implementation of
therapy. The difference with Law
et al’s39 context-focused study is that 2
novel approaches are compared:
“hands off and hands on.” In a typical
clinical situation it is unlikely that only
child-focused (“hands on”) or context-
focused therapy (“hands off”) would be
provided. A combination of strategies
that target both the child and the con-
text is more likely. Our review did not
locate any studies that used these
functional motor learning, goal-driven,
and environmentally enriching ap-
proaches for infants with little or no
motor repertoire. This remains a gap
in literature, warranting further study.
Wallen et al42 and Taub et al41 used
different models of CIMTas a form of EE
(as per our deﬁnition). It is the motor-
learning strategies, or shaping, that co-
occur with use of a constraint that
make this approach motor-speciﬁc
enrichment. The 2 studies used quite
different approaches with variations in
intensity and the type of constraint
used. However, both experimental
groups offered a similar total amount
of intervention (mean 119 hours) but
over different durations (3 weeks or 10
weeks). Although the study by Taub
et al41 demonstrated impressive motor
outcomes for the constraint group,
a subsequent Cochrane review outlines
substantial sources of bias in this
study.45 In contrast, both groups in the
Wallen et al42 study used an EE ap-
proach in which the experimental
group constraint was the “added ex-
tra.”Motor outcomes improved in both
groups. It may be that the consistent
motor-learning/task-practice approach
is the key component of these studies.
Limitations of This Review
Some of the included studies in this
review did not provide adequate
descriptions of standard care inter-
ventions, resulting in thepossibility that
enrichment activities were indeed part
of these comparison groups, which
would ultimately dissolve statistical
power. It is, however, our experience
that standard care for young infants is
typically a “wait-and-see” approach,
which mostly involves active monitor-
ing of the infant over the ﬁrst 12
months. It is also possible that because
of the deﬁnition of EE used, intervention
studies that actually offered enrich-
ment were omitted. This confounder
was minimized by clearly deﬁning EE
and features of enrichment, using ex-
tensive hand searching and using
search terms indicative of the early
intervention ﬁeld. In particular, oppor-
tunities for motor task practice were
includedwithin the deﬁnition of EE, as it
seems evident that for infants to de-
velop motor skills, opportunities must
be provided within their learning en-
vironment. However, other deﬁnitions
of EE may single out EE from task
practice opportunities. Future studies
should therefore be careful to detail
the approaches and strategies in use,
the frequency and intensity of in-
tervention of all groups, and account
for the effect of cointerventions. In
particular, the breakdown of the ap-
proach and the extent of parent in-
volvement should be speciﬁed to
advance our understanding of human
EE.
CONCLUSIONS
Enrichment interventions to improve
motor outcomes in infants at high risk
of CP appear promising. Therefore,
more high-quality, low-bias, large-
sample, longitudinal RCTs that exam-
ine the effects of motor task practice
with deliberate attention to environ-
mental enrichment via appropriate
parent training and a variety of stim-
ulating opportunities for learning are
urgently needed. Researchers also
need to use the best available evi-
dence to accurately identify those at
the highest risk of CP for inclusion in
these trials to ensure adequate study
power.
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Chapter 4 | STUDY 3 SENSITIVITY AND SPECIFICITY OF EARLY 
DETECTION 
PUBLICATION  
Morgan C, Crowle C, Goyen TA, Hardman C, Jackman M, Novak I, Badawi 
N. Sensitivity and specificity of General Movements Assessment for 
diagnostic accuracy of detecting cerebral palsy early in an Australian context. 
(Accepted for publication in Journal of Paediatrics & Child Health 2015) 
 
Our literature review (Study 1) demonstrated the depth and quality of 
evidence available for predicting CP in high-risk infants when the right 
assessment tools are used at the right time. We established a network of trained 
general movements (GMs) assessors who continue to meet biannually to 
share cases and maintain inter-observer reliability. In Study 3, five sites 
collaborated to assess whether our network could detect CP using the 
General Movements Assessment with sensitivity and specificity rates similar 
to published European standards. Using Standards for the Reporting of 
Diagnostic Accuracy studies (STARD) criteria, we assessed our diagnostic 
accuracy in a high-risk group that included both preterm and term infants. 
Our results were similar to rates previously published, confirming we were 
detecting CP accurately from this high-risk group of infants. Furthermore, 
we confirmed we could accurately detect the “right” infants for early 
intervention trials, which is vital to advance the evidence base in this field. 
The establishment of the GMs rater network and the confirmation of 
diagnostic accuracy served to “set the scene” for the recruitment of infants to 
clinical trials  (Studies 5 and 6). 
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ABSTRACT!
!
AIM(
To!calculate!the!sensitivity!and!specificity!of!the!General!Movements!Assessment!
(GMA)!for!estimating!diagnostic!accuracy!in!detecting!cerebral!palsy!(CP)!in!an!
Australian!context!by!a!newly!established!NSW!rater!network. 
!
METHODS(
A!prospective!longitudinal!cross\sectional!study!was!conducted.!The!GMA!was!
blind\rated!from!conventional!video!by!two!independent!certified!raters,!blinded!to!
medical!history.!A!third!rater!resolved!disagreements.!High\risk!population!
screening!for!CP!using!the!GMA!during!the!fidgety!period!(12\20!weeks)!was!carried!
out!in!four!neonatal!intensive!care!units!and!one!CP!service!over!a!30\month!period!
(2012\2013).!Participants(were!259!high\risk!infants.!Sensitivity!and!specificity!
values!were!calculated!with!true!positives!defined!as!a!confirmed!diagnosis!of!CP!
from!a!medical!doctor.!
!
RESULTS!!
Of!the!259!infants!assessed,!one\year!follow\up!data!was!available!for!187.!Of!
these,!n=48!had!absent!fidgety!(high!risk!for!CP),!n=138!had!normal!fidgety!(low!risk!
for!CP),!and!n=!1!had!abnormal!fidgety!(high!risk!for!a!neurological!disorder).!Of!the!
48!with!absent!fidgety!movements,!39!had!received!a!diagnosis!of!CP!by!18!months!
and!another!6!had!an!abnormal!outcome.!Of!the!n!=138!normal!fidgety!cases,!n=99!
cases!had!a!normal!outcome,!n=!38!had!an!abnormal!outcome!but!not!CP,!and!n=1!
had!CP.!For!detecting!CP,!we!had!a!sensitivity!of!98%!and!specificity!of!94%.!!
!
CONCLUSION!!
GMA!was!feasible!in!an!Australian!context!and!accurately!identified!CP!with!a!
sensitivity!and!specificity!comparable!to!European!standards!and!published!
neuroimaging!data.!!
 
 
 
KEY!WORDS: general!movements!assessment,!cerebral!palsy,!infants!
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Introduction!
!
Cerebral!palsy!(CP)!is!defined!as!a!group!of!disorders!of!movement!and!posture!that!
results!from!a!lesion!to!the!developing!brain(1)!and!is!the!most!common!physical!
disability!of!childhood.!Early!detection!of!CP!is!important!as!it!allows!referral!to!
early!interventions!aimed!at!maximising!motor!and!cognitive!outcomes!in!children!
and!providing!support!to!families!(2,!3).!
!
Data!from!the!Australian!Cerebral!Palsy!Register!shows!that!the!average!age!for!
diagnosis!of!CP!is!17!months!although!the!range!varies!from!a!few!weeks!to!4!years!
of!age!(I.!Novak,!unpubl!data,!2014).!About!half!of!all!children!diagnosed!with!CP!
have!identifiable!markers!that!enable!them!to!be!labelled!“at!risk”!during!the!
neonatal!period,!e.g.!prematurity!or!neonatal!encephalopathy!(2).!These!infants!are!
typically!cared!for!in!neonatal!intensive!care!units!(NICUs)!and!are!often!enrolled!in!
follow\up!programs!to!ascertain!their!long\term!outcome.!These!programs!follow!
protocols!to!monitor!infants!for!evidence!of!developmental!delay!or!disabilities,!
referring!for!early!intervention!once!signs!become!apparent.!
!
Recent!systematic!reviews!have!demonstrated!that!in!fact!CP!can!reliably!be!
detected!as!early!as!3!months!post!term!age!using!Prechtl’s!Qualitative!Assessment!
of!General!Movements!Assessment!(GMA)!and!Medical!Resonance!Imaging!(MRI)!
(4,5\6).!The!GMA!was!developed!by!Professor!Heinz!Prechtl!in!the!early!1990s!and!is!
an!assessment!of!the!spontaneous!movement!patterns![“general!movements”!
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(GMs)]!of!young!infants(7,8).!Two!periods!of!GMs!are!described;!the!“writhing!
period”!from!preterm!until!6\9!weeks!post!term!age,!and!“fidgety!period”!from!9\20!
weeks!post!term!age(9).!Normal!GMs!are!shown!to!have!a!high!correlation!with!a!
normal!outcome,!while!abnormal!GMs,!in!particular!absent!fidgety!GMs!(F\),!are!
highly!predictive!of!CP!(sensitivity!as!high!as!98%!and!specificity!91%,(6)).!Thus!the!
GMA!is!considered!the!reference!standard!for!early!detection!of!CP.!Validity!of!the!
tool!is!established(9)!and!inter\rater!reliability!of!the!GMA!has!been!repeatedly!
demonstrated(9\11).!Importantly,!a!number!of!studies!have!demonstrated!that!the!
predictive!validity!of!the!GMA!is!superior!to!neuroimaging!(6),!while!the!
combination!of!abnormal!GMA!and!white!matter!injury!evident!on!MRI!has!been!
shown!to!be!100%!predictive!of!an!outcome!of!CP!in!a!cohort!of!preterm!infants!
(13).!Studies!in!infants!with!Hypoxic!Ischaemic!Encephalopathy!(HIE)!showed!a!high!
correlation!between!abnormal!GMs!and!lesions!of!the!basal!ganglia!and!
thalamus(12).!!
!
Despite!the!compelling!psychometric!data,!implementation!of!GMA!in!clinical!
practice!outside!of!Europe!has!been!ad!hoc!and!is!a!“know\do”!evidence!to!practice!
gap.!Systematic!reviews!on!the!predictive!validity!of!the!GMA!have!proposed!that!
the!lack!of!non\European!data,!especially!outside!the!expert!group!(General!
Movements!Trust),!is!a!potential!limitation!to!the!generalizability!of!findings!and!
possible!explanation!for!the!know\do!gap(5).!Use!of!the!GMA!has!been!growing!in!
Australia!in!the!last!7\8!years.!Spittle!and!colleagues!from!Melbourne!Australia!have!
demonstrated!sensitivity!and!specificity!results!similar!to!European!rates!in!very!
preterm!children.!In!addition,!their!work!has!demonstrated!important!associations!
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between!neuroimaging!findings!and!the!GMA!in!predicting!later!
neurodevelopmental!outcomes!(13\15).!These!important!studies!have!focused!on!
preterm!infants,!a!population!that!make!up!about!30%!of!all!CP!(2).!To!date!little!
published!data!exists!on!the!diagnostic!accuracy!of!the!GMA!for!a!more!
heterogeneous!clinical!population!of!high\risk!infants!in!an!Australian!context.!In!
2011,!a!knowledge!translation!program!to!close!the!GMA!know\do!gap!was!
implemented!in!New!South!Wales!!(NSW)!Australia.!!First,!European!trainers!were!
brought!to!Australia!to!remove!the!barrier!of!needing!overseas!rater!training.!
Second,!educational!scholarships!were!provided!to!remove!the!costs!of!obtaining!
rater!training.!Third,!a!new!rater!network!was!established!in!NSW!for!the!purpose!of!
providing!peer\to\peer!support!for!maintaining!GMA!scoring!reliability!and!
troubleshooting!any!difficulties!embedding!the!GMA!in!clinical!practice.!Network!
meetings!are!held!twice!a!year!and!trained!assessors!from!all!participating!centres!
present!cases!for!blind!scoring!to!help!maintain!inter\rater!reliability.!Between!
network!meetings,!de\identified!videos!are!shared!for!blind!scoring!purposes!to!
arbitrate!any!discrepancies.!
!
The! aim! of! this! study! was! to! calculate! the! sensitivity! and! specificity! of! the! GMA! for!
diagnostic! accuracy! of! detecting! CP! at! 3\5! months! of! age! in! high\risk! infants,! in! an!
Australian!context!when!scored!by!the!NSW!rater!network.!
 
 
 
Methods)
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)
Participants!
Inclusion!criteria:!(1)!All! infants!included!were!those!prospectively!enrolled!in!follow!–up!
clinics! and! screened! using! the! GMA! from! the! study! sites:! 4! NICUs! in! NSW! Australia!
(Westmead! Hospital,! the! Children’s! Hospital! at! Westmead,! John! Hunter! Children’s!
Hospital! and! Royal! Prince! Alfred!Hospital)! and! the! Cerebral! Palsy! Alliance! (CPA);! (2)! All!
infants!were! designated! high\risk! of! poor! neurodevelopmental! outcome! based! on! their!
medical!history!and!/or!neuroimaging!by!at!least!one!member!of!their!treating!team.!This!
included! infants! admitted! to! NICUs! post! surgery! or! with! neurological! risk! factors! (eg.!
severe! intraventricular! haemorrhage,! periventricular! leukomalacia,! neonatal! stroke),!
hypoxic!ischaemic!encephalopathy!(stage!II\III),!or!due!to!prematurity!(ie.!<29!weeks,!one!
unit!enrolled!<32!weeks);!or!infants!referred!to!CPA!with!motor!delay!or!neurological!signs!
suggestive! of! CP.! Recruitment! via! voluntary! participation! was! offered! to! all! infants!
meeting! the! inclusion! criteria,! unless! there!was! a! competing! concurrent! study! in!which!
case! they! were! offered! enrolment! to! both! studies,! with! researchers! respecting! the!
parent’s!choices.!Exclusion!criteria:!Nil.!!
!
Methodology!
High\risk!population!screening!for!CP!was!conducted!at!study!sites,!predominantly!in!the!
NICU!follow\up!clinic!over!a!30\month!period,!resulting!in!a!prospective!longitudinal!and!
cross\sectional! study.! The! CPA! received! referrals! from! concerned! parents! and!
professionals!in!the!community!to!screen!infants!for!signs!of!CP.!!
!
Instrument:!General!Movements!Assessment!
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Infants!were!assessed!during!the!fidgety!movement!period!at!the!developmental!follow\
up!clinic!or!in!the!family!home.!Since!GMs!in!the!fidgety!period!are!the!most!predictive!for!
a! later! diagnosis! of! CP,! our! outcome! of! interest,!we! focused! on! results! from! this! GMA!
period.!GMAs!for!259!infants!were!collected!on!conventional!video!following!the!protocol!
outlined!by!Einspieler!et.al!(9).!!
All! study! sites! used! certified! GM! assessors! to! score! the! videos! blinded! to!medical! and!
clinical!history.!Although!all!sites!had!certified!blind!raters!there!was!a!number!of!minor!
pragmatic! practice! variations! across! the! study! sites! in! relation! to! the! processes! for!
arranging! the! scoring.! Despite! uniformity! being! preferable,! in! the! clinical! setting! local!
variations!was! deemed! allowable! as! the! greater! knowledge! translation! goal! was! for! as!
many!raters!as!possible!to!be!using!the!GMA!and!all! study!sites! to!develop!feasible!and!
acceptable! local!processes! that! led! to! routine!GMA!use.!For! instance,!one!service!had!a!
number!of!raters!who!scored!independently!and!were!blinded,!another!had!two!raters!but!
only!one!blinded,!and!the!other!services!had!two!blinded!raters.!A!third!rater,!unaware!of!
medical!and!clinical!history!and!part!of!the!GM!Network,!resolved!disagreements!for!any!
case! at! any! site.! There! were! no! scoring! accuracy! differences! between! the! study! sites,!
despite!the!differing!processes.!!
!
Neurodevelopmental!Outcome!
Infants!were!followed!to!12!\24!months!post\term!age.!True!positives!were!defined!as!a!
confirmed!diagnosis!of!CP! from!a!medical!doctor.!The!diagnosis!was! typically!given!at!a!
follow! up! time! point! by! a! developmental! paediatrician! or! neonatologist! based! on!
neurological! examination,! clinical! history,! and! developmental! motor! assessment.! For!
infants!not!diagnosed!with!CP!an!abnormal!outcome!was!defined!as!having!scores!on!one!
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or!more!domains!of!the!BSID\III!(14)!greater!than!1!standard!deviation!below!the!mean!at!
follow\up.! If! the!only!delay!on! the!BSID\III!was! in! the!domain!of! language,! the!outcome!
was!not! coded!as! abnormal,! given! these! children! can! go!on! to!have! a!normal!outcome!
despite!delayed!speech!and!language!(16).!
Ethics!
Ethics!approval!was!obtained!from!all!study!sites,!with!The!Royal!Prince!Alfred!
Hospital!Human!Research!Ethics!Committee!as!the!lead!committee!and!site!specific!
approval!from!all!other!participating!institutions.!Parental!consent!was!previously!
obtained!from!families!at!the!point!of!GMA.!The!accompanying!history!data!was!
abstracted!from!medical!records.!
Statistical!Analysis!
This!was!a!prospective!study;!with!data!analysis!planned!a!priori!to!data!collection.!
Study!design!and!data!analysis!were!reported!in!accordance!with!the!STARD!
checklist!for!reporting!of!studies!of!diagnostic!accuracy.!Neurodevelopmental!
outcome!data!was!compared!with!GMA!results!from!the!fidgety!period.!Statistical!
analysis!was!completed!using!SPSS!using!conventional!sensitivity!and!specificity!
calculation!methods.!Confidence!intervals!were!calculated!for!sensitivity!and!
specificity!for!predicting!an!outcome!of!CP!and!for!any!abnormal!outcome.!!
Results))
Participants!
Data!were!collected!on!all! infants! recruited!and!screened!between!2011\2013,!although!
some! study! sites! did! not! collect! data! for! the! full! study! period! while! awaiting! Ethics!
Clearance.!Infants!were!all!between!10\20!weeks!post!term!age!at!the!time!of!their!GMA!
fidgety!assessment!and!within!2!weeks!of!their!first!or!second!birthday!at!their!one!or!two!
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year!aged! follow!up.!The!most!common!reason! for!a!GMA!was!prematurity! followed!by!
neonatal!encephalopathy.!
Complete! one\year! follow\up! data! were! available! for! 187! infants.! Partial! data! were!
available! for!another!72! infants!who!had!not!yet! reached!12\24!months!or!were! lost! to!
follow! up! (n=62)! and! for! n=10! whose! GMA! was! not! able! to! be! scored.! Reasons! for!
conducting!GMA!are!presented!in!Figure!1.!
Figure!1:!Reasons!for!conducting!General!Movements!Assessment!(%)!
 
 
!
!
!
!
Quality!of!GMs!
Data!were!analysed!when!both!the!fidgety!GMA!and!12\month!outcomes!were!available,!
all! other! cases! were! treated! as! missing! and! excluded! from! the! analysis.! Of! the! 187!
complete!cases,!n=138!were!scored!as!normal!fidgety!(F+)!i.e.!low\risk!for!CP,!n=48!were!
scored!as! absent! fidgety! (F\)! i.e.! high\risk!of!CP,! and!n=1!were! scored!abnormal! fidgety!
(AF)!i.e.!high\risk!for!a!neurological!disorder.!No!adverse!events!were!reported!as!a!result!
of!testing.!
!
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!
Neurological(Outcome(
At! one\year! follow\up,! of! the! n=187! cases:! 102! children! had! a! normal! outcome! and! 40!
children!had!a!diagnosis!of!CP.!A!further!45!children!had!an!abnormal!outcome!(not!CP)!
(Table!1).!
Table!1:!GMA!Fidgety!Results!and!12!Month!Outcome!Results!
GMA)result) 12)month)outcome)
Type!of!Fidgety! Normal! CP! Abnormal!
Normal)
)[F+])
n=138!
(74%)!
!n=99!
(72%)!
n=1!
(<1%)!
n=38!
(28%)!
Abnormal)
[AF])
n=1!!
(<1%)!
n=0!!
(0%)!
n=0!!
(0%)!
n=1!!
(100%)!
Absent))
[FP])
n=48!
(26%)!
n=3!!
(6%)!
n=39!!
(81%)!
n=6!!
(13%)!
!!!!!!!!!!!!!!!!NB:!Shading!indicates!the!predicted!outcome!from!GMA!
!
First,!in!the!n=138!with!F+!movements!there!were!n=99!with!a!normal!outcome,!n=1!later!
diagnosed!with!CP,!and!n=38!with!a!neurodevelopmental!delay!other!than!CP.!Abnormal!
neurodevelopmental! outcomes! that! were! not! CP! included;! n=1! with! Prader\Willi!
syndrome,! n=2! with! hearing! impairments! and! n=35! with! global! developmental! delay,!
including!n=1!suspected!autism.!The!infants!with!global!developmental!delay!ranged!from!
mild!motor!and/or!cognitive!delay!at!12!months!to!significant!delays!in!both!the!cognitive!
and!motor!domains,!as!scored!on!the!BSID\III.!
!
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Second,! in! the!n=48!with!F\!movements,!n=39! infants!were!diagnosed!with!CP!by!12\18!
months.!Of!the!n=9!with!F\!and!not!diagnosed!with!CP!all!had!a!suspected!or!confirmed!
diagnosis! of! an! abnormal! outcome,! including:! n=1! had! a! genetic! disorder;! n=1! had! a!
mitochondrial! disorder;! n=1!was! recovering! from!meningitis;! n=3! had!moderate\severe!
global! developmental! delay;! and! n=3! had! suspected! CP! at! 12!months,! but! had! not! yet!
been!formally!diagnosed!but!were!undergoing!monitoring!for!a!diagnosis!of!CP!(coded!as!
normal!outcomes!however!at!12!months).!!
!
Third,! the! n=1!with! AF!movements! had! a!motor! delay! at! 12!months! >! 1! SD! below! the!
mean.!
!
Sensitivity(and(specificity(((
Sensitivity!and!specificity!scores!were!calculated!for!predicting!CP!and!for!predicting!
an! abnormal! outcome.! Sensitivity! for! detecting! CP!was! 98%! (95%CI:! 86.79\99.58)!
and! specificity! 94%! (95%CI:! 88.69\97.16).! Sensitivity! for! detecting! any! abnormal!
outcome!with!abnormal!or!absent!fidgety!GMs!was!54%!(95%CI:!42.66\64.98)!and!
specificity!97%!(95%CI:!91.63\99.36).!
!
The!mean!age!of!CP!diagnosis!for!children!identified!at!high!risk!of!CP!by!the!NSW!GMA!
rater!network!was!8.5!months!(SD=4!months).!All!infants!identified!as!high!risk!of!CP!by!F\!
GMs!at!3\4!months!were!referred!to!early!intervention!services.!The!child!later!diagnosed!
with!CP!but!with!normal!fidgety!movements!was!also!referred!for!early!intervention!due!
to!concerns!about!motor!development!that!were!identified!at!follow\up!from!tests!other!
than!the!GMA.!
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Discussion)
The!GMA! has! consistently! been! shown! to! be! a! sensitive!method! for! early! detection! of!
adverse!neurodevelopmental!outcomes!especially!CP.!Although!clinical!use!has!generally!
been! lacking! outside! the! European! context,! this! study! confirmed! that! the! GMA! had!
excellent!sensitivity!and!specificity!to!predict! infants!who!would! later!be!diagnosed!with!
CP! as! well! as! those! with! normal! outcomes.! Our! results! are! comparable! to! previous!
Australian! and! European! studies! demonstrating! that! the! reliability! of! the! GMA! can! be!
replicated!in!different!parts!of!the!world.!!
In!the!clinical!setting,!making!a!diagnosis!of!CP!utilises!a!combination!of!robust,!evidence\
based!tools!including!neuroimaging,!neurological!and!standardised!motor!testing!(2).!The!
GMA!is!a!highly!predictive,!non\invasive!assessment!that!would!be!a!valuable!tool!to!add!
to!the!diagnostic!work\up.!Results!of!this!study!suggest!that!one!benefit!of!early!detection!
using!GMA!was!that!diagnosis!occurred!earlier,!on!average!at!8.5\months!compared!to!the!
Australian!CP!Register!convention!of!17\months.!Previous!Australian!studies!of!preterm!
infants!have!followed!infants!until!four!years!and!demonstrated!the!value!of!the!GMA!in!
predicting!adverse!neurodevelopmental!outcomes!(15).!The!current!study!builds!on!this!
work!with!a!broader!group!of!high\risk!infants,!indicating!very!early!identification!of!
infants!at!the!highest!risk!of!motor!impairment!is!possible!and!clinicians!can!be!confident!
in!referring!those!most!in!need!of!early!intervention!in!the!first!few!months!of!life.!!Clinical!
application!of!the!GMA!is!useful!to!build!a!clinical!profile!of!high\risk!infants!over!time.!It!
allows!early!entry!of!infants!into!targeted!treatment!programmes!and!enrolment!into!
intervention!studies!during!the!period!of!greatest!neuroplastic!change.!!
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All!study!infants!designated!“high!risk!of!CP”!on!the!basis!of!F\!GMs!were!referred!for!early!
intervention.! Unless! there! were! very! clear! markers! such! as! severe! MRI! findings,! a!
definitive! diagnosis!was! not! given! at! this! time,! due! to! diagnostician\preferred! practices!
(2).! Importantly,! our! high! sensitivity! rates! confirm! that! parents! were! not! “worried!
unnecessarily”,!given!that!almost!all!the!infants!with!F\!movements!were!found!to!have!an!
abnormal!outcome.!
The!high!rate!of!abnormal!outcomes!found!in!this!study!is!consistent!with!previous!studies!
reporting!outcomes!in!this!high\risk!population!(18\20).!We!defined!“abnormal”!as!a!delay!
in!at!least!one!developmental!domain!of!the!BSID\III,!which!is!the!commonly!used!criteria!
in!some!follow\up!services,!although!some!services!prefer!to!define!an!abnormal!outcome!
as!one!where!at!least!2!domains!of!the!BSID!are!>!1!SD!below!the!mean.!In!our!analysis,!
only! delays! in! language! alone! were! not! counted! as! abnormal! due! to! the! high! level! of!
variability! in! the!emergence!of! these!skills!and!high!prevalence!of!early! language!delays!
that! resolve! (17).! Not! surprisingly,! the! GMA! did! not! detect! infants!with! developmental!
delay,!highlighting! the! importance!of!using!complementary!assessments!when! following!
high\risk! infants.! Detecting! a! probable! CP! outcome! versus! one! of! mild! developmental!
delay!is!important!as!it!allows!referral!for!diagnosis\specific!intervention!(21).!
The!GMA!has!now!been!embedded! in!clinical!practice!across!NICU! follow\up!services! in!
NSW,!Australia.!Use!of! the!GM!Rater!Network!has!provided!support! for!use!of! this! tool!
and!for!the!accuracy!of!results.!To!accommodate!timing!of!peak!fidgety!period,!a!number!
of! services! have! brought! forward! their! initial! follow\up! clinic! visit! to! 3! months! of! age!
rather! than! the! conventional! 4! months! of! age,! in! order! to! capture! the! GMs! of! at\risk!
infants!during!the!ideal!fidgety!period.!
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It! is! recommended! that! the! following! high\risk! groups! of! infants! be! screened! using! the!
GMA;! preterm! (including! late! preterm),! all! with! neonatal! encephalopathy,! cardiac! and!
surgical! infants,! those! with! stroke! and! neurological! signs! such! as! seizures,! growth!
restriction!and!those!with!birth!defects!(22).!
!
Limitations)
There! are! several! limitations! related! to! our! study.! First,! as! has! been! noted! in! previous!
publications! sampling! is! a! potential! source! of! bias! (23).! All! infants! in! this! study! were!
already! considered! at! high! risk! of! adverse! neurodevelopmental! outcome.! Within! our!
group!the!level!of!risk!for!CP!specifically!was!variable.!For!example,!the!sample! included!
term!infants!with!HIE!(very!high!risk!for!CP)!and!those!with!congenital!heart!defects,!very!
preterm! and! late! preterm! infants.! In! addition,! cases! were! recruited! for! the! most! part!
sequentially;!however!some!cases!were!excluded!as!they!were!recruited!to!other!studies,!
and!some!study!sites!did!not!collect!data!for!the!full!study!period!owing!to!the!differing!
timelines!for!study!approval!from!Ethics.!
Second,!outcome!data!was!mostly!only!at!12!months!and!it!is!known!that!milder!forms!of!
CP!may!only!be!diagnosed!later!in!childhood!when!the!diagnostician!is!sure!that!the!motor!
impairment! is!permanent.! Indeed!n=3! infants!were! suspected! to!have!a!mild!CP!due! to!
tone! abnormalities! but! had! not! yet! been! formally! diagnosed! but! were! being! closely!
monitored!by!allied!health!practitioners!who!suspected!they!had!CP.!Potentially!the!rate!
of!CP! therefore!has!been!under! identified! in! this! sample,!and! that! the! sensitivity!of! the!
GMA!might!have!been!even!higher.!Future!studies!should!report!2\year!outcomes!in!this!
high\risk! cohort,! as! has! been! done! previously! in! very! preterm! groups! (15).! Third,!
additional!analysis!of!sensitivity!and!specificity!of!GMs!in!the!earlier!writhing!period!might!
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lead!to!the!development!of!effective!very!early!interventions!that!could!be!applied!in!the!
NICU!within!first!2\3!months!of!life!closest!to!the!timing!of!the!brain!injury.!Fourth,!sex!of!
participants!was!deliberately!not!recorded!so!as!to!protect!the!anonymity!of!children!with!
an! absent! fidgety! score! from! small! study! sites,! where! the! n\value! was! below! the!
conventional!n=4!cut\off!for!anonymity.!The!accuracy!of!GMs!is!not!however!known!to!be!
affected!by!gender!and!therefore!this!is!unlikely!to!have!influenced!the!results.!Finally,!as!
previously! outlined,! the!practice! variation!between! sites! in! terms!of! number!of! blinded!
GMs!scorers!is!a!further!limitation!of!the!study.!
Conclusion)
The!GMA!is!an!accurate,!important!and!feasible!assessment!tool.!It!is!non\invasive!
and!therefore!should!be!used!regularly!in!the!NICU!environment!and!in!follow\up!
programmes!for!early!identification!of!infants!at!the!highest!risk!of!CP.!It!is!clinically!
feasible!to!use!and!has!excellent!predictive!validity!when!used!by!certified!
Australian!assessors.!Early!detection!of!CP!is!possible!and!implementation!of!
screening!high\risk!infants!will!allow!those!identified!timely!access!to!intervention!
services!that!aim!to!optimise!their!developmental!outcomes.!In!conclusion,!we!
recommend!that!the!GMA!be!widely!adopted!into!clinical!practice,!to!close!the!
know\do!gap!about!late!diagnosis!of!CP,!which!is!potentially!harmful!to!infants.!
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Our systematic review (Study 2) revealed firstly the paucity of early 
intervention trials that accurately identified infants with CP in the first year 
of life, and secondly, that those interventions that were effective in this 
population were based on motor learning principles including enrichment of 
the learning environment. 
 
We developed a novel early intervention programme we labelled GAME 
(Goals – Activity - Motor Enrichment) that focused on intensive motor 
training, co-delivered by therapists and parents in an enriched home 
environment.  
 
This methods paper describes the GAME protocol for the randomised trials 
that followed (Studies 5 and 6). 
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GAME (Goals - Activity - Motor Enrichment):
protocol of a single blind randomised controlled
trial of motor training, parent education and
environmental enrichment for infants at high
risk of cerebral palsy
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Abstract
Background: Cerebral palsy is the most common physical disability of childhood and early detection is possible
using evidence based assessments. Systematic reviews indicate early intervention trials rarely demonstrate efficacy
for improving motor outcomes but environmental enrichment interventions appear promising. This study is built
on a previous pilot study and has been designed to assess the effectiveness of a goal - oriented motor training and
enrichment intervention programme, “GAME”, on the motor outcomes of infants at very high risk of cerebral palsy
(CP) compared with standard community based care.
Methods/design: A two group, single blind randomised controlled trial (n = 30) will be conducted. Eligible infants
are those diagnosed with CP or designated “at high risk of CP” on the basis of the General Movements Assessment and/
or abnormal neuroimaging. A physiotherapist and occupational therapist will deliver home-based GAME intervention at
least fortnightly until the infant’s first birthday. The intervention aims to optimize motor function and engage parents in
developmental activities aimed at enriching the home learning environment. Primary endpoint measures will be taken
16 weeks after intervention commences with the secondary endpoint at 12 months and 24 months corrected age. The
primary outcome measure will be the Peabody Developmental Motor Scale second edition. Secondary outcomes
measures include the Gross Motor Function Measure, Bayley Scales of Infant and Toddler Development, Affordances in
the Home Environment for Motor Development – Infant Scale, and the Canadian Occupational Performance Measure.
Parent well-being will be monitored using the Depression Anxiety and Stress Scale.
Discussion: This paper presents the background, design and intervention protocol of a randomised trial of a goal driven,
motor learning approach with customised environmental interventions and parental education for young infants at high
risk of cerebral palsy.
Trial registration: This trial is registered on the Australian New Zealand Clinical Trial register: ACTRN12611000572965.
* Correspondence: cmorgan@cerebralpalsy.org.au
1School of Medicine, University Of Notre Dame Australia, PO Box 6427,
Frenchs Forest, NSW 2086, Australia
2Cerebral Palsy Alliance Research Institute, University of Notre Dame
Australia, PO Box 6427, Frenchs Forest, NSW 2086, Australia
Full list of author information is available at the end of the article
© 2014 Morgan et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Morgan et al. BMC Neurology 2014, 14:203
http://www.biomedcentral.com/1471-2377/14/203
Background
Cerebral palsy (CP) is the most common physical disabil-
ity of childhood with a prevalence of 2.1/1000 live births
[1]. Late diagnosis, conservative “wait and see” monitoring
and late referral to early intervention is the prevailing
norm for two main reasons. First, because only half of in-
fants with CP have clearly identifiable risks in the newborn
period, for example prematurity or neonatal encephalop-
athy (NE) [2], and second, because not all infants with pre-
maturity or NE will go on to have CP. Wait and see
monitoring can mean brain injured infants do not always
receive intervention in the most crucial period of brain de-
velopment [2]. Furthermore children with CP reach ap-
proximately 90% of their gross motor potential by age 5
(or younger for more severely impaired), but for 40% of
this critical window the ultimate severity of their condition
is largely unknown [3], however severity itself is a likely
predictor of responsivity to early intervention. The field
of neuroscience has repeatedly demonstrated the plasti-
city of the infant brain and persistence of neurogenesis and
activity- dependent plasticity are two of the basic mecha-
nisms at work [4]. Intervention for infants with brain injur-
ies aims to optimise these neuroplastic mechanisms.
In recent years, research into the predictive validity of
Prechtl’s Qualitative Assessment of General Movements
(GMs) has allowed earlier diagnosis of high risk of CP to
be reliably made at 3 months of age [5,6]. GMs is now
the gold standard tool for early diagnosis of CP because of
higher specificity and sensitivity than other traditional
tests such as neurological examinations, cranial ultrasound
and MRI [7]. For the preterm population, the combination
of GMs and evidence of white matter injury on MRI pre-
dicts CP at 3 months with 100% accuracy [6].
Early intervention and early enrichment
Early intervention (EI) studies have typically not used this
combination of assessment tools to recruit homogenous
samples of infants at high risk of CP. Rather heteroge-
neous infants are included in EI studies and labelled “high
risk” because they were preterm, display delayed develop-
ment or had complex social issues [8]. In many of these
studies the proportion of children who actually go on to
be diagnosed with CP are relatively small resulting in
underpowered type II trials for CP. As a result it is virtu-
ally impossible to ascertain the effects of EI on the motor
outcomes of infants with CP. Most systematic reviews
conclude that EI approaches currently in use for CP do
not have any effect on motor outcomes greater than what
would be expected as a result of maturation [9,10]. It is
important to note, however, that evidence for the effective-
ness of general EI to improve cognition is well established
for the more heterogeneous “high risk” groups [11].
It remains to be determined whether intervention ap-
proaches that are goal-oriented and involve active motor
training [12,13] currently used in older children with CP
are actually applicable to infants with a small emergent
motor repertoire. In addition, what “active ingredients”
from EI approaches are vital to maximise developmental
outcomes?
Environmental enrichment (EE) has been proven to
enhance neuroplasticity and promote memory and
motor function in animal studies [14] but the effect in
humans is less understood. In animal studies, an EE is
defined as one that facilitates enhanced cognitive, motor
and sensory stimulation. Although there is no agreed pa-
rameters for enrichment, these animal housing condi-
tions typically include high levels of complexity and
variability with arrangement of toys, platforms and tun-
nels being changed every few days to promote motor
learning and memory. The motor opportunities afforded
by EE are a critical success factor.
Translating these ideas into the human context is
complex. Much more is known about the detrimental
impact of deprivation (under-enrichment) on child de-
velopment than is known about what constitutes enrich-
ment for infants raised in “expected environments” [15].
Thus a continuum of enrichment is implied, but has not
been well explained in terms of the type or amount of
enrichment required for children who are not typically
developing. One recent systematic review [8] has dem-
onstrated a small positive effect on motor outcomes for
infants at high risk of CP when the utilised interventions
are based on principles of environmental enrichment.
The enhanced plasticity mechanisms present in the in-
fant brain allow it to be more strongly influenced by the
environment than adult brains, so furthering our under-
standing of what constitutes enrichment for brain in-
jured babies is important [16,17].
In children with CP the key environmental factors which
influence motor development are yet to be determined,
however clinical and neuroscience do provide a clear ra-
tionale for the urgent need for the development of EI pro-
grammes that focus on EE strategies to improve motor
outcomes in these children [18]. Ulrich’s [19] recent re-
view discusses the opportunities for the development of
early intervention programs which link neuroscience with
clinical science and states in her summary, “A growing
body of basic and clinical science results suggest we are
missing the boat on opportunities for infants with motor
disabilities if we do not develop more empirically based
protocols to use very early in life in order to optimize
developmental outcomes” [19], p10.
We have developed such a protocol, “GAME”, based
upon the principles of motor learning and widely ac-
cepted EI frameworks including family centred practice
[20] and the ecological framework [21]. Data from our
recent pilot randomised controlled trial RCT (n = 13) in-
dicates that GAME, a goal-oriented, intensive motor
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training programme that actively involves parents and
includes EE strategies, could be effective in advancing
the motor trajectories of infants at high risk of CP [22].
After 12 weeks, GAME intervention infants (n = 6) had
an 8.05 point advantage on the Total Motor Quotient of
the Peabody Developmental Motor Scales – second edition
compared to infants who received standard care therapy
(n = 7). Although small, the pilot study confirmed feasibility
of recruitment and randomisation procedures, and enabled
confirmation of outcome measures and the sample size re-
quired for a larger RCT of GAME intervention. This pro-
posed study will address this gap in the literature.
Objective
The aim of this study is to evaluate whether a goal ori-
ented, intensive motor training programme with EE
strategies (GAME) is more effective than current stand-
ard care practices in influencing the early motor devel-
opment of infants at high risk of CP.
Methods
A single blind RCT with 2 parallel groups will be con-
ducted to evaluate the efficacy of GAME compared to
standard care. The outcomes of this trial are the infant’s
motor function after 16 weeks of intervention and at 12
and 24 months corrected age, home enrichment, parent
perception of and satisfaction with their child’s perform-
ance and parental well - being.
We hypothesise that:
1. Infants diagnosed with CP or at risk of CP that
receive GAME intervention will have higher short
term (after 16 weeks of intervention) Peabody
Developmental Motor Scale (PDMS II) scores than
infants that receive standard care
2. Infants diagnosed with CP or at risk of CP that
receive GAME intervention will have higher long
term (at 1 year of age) scores on the PDMS II scores
than infants that receive standard care.
3. Infants diagnosed with CP or at risk of CP that
receive GAME intervention will have higher Gross
Motor Function Measure (GMFM) scores than
infants that receive standard care at 1 year of age.
4. Infants who have received GAME intervention will
have sustained higher PDMS –II scores long term
(at 24 months) compared with infants who have
received standard care.
Study sample and recruitment
Thirty infants will be recruited from their treating insti-
tution, community physician or local therapist. The in-
fants will be recruited in and around Sydney, NSW
Australia. Seven NICUs and the Cerebral Palsy Alliance
will actively recruiting to this study although infants
may be referred from any source. Study sites are listed
in the Appendix.
All parents of eligible infants will be informed about the
study only after they have had discussions with their med-
ical team regarding the high risk status of their child, or a
confirmed diagnosis of CP. Families will be given a site
specific information sheet regarding the purpose and de-
sign of the study and have opportunity to speak with in-
vestigators before consenting to the study. Parents who do
not wish to consent to the study will be offered standard
community based therapy.
After consent is obtained, prior to randomisation, the
investigators will visit the family at home to complete all
baseline assessments and collect demographic and peri-
natal data. MRI and medical data will be obtained from
the infant’s medical record.
The Human Research and Ethics Committees of the
Sydney Children’s Hospital Network (SCHN), Cerebral
Palsy Alliance (CPA) and the University of Notre Dame
Australia (UNDA) have approved this study. The experi-
mental design including time points and outcome measures
are depicted in the CONSORT [23] flowchart (Figure 1).
Inclusion criteria
Infants aged between 3 and 6 months (corrected age) with a
diagnosis of CP or at high risk of CP are eligible for the
study. Infants referred between 9–18 weeks post term age
(PTA) will be screened using the General Movements As-
sessment (GMs). At least 2 certified assessors blinded to the
infant’s history will score the GMs videos. Infants with ab-
normal general movements (absent fidgety) are eligible for
enrolment, ie 95% high risk of CP. Where assessors disagree,
a third blinded assessor will be required to assess the video.
Infants over 18 weeks corrected age up to 6 months of
age, outside the window of reliable GMs assessment,
will be included on the basis of a confirmed CP diagno-
sis and/or abnormal neuroimaging as described by
Krageloh-Mann [24].
Imaging commonly associated with CP include:
1. Periventricular Leucomalacia (PVL) and cystic PVL
2. Intracranial Haemorrhage
3. Periventricular infarction
4. Lesions of the basal ganglia and thalamus
5. Unilateral parenchymal injury eg middle cerebral
artery infarction
6. Cortical malformation
A pediatric neurologist blinded to group allocation will
confirm MRI features.
Exclusion criteria
Infants otherwise eligible but with severe genetic abnor-
malities, or not discharged from hospital, or residing in
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remote areas not accessible to the research team will not
be eligible for the study.
Sample size
The planned study sample size (n = 30; 15 per group) has
been estimated from a power calculation based on our
pilot data using motor composite scores of the PDMS-2,
with an alpha value of 5% and power of 80%, using a min-
imal clinically important difference of 10%, accounting for
a 20% dropout rate.
Randomization process
After informed consent and baseline measures are taken,
an officer not connected with the study will randomise
participants at a separate location using a pre-prepared
random assignment schedule stored within 30 concealed
opaque envelopes generated using computer generated
random numbers. The Primary Investigator will be in-
formed by the independent randomisation officer of group
allocation and will inform parents. Twins will be rando-
mised together due to the nature of the intervention.
Figure 1 Consort flow chart.
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Blinding arrangements
The independent assessors will be blinded to group allo-
cation and will carry out all assessments after random-
isation. Assessments of the child’s movement for the
primary outcome measure and GMFM-66, will be com-
pleted via scoring from video. Other secondary outcome
measure assessments will be conducted over the phone, via
home visit or parent self report, as per the test and clinical
conventions. Research Assistants from the Cerebral Palsy
Alliance Research Institute and trained physiotherapists
and/or occupational therapists will score the measures as
the blind assessors.
It is not possible for either the participating families or
those conducting the intervention to be blinded in this
trial due to the nature of the intervention.
Intervention
Therapists
Investigators CM, an experienced physiotherapist and IN,
an experienced occupational therapist are the primary
therapists providing the GAME intervention to maximise
fidelity of the intervention. If a speech pathologist or fam-
ily support worker is required based on identified family
goals this will be provided. Infants in the standard care
group will receive services from local therapists according
to the centre’s protocol. Typically in Sydney this would in-
clude physiotherapists and/or occupational therapists.
Some sites offer a multidisciplinary team approach while
others a keyworker model with a primary therapist.
Interventions
GAME is a therapy intervention based on contempor-
ary motor theory. This intervention approach has been
previously described in a small pilot RCT that tested
the feasibility of GAME [22]. GAME intervention con-
sists of three components: goal-oriented intensive
motor training, parent education, and strategies to en-
rich the child’s motor learning environment. Although
described as distinct aspects of GAME, these compo-
nents are fully integrated into therapy sessions with
the emphasis on any particular component varying
from session to session.
Game part 1
Goal-oriented intensive motor training Families col-
laborate with the therapists to determine a set of goals
for their child’s development [25]. Typically the goals
would relate to motor development but might also
include health related concerns known to affect develop-
ment such as sleeping and feeding. The therapist plays
an important role in helping parents set realistic and
appropriately time framed goals. As goals are attained
the family and therapist work together to develop new
goals. These parent identified goal areas are targeted for
practice during therapy sessions and built into a home
programme (HP).
The motor learning component of the intervention is
based on the principles of motor learning and dynamic
systems theory [26,27]. Therapist assessment of the relative
contributions of weakness, selective motor control and al-
tered tone to difficulties in goal achievement are discussed
with the family and solutions are identified and tried [28].
Parents are encouraged to use their knowledge of their
child’s play preferences to elicit self-generated motor activ-
ity. Minimal manual guidance is provided when required
and withdrawn as soon as the child has the idea of the
movement or begins to demonstrate the ability to recruit a
successful muscle action or sequence. Parents are coached
in understanding “missing components” of the desired ac-
tion and problem solve with the therapists ways of simplify-
ing the task to enable at least part task attainment.
Motor tasks are scaffolded, so that the infant can al-
ways actively complete at least a part of the task [29]. As
performance improves, the motor challenge is increased
by altering the task or environment to encourage prob-
lem solving. Manual assistance is reduced or withdrawn
as soon as the infant demonstrates self-initiated progress
with the task; ensuring self-generated motor activity is
promoted in all practice sessions. Once a motor skill is
learned, variability of practice is introduced to increase
the complexity and generalizability of the skill [30]. Early
weightbearing and sit to stand from the parents’ lap are
routinely included for each infant even if standing is not
identified as a specific goal. Rehabilitation research in
older children and adults with brain injuries suggest that
functional weight bearing exercises can both improve
motor control and provide strength training [26]. Given
that the expected impairments of CP include weakness
and reduced selective motor control, early activation of
muscles of the lower limb using both concentric and ec-
centric exercise could enhance the development of upright
mobility. Similarly, practice of reaching and grasping a var-
iety of objects is also a standard part of motor training for
all infants in order to expose the infants who are expected
to be delayed, to a variety of objects to advance grasp and
reach behaviours [31]. Modified constraint induced move-
ment therapy and/or bimanual training is used when
asymmetrical hand function is evident.
Practice schedules are discussed and designed based on
family time constraints. A written HP, illustrated with pho-
tographs and related to parent identified goals, weightbear-
ing and reach and grasp is provided. The HP describes
parenting strategies, environmental enrichments and child-
activities as per published guidelines on effective home pro-
grammes [32]. Activities in the HP are organised into those
in which the carer plays an active role and those where
practice can be “set up” for the infant to carry-out inde-
pendently. The HP is updated as goals are attained.
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Game part 2
Parent education Parent education is known to be an im-
portant component of early intervention that is grounded
in family centred practice [33]. Since most of the infant’s ac-
tive practice opportunities are provided in the child’ daily
routines, parent education is vital [34]. In GAME interven-
tion, parents are coached to identify their child’s voluntary
attempts to move and self-regulate, plus understand the
usual trajectory of emergent motor skills and how to stimu-
late progress. Parents are trained in simple motor task ana-
lysis and coached in appropriate strategies to enhance their
child’s development both at a specific goal level and in gen-
eral early learning and development principles. Parents are
taught to optimise the best use of their infants’ “awake”
time and the naturally occurring opportunities for learning.
Learning optimisation includes both parent-directed and
structured practice of desired motor tasks, where the parent
role is integral to the child’s learning (e.g. creating repeti-
tions) and constructing opportunities for independent play
(e.g. playing alone with motor enriching toys set up for the
child). Parents are encouraged to both observe the therapist
eliciting a motor behaviour from the baby and to attempt it
themselves. Specific feedback, in a warm and supportive
context, is given to parents to enable them to tease out why
some attempts were successful for the baby and others wer-
en’t. As new motor skills emerge parents are coached in
strategies to increase the challenge of the task; for example
removal of support or the introduction of more complex
toys. The importance of allowing trial and error during
practice is discussed and parents are encouraged to devise
their own activities to enhance goal attainment. Prognostic
information is given when possible as well as evidence
based information regarding sleeping, feeding and respon-
sive parenting.
Game part 3
Environmental enrichment It is clear that many as-
pects of a child’s environment influence his or her motor,
cognitive and social-emotional outcomes. Parental respon-
sivity, a variety of daily experiences, equipment use and
the structure of the physical space are all known to influ-
ence child development [35-37]. In GAME, all visits are
conducted within the family’s home and deliberate atten-
tion is paid to aspects of the home environment to en-
hance developmental outcomes. This enrichment includes
assistance in setting up motor enriched play environments
to promote child self-generated movements, exploration
and task success. This includes instruction in careful toy
selection “matched” to the desired motor task, plus phys-
ical set up of areas for practicing and repeating activities
related to the identified goal areas, weightbearing, and
reaching and grasping tasks. Conventional baby equip-
ment (e.g. highchairs, toys) already purchased by the fam-
ily is used wherever possible. The whole environment for
motor learning is taken into account and therefore inter-
vention may also include: (a) evidence-based early
learning stimulation and role modelling to enhance cog-
nitive and language development (e.g. reading books to
children, limiting passive television watching); (b) opti-
mising sleep hygiene; and (c) feeding interventions (e.g.
anti-reflux medications) to ensure adequate caloric nu-
trition and pain-free backdrops for learning. The im-
portance of variable daily experiences for infants is
deliberately addressed and support given when parents
articulate difficulty leaving the house. Siblings and ex-
tended family members are also actively encouraged to
take part in the HP and therapy sessions to promote:
family knowledge; family acceptance; family wellbeing;
repetition of learning opportunities; and provide a nat-
ural source of varied social interaction for the infant.
Parent well-being is openly discussed and support given
to parents to access appropriate services when required.
Home visits from the GAME treating therapists are of-
fered weekly initially and then frequency of intervention
negotiated with each family around their preferences,
availability and family resources required to carry out
the intervention with fidelity. Visits are approximately
60 to 90 minutes duration.
Standard care
“Standard care” (SC) describes the current follow-up and/
or therapeutic interventions used when an infant deemed
at high risk of CP is discharged from hospital in New South
Wales Australia. It is not possible to standardise the fre-
quency, intensity or type of interventions received in the
SC group. Approaches used are varied and might include
neurodevelopmental therapy, the developmental skills ap-
proach, group therapy or motor learning approaches re-
flective of the current EI literature base. Most therapists
include parent education on positioning and handling and
suggested home activities within the therapy programme.
In the pilot study, SC therapy was offered approximately
monthly but ranged from fortnightly to 3 monthly. In order
to monitor the mode, frequency and intensity of interven-
tion received by those in the standard care group as com-
pared to the GAME group, all parents will be asked to keep
a “log book” so that these relevant parameters can be com-
pared between the groups. Similarly since the actual inter-
ventions provided in SC are likely to vary between services,
history taking will include information gathering regarding
the type of interventions used.
Outcome measures and procedures
Peabody Developmental Motor Scales -Second edition
(PDMS-2)
The PDMS-2 [38] is the primary outcome measure in
this trial and is a frequently used assessment of motor
skills. This test is standardised and normed for children
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aged from birth to 6 years and has been validated for
use as a discriminative measure. Two studies have dem-
onstrated that it is responsive to change in the CP popu-
lation for both infants [39] and toddlers [40]. It has
demonstrated concurrent validity with the GMFM [41]
and the Bayley [42]. PDMS-2 assessments will be ob-
tained at baseline, 16 weeks after therapy has com-
menced and at 12 months and 2 years. Assessments will
be blind scored from video.
Gross Motor Function Measure (GMFM)
The GMFM [43] is a criterion-referenced tool that is
widely accepted as the gold standard for gross motor as-
sessment in children with CP. There are a total of 5 di-
mensions measured including rolling, sitting, creeping,
standing and walking. Infants will be videoed during the
assessment and blind raters will score from the video
using the appropriate manual. The GMFM- 66 will be
used in this study at the secondary endpoint, (12 months)
and at the 2-year follow up.
Canadian Occupational Performance Measure (COPM)
The COPM [44] is an individualised criterion referenced
measure of performance of a self-selected range of activ-
ities. Functional problem areas are identified, prioritised
and rated for performance and satisfaction via a semi-
structured interview. The COPM will be used to prioritise
goals and measure change in performance and satisfac-
tion. The COPM will be used at baseline, 16 weeks after
therapy has commenced and at 12 months. Data will be
collected via face to face or phone interview by independ-
ent raters.
Affordances in the Home Environment for Motor
Development-Infant Scale (AHEMD-IS)
The AHEMD-IS [45] is a measure of the quality and
quantity of motor enrichment opportunities available to
a child within the home environment. This tool has
demonstrated validity and reliability in the toddler for-
mat. Data is collected via a parent self report on a stan-
dardised questionnaire. A total raw score is calculated.
This measure will be taken at baseline and at 12 months.
Depression, Anxiety and Stress Scale-21 (DASS)
The DASS-21 [46] is an adult self-report designed to
measure the emotional states of depression, anxiety and
stress. It is a 21-item questionnaire and will be used to
measure parent emotional well-being at baseline, before
randomisation and at all time points thereafter.
Bayley Scales of Infant and Toddler Development Third
Edition (BSID-III)
The BSID-III [47] is a standardised and norm referenced
assessment, which measures the cognitive, motor, language
and social-emotional development of infants and toddlers
aged 0–3. It consists of a number of developmental play
tasks that can be completed at the child’s home and vid-
eoed for scoring by blind raters. Alternatively infants en-
rolled in follow up programmes from recruitment sites may
be assessed by staff blinded to group allocation at their 1-
year clinic appointment. Infants will be assessed on the
BSID-III at 12 months and 2 years.
Statistical methods
Analysis will be conducted on an intention-to-treat basis
using SPSS and reported according to the CONSORT
statement. Descriptive statistics (frequencies, means and
95% CIs) will be used to describe the sample at baseline
and data from each outcome measure used will be sum-
marised for both treatment groups. Between-group dif-
ferences following intervention will be analysed using
multiple regression to determine whether group alloca-
tion predicts outcome. MRI classification, SES and co-
morbidities including vision impairment and epilepsy
will be considered as covariates in the analysis.
Discussion
This paper outlines the design and background for a sin-
gle blind RCT comparing a novel intervention “GAME”
with standard care to improve the motor outcomes of
infants at high risk of CP.
Appendix
Study Sites
1. Cerebral Palsy Alliance, NSW Australia
2. Sydney Childrens Hospital Network, NSW Australia
3. Royal Prince Alfred Hospital, NSW Australia
4. Westmead Hospital, NSW Australia
5. Royal North Shore Hospital, NSW Australia
6. Liverpool Hospital, NSW Australia
7. Royal Women’s Hospital, NSW Australia
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Optimising motor learning in infants at high risk
of cerebral palsy: a pilot study
Catherine Morgan1,2*, Iona Novak1,2, Russell C Dale3 and Nadia Badawi4
Abstract
Background: The average age for the diagnosis of cerebral palsy (CP) is 19 months. Recent neuroplasticity literature
suggests that intensive, task-specific intervention ought to commence as early as possible and in an enriched
environment, during the critical period of neural development. Active motor interventions are effective in some
populations, however the effects of active motor interventions on the motor outcomes of infants with CP have not
been researched thoroughly, but pilot work is promising. The aim of this study was to determine the short- term
effects of “GAME”; a new and novel goal-oriented activity-based, environmental enrichment therapy programme
on the motor development of infants at high risk of CP and test study procedures for a randomized controlled
trial (RCT).
Methods: Pragmatic 2-group pilot RCT to assess motor outcomes, goal attainment, parent well-being and home
environment quality, after 12-weeks of GAME intervention versus standard care. GAME included: creation of
movement environments to elicit motor behaviours; parent training in motor learning and task analysis; frequent
practice of motor tasks using a programme that was individualised to the child, was varied and focused on
self-initiated movement. Data were analyzed using multiple regression.
Results: Thirteen infants were consented, randomised, treated and completed the study. At study conclusion, the
GAME group (n = 6) demonstrated an advantage in Total Motor Quotient of 8.05 points on the Peabody Developmental
Motor Scale-2 (PDMS-2) compared to the standard care group (n = 7) (p < .001). No significant differences existed
between groups on any other measure.
Conclusions: GAME appears to offer a promising and feasible new motor intervention for CP, with favourable
short-term motor outcomes. A pressing need exists for an adequately powered RCT with long-term end points, to
determine if GAME may advance these children’s motor trajectory.
Keywords: Cerebral palsy, Infant, Environmental enrichment, Motor skill
Background
Late diagnosis is the norm for children with cerebral
palsy (CP) since very few diagnostic biomarkers exists;
only half are unwell in the neonatal period [1]; and neu-
roimaging does not accurately predict severity except in
severe cases. This most often leads to a “wait and see”
approach, where brain injured babies are monitored but
not referred for rehabilitation until marked developmen-
tal delay is evident. Formal diagnosis of CP is made on
average at 19 months and can be as late as 4 years for
those mildly affected, usually after failed motor mile-
stones, or the emergence of clinical signs such as spasti-
city or involuntary movements. Identifying infants at
very high risk of CP early and discriminating them from
those with other diagnoses could lead to the provision of
more specific, timely and evidence-based CP rehabilita-
tive therapies in the critical period of brain development
[1]. Current thinking is that these diagnostic-specific in-
terventions should be applied very early rather than de-
livering general early intervention (EI), in an effort to
optimise outcomes and limit maladaptive plasticity [2,3].
A consequence of the lack of a definitive CP biomarker
and late diagnosis is that only a handful of EI clinical trials
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exist where all participants actually have CP or are at very
high risk of CP. Rather, most EI trials comprise of hetero-
geneous “at risk” populations, including many infants who
go on to have normal outcomes, resulting in underpow-
ered trials that do not tell us much about effect of EI in
CP [4]. Studies specifically recruiting infants with brain in-
juries in the newborn period have typically not accurately
identified infants who will later go on to be diagnosed
with CP and disconcertingly, rarely have the study inter-
ventions resulted in motor improvements [5]. Prechtl’s
qualitative assessment of general movements (GMs) is
the most predictive assessment tool to detect infants, as
young as 3 months who have the highest risk of CP,
however it is rarely used when recruiting infants to
intervention studies [6]. A further confounder in CP
intervention studies is the heterogeneity of the condi-
tion, creating wide distributions of baseline and change
scores making it difficult to detect change and identify
best responders and non-responders.
As evidence of the benefits of Environmental Enrich-
ment (referred to as EE from now on) on brain recovery
grows [2,5], the focus of CP rehabilitation in older chil-
dren has shifted towards approaches that emphasise
goal-oriented activity-based therapy [7], and frequent
task practice with deliberate creation of optimal environ-
ments for motor learning. These approaches, based on
motor learning principles do not focus on passive inter-
ventions such as stretching, or the normalisation of
movement like traditional Neurodevelopmental Therapy
(NDT), but rather on task practicability and environ-
mental context [8,9]. Improvements in motor behaviour
depend upon intentional goal directed practice where
the therapist is a “change agent” setting the stage for
learning and facilitating the child’s exploration of effect-
ive movement solutions [10,11]. Examples of proven ef-
fective interventions utilising motor learning principles
include constraint induced movement therapy and bi-
manual therapy. Typically these interventions are offered
to children with CP from 2 years of age. Recently, a sys-
tematic review and meta-analysis of infants at high risk of
CP, showed a small but significant effect of EE interventions
on motor outcomes [5], suggesting that diagnostic-specific
interventions including EE lead to better outcomes for in-
fants. There remains a significant gap in our understanding
of how the motor learning approaches effective in older
children with CP can be applied to infants with a very lim-
ited motor repertoire. In addition, parent education is
known to be an important component of early interven-
tion [12] and since most of the infant’s active practice op-
portunities are provided within daily routines, parent
education and coaching is crucial in order for the neces-
sary practice to take place [13]. We therefore developed a
new infant intervention approach: “Goals, Activity and
Motor Enrichment” (GAME) that utilized motor learning
principles, goal-oriented activity-based therapy, parent
education and EE strategies.
The aim of our study was to determine the short-term
effects of GAME intervention on the motor develop-
ment of 3–5 month old infants at very high risk of CP,
and to test study procedures in preparation for a Rando-
mised Controlled Trial (RCT). We hypothesized that in-
fants in the GAME intervention group would have
higher goal attainment and Peabody Developmental
Motor Scale-2 (PDMS-2) scores after 12 weeks of inter-
vention than infants receiving Standard Care (referred to
as SC from now on).
Methods
A pragmatic 2-group pilot RCT was used to explore the
feasibility and effects of 12 weeks of GAME (Goals –Ac-
tivity –Motor –Enrichment) intervention in infants at
high risk of CP. GAME intervention is a home-based
motor learning approach that aims to advance motor
skills of infants and young children via motor task prac-
tice, parent education and environmental enrichment.
The study also aimed to test the acceptability of ran-
domisation procedures and the intervention to families
and referring institutions, and to check outcome meas-
ure sensitivity and determine likely effect sizes.
Study rationale
This study is both an RCT and a feasibility study [14].
We conducted and reported the pilot/feasibility study as
an RCT because: 1) we wanted to test whether the ran-
domisation procedure itself was acceptable to referring
institutions and parents and therefore it was important
to test whether or not it was feasible to recruit partici-
pants to an RCT. Since the GMs was new in our locality
we were unsure that once the label “high risk of CP” was
given to infants whether referral institutions were likely
to promote a study where there was equal chance the in-
fant would get a therapy program from a “CP specific”
service vs general pediatric therapy programs, which are
varied in type and intensity. Moreover, we wanted to see
if parents “dropped out” of the study if they were rando-
mised to SC; 2) The intervention was not previously de-
scribed and we wanted to test the feasibility of both
carrying out the intervention and its’ acceptability to
parents; 3) The dearth of available outcome measures
that are criterion-referenced for infants with disabilities
is well established. As Goal Attainment Scaling (GAS) is
widely used in toddlers and children with CP we wanted
to test whether this was useful with infants who are yet
to meet their motor potential; 4) We wanted to test stat-
istical procedures. CP is a heterogeneous condition and
the GMs assessment does not predict severity. We ex-
pected therefore to recruit infants across the severity
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levels and for this reason used regression to enable us to
account for differing motor ability affecting outcome.
Participants
Thirteen infants were recruited from 6 Neonatal Intensive
Care Units (NICUs) in the Sydney Children’s Hospital
Network (SCHN) and from the Cerebral Palsy Alliance,
Australia. Infants 3–5 months of age were eligible for en-
rolment if parental consent was obtained and they had an
abnormal GMs assessment score between 11–18 weeks
post term age. Since “absent fidgety” GMs are the most
predictive of a future diagnosis of CP, we used results from
this period [6] rather than the earlier “writhing” period.
GMs assessments were scored by at least 2 certified GMs
assessors blinded to the infant’s history. No official diagno-
sis by a medical professional was made at enrolment, ra-
ther, parents were counselled about the results of the
GMs meaning their baby was at very high risk for CP.
Infants were excluded if oxygen dependent, still an in-
patient, or lived in a remote location precluding home
visits from investigators.
Procedures
Ethics approval was obtained from the University of
Notre Dame Australia, Cerebral Palsy Alliance and the
SCHN. After eligibility was determined, informed writ-
ten consent was obtained and baseline measures taken.
Infants were randomised to either the GAME or SC
groups using sequentially numbered opaque sealed en-
velopes. The randomisation sequence was computer
generated by an independent officer and group alloca-
tion was managed off-site. Intervention was carried out
for 12 weeks as per the trial protocol for the 2-groups.
Measures were taken at baseline within the child’s home
and were repeated at the primary end-point, after 12 weeks
of intervention.
Intervention
GAME: All GAME interventions were provided by the
investigators (CM and IN) and carried out within the
home environment. GAME has been described else-
where [15] but always consisted of three components:
goal oriented activity-based motor training, parent edu-
cation, and strategies to enrich the child’s learning
environment.
1. Goal-oriented intensive motor training – parent
identified goal areas were targeted for practice
during the therapy session and after further
assessment, a home program (HP), which was a
detailed goal focussed activity based home practice
plan was devised [16]. The therapist scaffolded all
motor tasks, so that the infant could always actively
complete at least a part of the task. As performance
improved, the challenge was increased by altering
the task or environment to a new and appropriate
level of difficulty. Manual assistance was provided by
the therapist and parent only when necessary for
safety or to give the infant the “idea” of the movement.
Manual assistance was reduced or withdrawn as soon
as the infant demonstrated self-initiated progress with
the task; ensuring self-generated motor activity was the
focus of all practice. Once a motor skill was learned,
variability of practice was introduced to increase the
complexity and generalizability of the skill. Early
weightbearing and sit to stand from the parents’ lap
were part of each HP even if standing was not
identified as a specific goal. Rehabilitation research in
older children and adults with brain injuries suggest
that functional weight bearing exercises can both
improve motor control and provide strength training
[17]. Given that the expected impairments of CP
include weakness and reduced selective motor control,
early activation of muscles of the lower limb using
both concentric and eccentric exercise could enhance
the development of upright mobility. Similarly,
practice of reaching and grasping a variety of objects
was a standard part of motor training for all infants in
order to expose the infants who are expected to be
delayed, to a variety of objects to advance grasp and
reach behaviours [18].
The written HP was related to parent identified goals,
weightbearing and reach and grasp. The HP included
photographs, describing parenting strategies, environ-
mental enrichments and child-activities as per pub-
lished guidelines on effective home programmes [16].
Activities in the HP were organised into those in
which the carer played an active role and those where
practice could be “set up” for the infant to carry-out
independently. The HP was updated once during the
12-week period.
2. Parent Education: Parents were coached to identify
their child’s voluntary attempts to move and
self-regulate, plus understand the usual trajectory of
emergent motor skills and how to stimulate
progress. Parents were trained in simple motor task
analysis and coached in appropriate strategies to
enhance their child’s development both at a specific
goal level and in general early learning and
development principles. Parents were taught to
optimise the best use of their infants’ awake time and
the naturally occurring opportunities for learning.
Learning optimisation included both parent-directed
and structured practice of desired motor tasks, where
the parent role was integral to the child’s learning (e.g.
creating repetitions) and constructing opportunities
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for independent play (e.g. playing alone with motor
enriching toys set up for the child). Parents were
encouraged to both observe the therapist eliciting a
motor behaviour from the baby and to attempt it
themselves. Specific feedback was given to parents to
enable them to tease out why some attempts were
successful for the baby and others weren’t. As new
motor skills emerged parents were coached in
strategies to increase the challenge of the task; for
example remove support or introduce a more complex
toy. The importance of allowing trial and error during
practice was discussed and parents were encouraged
to devise their own activities to enhance goal
attainment.
3. Environmental Enrichment – Parents were
encouraged and assisted to set up motor enriched
play environments to promote child self-generated
movements, exploration and task success. This
included instruction in careful toy selection
“matched” to the desired motor task, plus physical
set up of areas for practicing and repeating activities
related to the identified goal areas, weightbearing, and
reaching and grasping tasks. Conventional baby
equipment (e.g. highchairs, toys) already purchased
by the family was used wherever possible. The
whole environment for motor learning was taken
into account and therefore intervention also included:
(a) evidence-based early learning stimulation and
role modelling to enhance cognitive and language
development (e.g. reading books to children, limiting
passive television watching); (b) optimising sleep
hygiene, for example assisting with implementing sleep
routines; and (c) feeding interventions (e.g. anti-reflux
medications) to ensure adequate caloric nutrition and
pain-free backdrops for learning. The importance of
variable daily experiences for infants was deliberately
addressed and support given when parents articulated
difficulty leaving the house. Siblings and extended fam-
ily members were also actively encouraged to take part
in the HP and therapy sessions to promote: family
knowledge; family acceptance; family wellbeing;
repetition of learning opportunities; and provide a
natural source of varied social interaction for the
infant.
Intervention was customised for the child’s motor
ability, the family enrichment style, and parent goals.
Therapist visits were weekly initially and then fre-
quency was negotiated with each family around their
preferences, availability and parental skill level to carry
out GAME with fidelity. Visits typically lasted for 60 to
90 minutes.
Standard Care: Therapy intervention for infants at
high risk of CP is available in New South Wales (NSW)
free of charge, upon medical referral but varies enor-
mously with no gold-standard guidelines in existence.
Prior to study commencement, a survey was conducted
amongst the study recruiting sites, revealing that the in-
tensity of SC therapy was an average of 14-hours in the
first year of life, spread typically over fortnightly or
monthly appointments. Not all NICU recruitment sites
offered ongoing intervention and referred infants to
community-based organisations. The content of SC typ-
ically involved physical guidance to facilitate normal
movement patterns and parental advice on positioning
and handling. As no employer guidelines exist the choice
of therapy approach is decided by the treating therapist
and might have included NDT, motor learning, the
developmental skills approach or a combination of ap-
proaches. For study purposes the SC offered to the con-
trol group was outside the investigators control both in
terms of type of therapy and intensity of therapy, but
was however representative of SC. Infants randomised to
SC were referred to the provider by the centre referring
the infants to the study. Infants received SC from either
a hospital (n = 2), a community-based health centre (n = 3),
or a Not-For-Profit Organisation (n = 2).
Outcome measurement
The primary outcome measure was Goal Attainment
Scaling (GAS), an individualised criterion-referenced
measure of goal performance. Goals are set, with five
possible outcomes specified for each goal. Composite
T-scores are calculated for multiple goals and change
over time is quantified using change scores and using
conventional procedures recommended in literature [19].
We treated GAS scores as a continuous variable rather
than ordinal although both approaches are used in the
field and disagreement exists [19]. GAS is useful in CP re-
habilitation for detecting incremental change in functional
abilities that might not be detected on norm-referenced
tools such as the Bayley Scales of Infant and Toddler De-
velopment [20]. GAS is widely used and recommended in
childhood CP research because it is valid, reliable and re-
sponsive [19]. The use of GAS to measure outcomes in in-
fants with CP has been validated [21] but never used in
RCTs of infants under 12 months of age with limited
motor repertoires and thus sensitivity is untested for this
younger population. We therefore wanted to test the use-
fulness and applicability of GAS in very young infants
across a broad spectrum of motor ability. We used GAS
because we wanted to capture incremental change in per-
formance. At the initial appointment after consent had
been obtained, parent identified functional developmental
goals for their child from interview. These were formulated
into individual goal scales prior to the commencement of
Morgan et al. BMC Pediatrics  (2015) 15:30 Page 4 of 11
therapy with the baseline level set by the investigators on
the basis of an initial assessment of ability of the identified
goal and confirmed by parent interview. GAS banks have
been recommended in literature as a way of improving
rigour. We used GAS banks wherever possible but indivi-
dualised the goals as per the tool conventions when banks
did not exist. For example, if the same baseline ability was
evident for different participants for a specific goal the same
GAS levels from a bank were used. As per test developer
conventions parents were encouraged to identify 3 to a
maximum of 5 goals for the 12-week period. Assessors
were blinded to group allocation and scored the infant’s 12-
week GAS performance from video.
Canadian Occupational Performance Measure (COPM)
The COPM is an individualised, criterion referenced tool
measuring perceived change in infant performance and
parental satisfaction with performance over time on
family priorities. The COPM is widely used in CP re-
search and is valid, reliable and responsive [8,22]. During
a semi-structured interview parents identified a number
of areas that they would like to focus on with their baby
during the study period. The standard 10-point scale
was used to rate the infant’s performance and their own
satisfaction with the infant’s performance on the identi-
fied focus areas. This was repeated after 12-weeks by a
blinded assessor. An improvement of two or more
points is regarded as clinically significant [22].
Peabody Developmental Motor Scales - Second edition
(PDMS-2)
The PDMS-2 [23] is standardised norm-referenced tool,
which is valid, reliable, and widely accepted. A total of 5
sub-scales are assessed including reflexes, locomotion,
stationary, grasp and visual motor integration. A total
motor quotient (TMQ) is calculated with a mean of 100
and SD of 15. Responsivity has been established for in-
fants for the original version [24] and for toddlers with
CP for the PDMS-2 [25]. The PDMS-2 was selected pref-
erentially over the gold standard Gross Motor Function
Measure (GMFM) because it evaluates fine motor skills
that are targeted in many early intervention programmes.
Home Observation Measurement of the Environment
(HOME) - infant-toddler version
The HOME [26-28] is a reliable, valid standardised
measure of the quality and quantity of parent and home
environmental stimulation and support available, scored
from parent interview and direct observations. Sub-scales
include parent responsivity, the availability of learning ma-
terials and variety of stimulation. The infant – toddler ver-
sion is suitable for ages 0–3 [26]. Higher total HOME
scores indicate a more enriched environment with 45 be-
ing the highest possible score.
Depression, Anxiety and Stress Scale (DASS-21)
The DASS-21 [29] is a mental health self-report measure
of the emotional states of depression, anxiety and stress.
The DASS-21 is psychometrically sound and is useful
tool in the postnatal period for assessing psychological
risks [29]. The primary caregiving parent completed the
DASS 21 at baseline and study completion.
Logbooks
All families were asked to complete a logbook of the
number and length of therapy sessions received over the
12-week study period. Families also documented the
amount of time they spent carrying out therapist recom-
mendations in the home environment. Parents who
chose to access additional therapist-provided interven-
tion documented the number of extra sessions.
Statistical analysis
Parent and infant characteristics and baseline measure
mean scores were compared using independent t-tests,
to ensure baseline equivalence of groups. Linear regression
was used (where baseline scores were entered as covariates)
to test the effect of providing GAME intervention com-
pared to SC, on the infant’s goal attainment and motor
performance, the home environment and the parent’s
mental health. We chose to use linear regression over
traditional t-tests as CP is known to be a heterogeneous
condition and we expected to recruit infants across the se-
verity spectrum leading to a wide variety of baseline scores
and large standard deviations in both groups. Linear re-
gression allowed us to treat baseline scores as a covariate.
Severity could not reliably be imputed as a covariate in
this short duration, small sample study, although this
would be highly desirable, because 42% of infants change
severity levels on the gold standard scale under 2-years of
age [30]. Post-hoc analysis of the effect of total therapy
dose (therapist delivered intervention plus parent deliv-
ered home program practice) in hours on the outcome
was also conducted because there was insufficient power
to use intensity of therapy as a covariate in the regression.
Analyses were conducted on the basis of intention to treat.
Missing values were imputed as last observation carried
forward. Results were presented as between group differ-
ences with 95% confidence intervals.
Effect size was computed using Cohen’s d. Commonly
used criteria specify that a value below 0.2 is regarded as
no effect, a value of 0.2–0.5 is a small effect, a value of
0.5–0.8 is a medium-sized effect and a value above 0.8 is
a large effect [31].
Results
Thirteen infants from twelve families, mean age 17.6 weeks
(SD =3.9), corrected for prematurity, and at very high
risk of CP were recruited between September 2011 and
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September 2012 (Table 1). Six infants were randomised
to the GAME and seven to SC. Twins were randomised
into the same group, as it would be impossible for par-
ents to operationalize two different treatment ap-
proaches without intervention contamination. The flow
of participants through the study is summarised in
Figure 1. Adherence to study protocols was excellent
with no dropouts. Participant characteristics are sum-
marised in Table 1. Groups were equivalent at baseline
on infant and parent characteristics. All child outcome
data was normally distributed at both baseline and
follow-up, therefore meeting the assumption for para-
metric statistics. The only exception to this was the
HOME follow-up data, which was skewed right (kur-
tosis of 3.24) indicating ceiling effects on the measure.
Primary outcome at the primary end-point – GAS at
12 weeks
Primary and secondary outcomes are presented in Table 2.
After 12-weeks of intervention, both groups improved.
The mean change score for GAME intervention was 38.67
(SD = 7.63) and 28.28 (SD = 18.33) for the SC group but
with no statistically significant between-group differences
and wide variation about the SC mean. Infants in both
groups achieved the expected motor outcomes for
parent-identified therapist-set goal scales (Table 2), im-
proving 2 SDs from baseline on GAS T-Scores (GAS
mean T-score = 50, SD = 10, with a T-Score 40–60 indi-
cating achievement as expected). Parents usually identi-
fied 4–5 motor goals for their infants including rolling
(77%), sitting (54%), reaching in prone (54%) and grasp-
ing toys (54%). One parent identified a non-motor goal
(improved sleeping).
Secondary outcome measures
PDMS-2: After 12 weeks of intervention, the infant’s
motor abilities were assessed using the PDMS-2. Statisti-
cally significant between group differences were found in
the Total Motor Quotient (TMQ) PDMS-2 scores, confer-
ring an 8.05 point advantage to the GAME intervention
Table 1 Baseline characteristics of participants
Characteristic GAME (n = 6) Standard care (n = 7) p value
Gestational age, mean (SD), weeks 35.50 (5.21) 33.57 (7.76) 0.61
Age at baseline, mean (SD), weeks (corrected for prematurity) 17.83 (4.17) 17.43 (3.95) 0.86
Sex: M/F 5/1 6/1 -
Birthweight, (kg) 2.85 (1.19) 2.40 (1.40) 0.54
Parent age, years
Mother 33.00 (3.34) 33.43 (5.0) 0.86
Father 39.17 (5.12) 38.43 (2.64) 0.76
GAS T-score, mean (SD) 21.50 (1.22) 22.43 (0.96) 0.47
COPM Performance score, mean (SD) 3.03 (1.01) 3.19 (0.58) 0.42
COPM Satisfaction score, mean (SD) 4.26 (0.89) 4.81 (1.31) 0.36
PDMS-2
Total Motor Quotient 80.17 (8.98) 81.29 (9.20) 0.83
Total Motor Standard Score, mean (SD) 35.67 (6.56) 36.43 (6.88) 0.87
HOME – IT score, mean (SD) 33.83 (3.66) 29.00 (8.08) 0.06
DASS 21 score, mean (SD) 19.67 (8.71) 24.57 (23.96) 0.16
Risk for CP*
• Premature
<28 weeks n = 1/6 n = 3/7 -
>28 - < 37 weeks n = 1/6 n = 0/7 -
• HIE n = 2/6 n = 3/7 -
• Multiple Birth n = 2/6 n = 0/7 -
• Hydrocephaly n = 0/6 n = 1/7
Absent Fidgety General Movements Score (12–16 weeks PTA) n = 6/6 n = 7/7 -
Diagnosis of CP between 5-12months n = 4/6 n = 6/7 -
*Primary risk factor - some participants had >1 risk factor. GAS = Goal Attainment Scaling; COPM= Canadian Occupational Performance Measure; PDMS-2 = Peabody
Developmental Motor Scales – second edition; HOME =Home Observation Measurement of the Environment; DASS 21 = Depression, Anxiety, Stress Scales short
(21 item) version; HIE = Hypoxic Ischaemic Encephalopathy; PTA = post term age.
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group (95% CI 3.88-12.27; p < 0.001). This represents just
over 0.5 of a SD on the PDMS-2, which is probably clinic-
ally significant based on Wang’s calculation for toddlers
[25], but since no data on clinically meaningful change exists
in infancy we cannot be certain. The total composite motor
scores are also provided in Table 2 but the primary analysis
was conducted on the TMQ because it is regarded as the
most psychometrically robust estimation of motor ability.
We calculated sensitivity to change coefficients using
Cohen’s effect size, to assist with interpretation of the re-
sults. The Cohen’s effect size for the GAME group was
0.5, which is considered a small to moderate effect size,
while the SC group was −0.4, which Cohen defines as
trivial since the change is <0.2.
COPM: COPM performance and satisfaction scores
improved in both groups with no between-group statis-
tical differences.
HOME: Scores on the HOME improved in both
groups however there were no statistically significant be-
tween group differences.
DASS 21: DASS 21 scores were calculated for 12
mothers and 1 father, with no between-group statistical
differences found. Mean DASS 21 scores dropped in the
GAME group by 13.67 points (SD = 11.83) but were
stable in the SC group with an endpoint mean of 26.00
(SD = 28.75). The large SD in the SC group is explained
by the scores of one parent who had a pre-existing se-
vere mental health condition.
Logbook: Adherence to the GAME study protocol was
high for all families. All GAME parents completed the
logbook indicating HP and therapy time. All families in
the SC group recorded therapy visits however 2/7 did
not record HP time. These were the only missing values
in the analysis and were coded as missing. Seven of the
13 infants were formally diagnosed with CP during the
study period. Another 3 were formally diagnosed by
12 months and the developmental outcome of another 3
is unknown (2 in GAME group and 1 in SC). No infor-
mation was collected about the type or severity levels of
those diagnosed in this small pilot study.
Assessed for 
eligibility
(n = 15)
Randomised (n=13)
Excluded n=2
Did not meet inclusion     
criteria (n=2)
Allocated to 
experimental group 
(n=6)
Received allocated 
intervention (n=6)
Allocated to 
standard care group 
(n=7)
Received allocated 
intervention (n=7)
Lost to follow up 
(n=0)
Lost to follow up 
(n=0)
Analysed (n=6) Analysed (n=7)
Figure 1 Flow of participants.
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Post-hoc analysis of the dose of therapy found a sig-
nificant difference between groups in both the number
of hours of therapy and the numbers of hours HP time.
Infants in the GAME group received an average of 9.93
(range 7.5-15 hours) hours of therapy, which was almost
three times higher than the 3.49 hours (range 1–6 hours)
received by the SC group (p < 0.00). Parents in the
GAME group also spent more time carrying out the HP.
The mean total dose of therapy (therapy plus HP) was
140.58 hours (SD 23.3) for GAME, and 54.17 hours (SD
32.62) for SC.
Discussion
We hypothesised that GAME infants would have higher
GAS scores than SC infants. Mean GAS score for the
GAME group was a full GAS T-Score SD higher than
that of the SC group. Statistical significance was not
reached but this was not expected in this feasibility RCT
which was underpowered to detect change, leading to a
probable type II error. Interestingly goal achievement
was higher and more homogenous in the GAME group
whereas great variation was evident in SC scores, per-
haps indicating GAME was more goal-focused - an issue
that could be further examined in future studies. We
also noted that therapists found it difficult to predict the
rate of infant’s motor development at baseline given the
limited motor repertoire at enrolment age and the lack
of a robust severity measure for infants. Prior to inter-
vention when goals were set, parents had difficulty pre-
dicting their baby’s rate of development and their
knowledge of what was “normal” varied. For example
some parents did not know when a child would nor-
mally sit or walk. Parents were taught information in the
parent education component of GAME but at baseline
knowledge of milestone attainment affected levels of
parental concern and GAS prediction accuracy. Al-
though GAS has been shown to be an effective measure
of motor change for infants [20,21] it might be more
useful for documenting incremental change rather than
standard milestone acquisition within clinical trials. We
concluded that whilst GAS is sensitive in older children,
the parent and therapist inaccuracy of predicting infant
motor outcomes substantially affected sensitivity and
therefore we would not recommend using GAS as a pri-
mary outcome in our own future GAME studies with
infants.
Table 2 Primary and secondary outcome measures with estimates of effect (between group differences and 95%
confidence intervals)
Outcome Group Estimate of effect
(95% CI)
p-value
Time
Point
Measure GAME (n = 6) SC (n = 7)
Mean (SD) Mean (SD)
Infant goal achievement on motor tasks:
Baseline GAS T-Score 21.50 (1.22) 22.43 (0.98) - -
12-weeks GAS T-Score 60.17 (6.62) 50.71 (18.33) 7.37 (−12.71, 27.45) 0.43
Parent perception of infant motor performance-
Baseline COPM Performance 3.03 (1.01) 3.19 (0.58) - -
12-weeks COPM Performance 7.24 (1.11) 6.58 (2.10) 0.72 (−1.49, 2.92) 0.49
Baseline COPM Satisfaction 4.26 (0.89) 4.81 (1.31) - -
12-weeks COPM Satisfaction 7.42 (1.05) 7.49 (2.56) 0.13 (−2.54, 2.79) 0. 92
Parent enrichment style
Baseline HOME Score 33.83 (3.66) 29.00 (8.08) - -
12-weeks HOME Score 39.83 (2.14) 36.43 (6.90) −0.13 (−3.48, 3.22) 0.93
Infant motor development
Baseline PDMS-2 TMQ 80.17 (8.98) 81.29 (9.20)
12-weeks PDMS-2 TMQ 84.67 (10.21) 77.71 (8.85) 8.05 (3.88-12.23) <0.00*
Baseline PDMS-2 Total motor SS 35.67 (6.56) 36.43 (6.88) - -
12-weeks PDMS-2 Total motor SS 38.83 (7.44) 33.86 (6.44) 5.72 (2.88, 8.56) .001*
Parent well being
Baseline DASS 21 Total 19.67 (8.71) 24.57 (23.96) - -
12-weeks DASS 21 Total 13.67(11.83) 26.00 (28.75) −7.49 (−24.86, 9.89) 0.36
GAS = Goal Attainment Scaling; COPM = Canadian Occupational Performance Measure; PDMS-2 TMQ = Peabody Developmental Motor Scales – second edition
Total Motor Quotient; PDMS-2 total motor SS = Peabody Developmental Motor Scales – second edition total motor standard score; HOME = Home Observation
Measurement of the Environment; DASS 21 = Depression, Anxiety, Stress Scales short (21 item) version.
*Indicates statistically significant.
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Although this study was a small pilot randomised trial
the secondary findings suggest that 12 weeks of GAME
intervention might have a beneficial effect on the devel-
opmental motor outcomes of infants at high risk of CP.
There have been no publications on the PDMS-2 about
how much change is required in terms of motor quo-
tients or raw score points to be regarded as clinically
meaningful in this very young population. However,
Wang et al. suggested a change of more than 9 raw score
points on the PDMS −2 may be clinically significant [25]
amongst toddlers. Our data exceeded the 9 points for all
participants but was even greater for the GAME group,
however this is a period of rapid motor development so
greater change is expected, limiting interpretation of our
results. While infants in both groups demonstrated im-
provements in terms of goal attainment, TMQ scores at
12 weeks on the PDMS-2 were significantly better in the
GAME group. This difference could be the result of in-
tensity alone or possibly a result of both the type and in-
tensity of the intervention, as GAME parents engaged in
more practice at home than did SC parents. Although
the PDMS-2 motor gain is pleasing in this study, chil-
dren with a permanent physical disability like CP usually
fall further behind peers as developmental motor expec-
tations increase. We would therefore expect that for a
study of longer duration, the TMQ would drop in chil-
dren with CP even if raw scores continued to increase.
The small-moderate effect size we found in this pilot
therefore needs to be confirmed in a larger sample of
children over a longer period of time.
The lack of significant between-group differences on
the subjective COPM was surprising given that the
GAME groups scored better on the PDMS-2. This result
might indicate that parents of infants at high risk of CP
are pleased with any noticeable improvement or with
natural developmental gains, and do not expect age ap-
propriate performance or do not know what motor skills
are considered “normal” at various time points. Most
parents expressed a general goal for their child to “de-
velop normally” although they were not sure what devel-
opmental milestones they should precisely expect. Even
though the COPM and GAS scores did not demonstrate
significant differences, we found the goal-oriented ap-
proach framed by these tools assisted parents to be more
specific in identifying concerns, thus enabling focussed
HP practice.
Environmental enrichment as measured by HOME
scores demonstrated gains in both groups but there were
no significant between-group differences. Notably ceiling
effects existed, with 9/13 participants having higher than
average baseline scores. Previous HOME studies have
confirmed this ceiling effect [32]. It should be noted that
the baseline HOME scores of the SC displayed a higher
degree of variance than the GAME group due to 3
families with scores below the published mean of 31 (26)
and only 1 in the GAME group. However after 12 weeks
only one family in the SC group still scored below the
mean. Future GAME studies should endeavour to ex-
plore the use of other measures of EE that might be
more sensitive to change.
DASS 21 scores between groups were comparable at
baseline and after intervention. At baseline, 23% of par-
ents (all mothers) had abnormal depression scores but
after intervention this had dropped to 15%. Miller at al
[29] reported a DASS 21 depression rate of 19% in prim-
iparous mothers, so our result was not surprising as
mothers in the study experienced additional stressors in
the newborn period. At baseline 31% of parents (all
mothers) had symptoms of anxiety and this had reduced
to 15% after 12 weeks of intervention. Our sample’s
baseline anxiety rate was higher than previously reported
rate of 13% in new mothers. Premature birth and expos-
ure to intense medical environments such as Neonatal
Intensive Care Units are known risk factors for adverse
psychological symptoms in mothers [33]. Adaptation to
the diagnosis of CP is another known stress point and
families participating our study were at risk of poor
emotional health because of these factors. Evaluating
parent wellbeing in studies of infants at high risk of CP
is important as parental depression and anxiety can
affect parent-infant attachment [33], negatively influence
child cognition [34] and might impact the mother’s abil-
ity to carry-out HPs.
Feasibility of the trial
We found GAME was both feasible to carry out and ac-
ceptable to parents and referrers, with no dropouts,
minimal missing data, and only n = 1 parent declining to
enrol. Ten of 12 families completed the logbook of HP
and two forgot, but were able to estimate data. Although
some described the logbook as tedious, it provided in-
valuable information about dose of practice.
GAME intervention fidelity was maintained as the
same therapists provided intervention for each infant in
the GAME group. Intensity of SC intervention was vari-
able and little information was available about the type
of SC intervention. Future studies should attempt to de-
scribe the content of SC more specifically.
The pilot study enabled us to confirm outcome mea-
sures for a planned larger RCT and calculate the sample
size required with PDMS-2 as the primary outcome
measure.
Limitations
There were several limitations to this pilot study. First,
the small sample size gives rise to the possibility that the
absence of GAS, COPM and HOME differences could
be type II errors arising from low statistical power.
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Second, the study period was relatively short and infants
were only 6–8 months old at the primary endpoint. It is
therefore not clear whether the advantage observed in
the GAME group would have been maintained long-term,
particularly since at one-year of age the more demanding
motor tasks of upright ambulation is the developmental
norm. Third, as previously discussed, it is possible that the
higher PDMS-2 GAME scores might have been solely at-
tributable to the dose of therapy rather than GAME inter-
vention. Dose of therapy will be entered as a covariate in
the planned larger trial, however GAME intervention itself
may in fact lead to greater parental participation in home
practice as parent education is regarded as a key compo-
nent of the intervention. Fourth, since SC is variable, areas
of overlap in approach could well have existed creating
contamination between the groups. Fifth, the lack of
evaluator blinding across some measures may have unin-
tentionally led to observer bias.
A larger blinded, RCT of infants from 3 months to
one year is required to investigate whether the benefits
of GAME confers a similar result to this pilot long-term.
We did not find GAS the most appropriate primary
measure to use in an RCT with young infants, and
recommend a suite of measures including both a norm
referenced tool complemented by criterion referenced
measures capable of detecting incremental motor change,
such as the COPM and GMFM. Future studies with larger
sample sizes should also treat severity of motor impair-
ment and dose as covariates in the analyses.
Conclusions
This pragmatic pilot study compared 12 weeks of goal-
oriented, activity-based, motor training centred on parent-
elicited goals (“GAME”) to SC in infants at high risk of
CP. While infants in both groups attained their goals,
GAME infants had higher scores on a standardised assess-
ment of motor ability, providing preliminary promising
evidence of efficacy of GAME. Parent reported improve-
ment in COPM performance and satisfaction and home
enrichment scores improved in both groups. Mothers
tended to report higher depression and anxiety scores
than mothers without infants with a disability, indicating
parental well-being is important to monitor. The recruit-
ment processes and intervention was clinically feasible to
do and acceptable to all families.
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The final study followed on from the pilot (Study 5) and recruited 30 
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were between 3 and 6 months at enrolment, we collected data after all 
infants had received the same number of weeks of intervention (16 
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Measure. Infants in GAME had superior motor scores on all assessments 
when severity of injury was taken into account. 
This study provides new and much needed evidence that rehabilitation 
intervention based on the principles of motor learning and environmental 
enrichment can advance the motor skills of infants with CP. 
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ABSTRACT 
 
BACKGROUND: Cerebral palsy (CP) is caused by a lesion in the developing 
infant brain. Recent neuroplasticity literature suggests that intensive, task-
specific intervention ought to commence as early as possible during the critical 
period of neural development. 
OBJECTIVE: To determine whether  “GAME”, a motor learning, environmental 
enrichment intervention, is effective for improving motor skills in infants at high 
risk of CP. 
METHOD: Single blind randomised controlled trial of GAME versus standard 
care. Primary outcome was motor skills on the Peabody Developmental Motor 
Scales-2 (PDMS-2). Secondary outcomes included Canadian Occupational 
Performance Measure (COPM), Bayley Scales of Infant and Toddler 
Development (BSID-III) and Gross Motor Function Measure-66 (GMFM-66). 
Outcome assessors were masked to group allocation and data analyzed with 
multiple regression. 
RESULTS: Of n=30 3-6 month old infants enrolled, all received the assigned 
intervention until 16 weeks post enrolment. At 12 months of age, n=26 
completed assessments. At both time points there were significant between 
group differences in raw scores on the PDMS-2 in favour of GAME (p <. 03) 
and at 12 months on the total motor quotient (p < .05). Significant between 
group differences also favored GAME participants in the composite scores of 
the cognitive and motor scales of the BSID-3 and satisfaction scores on the 
COPM at 12 months.  
CONCLUSION: GAME intervention appears to result in advanced motor and 
cognitive outcomes when compared with standard care. Further research is 
needed to evaluate whether these gains have any impact on severity of CP in 
the long term. 
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ACTRN12611000572965 
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Introduction 
 
Cerebral palsy (CP), the most common physical disability of childhood, occurs 
because of a lesion in the developing brain1. The lesions associated with an 
eventual diagnosis of CP usually occur during the prenatal or perinatal period. A 
small percentage acquires their injury after the neonatal period and account for 
approximately 5.6% of CP2. Since the brain injury of CP occurs early it is 
important to develop evidence based rehabilitation protocols that enhance the 
neuroplasticity mechanisms at work in the developing brain 3. Many effective 
rehabilitation interventions for older children with CP exist4, but most have not 
been trialled early with infants because recruitment is difficult, since the 
diagnosis typically occurs after 18 months of age. Consequently although early 
intervention is endorsed for high-risk infants, the efficacy for infants with CP is 
not yet firmly established 5. Early intervention research in the form of clinical 
trials for infants is burgeoning 6-8 with new knowledge expected in the coming 
years.  
We developed an early intervention programme, GAME (Goals Activity Motor 
Enrichment) 9 that was first tested in a small pilot study (n=13) 10 with promising 
results in improving motor outcomes of GAME participants when compared to 
standard care. Our earlier pilot also established feasibility of procedures for 
recruitment and randomisation. The aim of this phase 2 study was to determine 
whether GAME intervention improved motor outcomes and parent perception 
and satisfaction with motor performance after 16 weeks of intervention, and at 
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12 months when compared with SC.  We hypothesized that infants randomised 
to GAME would have superior motor skills at both time points. 
METHODS 
Participants 
Infants were included if they were corrected age 3-4 months and: scored as 
“absent fidgety” on General Movements Assessment (GMA); OR were aged 5-6 
months with a CP diagnosis OR had abnormal neuroimaging such that a CP 
diagnosis was considered extremely likely. Infants were excluded if they were 
inpatients, had medical conditions that precluded active involvement in therapy 
or lived in a remote location not accessible for home visits by the research 
team.  
Study timeline and protocol 
Infants were recruited from 6 participating Sydney hospitals with Neonatal 
Intensive Care Units (NICUs) and the Cerebral Palsy Alliance between 
February 2013 and June 2014. The study received ethical approval by the 
Sydney Children’s Hospital Network, the University of Notre Dame Australia and 
the Cerebral Palsy Alliance human research ethics committees. Once eligibility 
was determined, parental consent was obtained and all baseline assessments 
and demographic data were collected.  
Motor severity is a known predictor of responsiveness to intervention. Due to 
the young age of the participants, the Gross Motor Function Classification Scale 
(GMFCS) could not to be used to reliably rate the severity of motor 
impairment11. We therefore needed to use the best clinically available severity 
predictor which is neuroimaging blind-scored by a paediatric neurologist and 
paediatric radiologist to estimate severity of the brain injury. Neuroimaging was 
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not available for n=2 and only cranial ultrasound was available for n=3. A score 
form was created from best available literature12-14. When multiple images were 
available, the series closest to term equivalent age was used for preterm infants 
and closest to day 7 for infants with hypoxic ischaemic encephalopathy. 
Severity results were ordinally coded as: 0 = normal OR unlikely to have CP; 
1=likely to have ambulant CP (e.g. focal vascular insults); and 2= likely to have 
non-ambulant CP, (e.g. significant basal ganglia/thalamus lesions or diffuse 
brain injury). When neuroimaging data was not available it was coded as 
“missing”. 
An officer not connected with the study randomised participants at a separate 
location. The Primary Investigator was informed of group allocation and then 
informed parents. The allocation sequence was computer generated and 
assignments concealed using sequentially numbered opaque envelopes. No 
stratification was used in terms of gestational age, or type or severity of brain 
injury. 
Intervention 
Infants randomised to standard care either continued with pre-existing therapy 
arrangements or were referred to a local intervention site by their referring 
institution. Appendix 2 contains a checklist of intervention content for both 
GAME and standard care as recommended by the Tidier Guidelines15.  
GAME Intervention 
GAME is an acronym for Goals, Activity and Motor Enrichment. The intervention 
is based on the principles of active motor learning, family centred care, parent 
coaching and environmental enrichment. Refer to Appendix 2 for a detailed 
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description. The intervention was offered at least fortnightly until the infants first 
birthday (corrected age).  
Standard Care Intervention 
“Standard care” (SC) describes the current follow-up and/or therapeutic 
interventions used when an infant at high risk of CP is discharged from hospital. 
It is not possible to standardise the frequency, intensity or type of interventions 
received in the SC group. Therapeutic approaches used and modes and 
intensity of delivery are varied. Appendix 2 contains information about SC in this 
study.  
Outcome Measures  
The primary outcome was motor skills as measured by the Peabody 
Developmental Motor Scales -Second edition (PDMS-2), a norm referenced 
assessment of gross and fine motor skills in children 0-6 years. Results are 
expressed as raw scores, standard scores and total motor quotient (TMQ), 
which is regarded as the best estimator of motor ability. The PDMS-2 has been 
validated as a discriminative measure and two studies have demonstrated its’ 
responsivity to change in infants and toddlers with CP16-17. PDMS-2 
assessments were obtained at baseline, 16 weeks after therapy had 
commenced and at 12 months corrected age. Two highly experienced 
assessors (one physiotherapist and one occupational therapist) who were 
blinded to group allocation scored the PDMS-2 assessments from video. High 
inter-rater reliability has previously been established for this tool18. 
Secondary outcomes included the Canadian Occupational Performance 
Measure (COPM) 19, an individualised criterion-referenced measure of 
performance and satisfaction with performance of a parent-selected range of 
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activities. The COPM was used at baseline to prioritise parent goals for their 
baby’s development and assess parent’s perception of their infants’ 
performance on identified goals and their own satisfaction with the infants 
current ability. After 16 weeks of intervention the COPM was rescored and new 
priority areas identified. At 12 months the second COPM was rescored. Two 
blinded assessors scored all COPMs post enrolment via telephone call.  
Motor and cognitive skills were assessed using the Bayley Scales of Infant and 
Toddler Development – Third Edition (BSID-III) and motor function using the 
Gross Motor Function Measure (GMFM-66) 20. These measures were taken at 
12 months only and scored by blinded assessors.  
Enrichment of the home environment was assessed with the Affordances in the 
Home Environment for Motor Development – Infant Scale (AHEMD-IS) 21. 
AHEMD-IS identifies opportunities available within the home to promote motor 
development, including characteristics of the indoor and outdoor environment 
and the presence of a range of toys and equipment. This tool is a validated, 
parent self report however sensitivity to change has not been established22. 
Total score possible for infants younger than 11 months is 66 while from 12 
months possible total score is 93, to account for the expected increase in 
available learning materials. To compare change from baseline to follow-up at 
12 months we compared percentages of total score, as per test developer 
recommendations (personal communication). 
The Depression, Anxiety and Stress Scales – 21 (DASS-21) 23 is an adult self-
report designed to measure the emotional states of depression, anxiety and 
stress. It is a 21-item questionnaire and was used to measure parent mental 
health at baseline, 16 weeks after randomization and at the 12-month time 
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point. Lower scores are associated with more normal levels of depression, 
stress and anxiety.  
 
Sample size estimation 
The study sample size was estimated from a power calculation based on our 
earlier published pilot data using motor composite scores of the PDMS-2. We 
considered a clinical meaningful difference between the groups to be at least 5 
standard score points (0.5 of a standard deviation). With an alpha value of 5% 
and power of 80%, using a minimal clinically important difference of 10% and 
accounting for a 20% dropout rate, we estimated the sample size required to be 
n=30; 15 per group. 
Statistical Analysis 
Analysis was carried out using SPSS and reported according to the CONSORT 
statement. Descriptive statistics (frequencies, means and 95% CIs) were used 
to describe the sample at baseline. Random missing data was imputed as last 
observation carried forward. Where there were no results available due to 
dropouts, only the data available were analysed so as not to introduce new 
biases. Between-group differences for child outcomes were analysed using 
multiple regression to determine whether group allocation predicted outcome. 
As infants were too young to accurately use GMFCS as a motor severity 
variable, a blunt neuroimaging +/- vision impairment severity variable was used 
as a covariate within the regression analysis. The severity variable was the 
aforementioned imaging ordinal score, plus a weighting point of +1 if the infant 
had severe vision impairment (i.e. consistently visually unresponsive to a 
moving toy stimulus; but motorically responsive to the same stimulus if an 
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auditory cue was paired to the stimulus), since vision impairment is a known 
confounder of motor development. Outcomes on the COPM were analysed 
using linear regression without the severity covariate. Parent mental health 
scores and home environment scores were compared with independent t-tests. 
 
 
RESULTS 
Thirty infants from twenty-nine families were recruited between February 2013 
and June 2014 and randomised to GAME (n=15) or SC (n=15). Mean age at 
enrolment was 17.9 weeks (SD 5.31). There was one set of twins randomised 
to SC and two infants who were twins randomised to GAME. The flow of 
participants is summarised in Figure 1. Adherence to study protocols was 
excellent until the 16-week time point with no dropouts and all participants 
receiving intervention as per protocol.  
Between the 16-week primary endpoint and 12 month follow-up, 4 infants 
dropped out of the study, all from GAME group. Reasons for drop out included: 
relocation overseas or interstate for increased family support (n=3 of 4) and 
experimental stem cell treatment (n= 1 of 4). Data was analysed for all infants 
remaining in the study at 12 months, n=11 in GAME and n=15 in SC. In the 12-
month analysis, missing data could not have substantially biased the secondary 
results because there was only after treatment BSID-III and GMFM-66 data, 
plus baseline and severity covariates were available for all individuals and 
included in all analyses24.  
Participant characteristics are summarised in Table 1. Groups were equivalent 
at baseline on infant characteristics, except for age at enrolment where the 
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GAME infants were about 4 weeks younger by chance. Social risk was 
classified as “high” or “low” based on previously used criteria 25.There were no 
significant between group differences on child motor function (table 2) at 
baseline. Parent mental health scores were different at baseline with GAME 
parents having higher rates of depression, but no between group differences on 
the other sub-scales or total score.  
 
Child Outcomes   
Primary and secondary outcomes for GAME and SC infants are presented in 
table 2. 
Primary Outcome 16 weeks after enrolment 
After 16 weeks of intervention, no statistically significant between group 
differences were found on the TMQ but GAME participants were 0.5 of a SD 
better off. Significant between group differences were found in change in raw 
scores in favour of GAME.  
Primary outcome 12 months corrected age 
Statistically significant between-group differences were found at 12 months on 
both the PDMS-2 TMQ and raw scores favouring GAME. Confirmatory, 
significant between-group differences were evident on the other motor 
measures, the GMFM-66, BSID-III composite motor scores (B= 15.23; 95% CI 
1.21, 29.25; p<. 04), and BSID-III fine motor standard scores alone, all 
favouring GAME. No significant differences existed for the BSID-III gross motor 
scale alone. In addition, mean BSID-III cognition scores were significantly 
higher for GAME at 12 months. 
COPM  
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After 16 weeks of intervention both groups showed clinically meaningful change 
on the performance scale of the COPM. Significant between group differences 
were found in favour of GAME; mean change 3.55 (1.92) compared to 2.58 
(2.21) for SC. There were no statistically significant differences between the 
groups in change scores on the satisfaction scale (GAME: 1.62 [SD 3.22] and 
SC: 2.00 [SD 1.78]). 
At 12 months parent perception of their infant’s movement skills did not 
significantly differ between the groups, despite only the GAME groups’ COPM 
improvements reaching clinically significant thresholds of >2 points 
(performance change scores: GAME 2.57 [2.44]; and SC 1.09 [1.06]). Parents 
of infants in GAME did however have higher rates of satisfaction with their 
child’s improvements (satisfaction change scores: GAME 2.66 [2.68] and SC 
0.39 [1.17]).  
Child Diagnostic Outcomes 
Appendix 1 contains diagnostic outcome data for all 30 infants. At 12 months of 
age n=25 (83%) had received a diagnosis of CP including 3 of the 4 who had 
dropped out of the study. A further two infants were globally delayed, two were 
undiagnosed but displaying neurological abnormalities such as motor 
asymmetry and the developmental outcome of one infant was unknown. Of the 
3 children with either no imaging or normal imaging, n=2 had mild diplegia and 
n=1 had monoplegia and cognitive delay at 12 months.  
 
 
Parent and environment outcomes 
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Between-group differences on the AHEMD-IS scores at 12 months were non 
significant. DASS 21 scores were compared at 12 months and no statistically 
significant differences existed between the groups in total DASS 21 score or in 
any of the subscales (Table 3). Mean values for both groups dropped to more 
normal values between the 16-week time point and 12 months. 
Dose of intervention 
Complete logbooks were kept by 10 GAME families and 7 SC families and were 
collected at 12 months. Hours of face- to-face therapy could be ascertained for 
all families, however total dose could only be calculated for those with 
completed logbooks. Infants in GAME received a mean of 21.91 (SD 4.25) 
hours of therapy  (median 22 hours) over the study period and SC 14.82 (SD 
12.89) hours (median 13 hours). Parents in GAME reported they spent a mean 
of 47.70 (23.30) minutes per day (median 54 mins) carrying out the home 
programme while SC parents spent 42.29 (35.87) minutes (median 30 mins). 
The total dose of therapy for GAME infants from enrolment until 12 months was 
216.00 (87.26) hours and for SC infants 164.29 (98.79) hours. There were no 
statistically significant differences in dose of therapy over the entire study period 
(p =. 27), however there was a trend towards more intensive face-to-face 
intervention for GAME participants (p =. 09). 
DISCUSSION 
GAME intervention appears to lead to improved short and medium term motor 
outcomes when compared with a similar dose of SC. This is evidenced both in 
the norm referenced measures (PDMS-2 and BSID-III) as well as the criterion 
referenced GMFM-66. GAME appears to offer a new and positive benefit to 
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developing the motor skills of infants with CP, which is the first clinical trial data 
in CP to suggest this, since Palmer’s seminal work in the 1980s.  
The PDMS-2 TMQ scores were not statistically significant after 16 weeks, 
despite an estimate of effect of 7.5 favouring GAME, probably with the effect 
washed out due to large variances in both groups. At baseline, the TMQ 
variance was 0.5 of a SD for both groups, but increased to >1.0 SD by 16-
weeks, indicating: (a) infants were of heterogeneous severities with varying 
capacities to respond to intervention; and (b) that norm referenced 
assessments might overestimate ability at younger ages, when infants have a 
more limited motor repertoire. At baseline, mean PDMS-2 TMQ scores for both 
groups were “below average”, but after 16 weeks had dropped further into the 
“poor" range for both groups, despite receiving intervention. At 12 months the 
TMQ had dropped further again, into the “very poor” range for SC participants. 
This finding was not unexpected. Infants with CP continue to develop and “gain” 
raw score points over time, but are not expected to perform within the “normal 
range” but rather fall further behind peers over time. GAME appeared 
protective, that is, GAME participants did not fall as far behind. 
The great majority of our sample had bilateral brain injuries albeit of varying 
severities, whereas in the CP population one third typically have unilateral 
injuries with milder motor disabilities26. In addition during the study period it 
became clear that 8 of 30 (27%) had severe vision impairments (4 per group), 
which exceeds the CP population norm of 10% 2. Vision impairment is a known 
contributor to delayed motor development27 and in children with CP is a 
predictor of non-ambulation28. These sampling errors meant that our study 
sample was “more severely affected” than a representative CP “population 
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sample”. In practice this may have meant our recruited sample might have been 
lower responders than a more representative CP population sample. 
Given the unexpectedly high number of infants with severe vision impairments 
that were recruited to this study we would recommend formal visual function 
assessments be completed early (at around 3 months) 29 to allow appropriate 
supports and intervention to be put in place.  
After intervention, cognitive scores as measured by the BSID-III were superior 
for GAME infants, which we hypothesise could be a result of the environmental 
enrichment component built into GAME intervention. A recent meta-analysis 
demonstrated that in vulnerable families home visiting had a small positive 
mean effect on child cognitive outcomes30. The consistency of home visiting in 
GAME allowed specific exchanges and information sharing to take place 
concerning customisation of play space, toys and play routines to enrich the 
infant’s learning environment. Measuring cognitive outcomes by motor 
manipulation of cognitive test items in infants with CP is complex and may have 
dampened our ability to detect cognitive change. Many items are dependent on 
age appropriate hand motor function and most widely used tools are not 
validated or sensitive to change in children with CP31. A recent study of 4-5 year 
olds with CP showed that almost 40% of participants were unable to complete 
enough items to score a complete IQ test due to difficulties with items requiring 
verbal ability and accurate fine motor performance (for example, pointing) 32. It 
is likely that infants in this study with poor hand function may have scored lower 
than their actual ability. Measuring cognition accurately in children with severe 
forms of CP is an area requiring urgent research. 
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The high number of infants diagnosed with CP by 12 months (n=25; 83%) 
demonstrated the feasibility and accuracy of recruiting young infants with CP to 
clinical trials using Prechtl’s General Movements Assessment (GMA) 33. To our 
knowledge this is the first study published in literature to recruit a sample of 
young infants (<6 months) where over 80% had CP. The 2 infants not 
diagnosed with CP but whom had severe global delay (all domains <2 SDs 
below the mean) had absent fidgety movements at 12-16 weeks but non-
specific changes on neuroimaging. The combination of term equivalent MRI and 
GMA at fidgety age is recommended to most accurately identify infants with the 
highest risk of CP, as neuroimaging alone is less sensitive34. Two infants in this 
study were performing within the normal range on the PDMS-2 and the BSID-III 
at 12 months although they both had persisting mild asymmetries and one had 
spastic catches bilaterally at the ankle. Another infant who had also scored in 
the normal range on the norm referenced tests, was predicted from imaging not 
to have CP was nevertheless diagnosed with mild spastic diplegia at 12 
months. Defining clinical diagnostic criteria for this group of mildly affected 
infants is difficult and, in the absence of obvious activity limitations that are 
required for a diagnosis of CP1, clinicians are understandably reluctant to use 
the CP label. It is also a possibility that early motor intervention may have 
optimised the outcomes of these infants.  
Parent satisfaction with and perception of their infant’s performance on 
identified goals was clinically important at 12 months only in GAME but only 
significantly different from SC in satisfaction scores of the COPM. Interestingly 
this was different to results at the 16-week time point when performance scores 
were significantly higher for GAME families. Perhaps parent education about 
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CP in the GAME group led to parents being more realistic about their child’s 
motor skills at 12 months. 
Measuring home enrichment is complex and we attempted to do this by using a 
new scale, the AHEMD-IS. Although not statistically significant, mean scores in 
the GAME group increased as a percentage of total possible score over the 
study period. This may indicate that parents in this group were more likely to 
provide a wider variety of learning materials to match motor challenge as their 
child developed. A limitation of the AHEMD-IS is the focus on the physical 
home environment and variety of motor stimulation; it does not account for 
opportunities in other environments that the infant is exposed to. In addition, the 
scale does not capture parental responsiveness, a known contributor to child 
developmental outcomes35. Future studies of GAME should include measures 
of parental responsiveness as well as more responsive measures of the 
physical environment. 
Professional mental health support was offered to all mothers with abnormal 
DASS-21 anxiety or depression scores at any time point. Parent mental health 
remained stable over the course of the study, with the mean score for 
depression in the “mildly abnormal” range both at baseline and after 16 weeks 
for mothers in GAME and in the normal range for SC. Although by 12 months 
mean scores for all subscales were in the normal range, approximately 20% of 
mothers were scoring in the moderate to severe range for depression and/or 
anxiety. This finding highlights the importance of the availability of evidence 
based parent support programmes for parents of infants newly diagnosed with 
disabilities36. In addition, two thirds of the sample was considered to be at high 
social risk plus one third were from families where English was not the first 
!! 17!
language spoken at home. The combination of high social risk and higher than 
average levels of depression and anxiety amongst these mothers, highlights the 
vulnerability of families with young infants at high risk of CP and other 
disabilities. EI programmes should include family support options that assist 
parents in their role and provide strategies to support their mental health and 
enhance their well-being. 
Previous CP trials in older children have shown that high-dose motor-learning 
based therapy leads to better results than low-dose motor-learning therapy, 
causing experts to hypothesise that many therapy interventions studied to date 
might be under-dosed. Interestingly, in older children, when two effective motor-
learning interventions are compared head-to-head at the same high-dose, 
similar patient outcomes result. Recent systematic reviews have therefore 
identified that in addition to type of therapy mattering (effective versus 
ineffective) also the intensity of the therapy is important for treatment success37. 
In our GAME study, the dose of intervention was not statistically significant 
between the groups, due to the large variation within each group, however the 
median values clearly demonstrate that most GAME participants received a 
higher number of therapy sessions and most GAME parents engaged in more 
home practice. It is therefore likely that both the higher dose of intervention as 
well as characteristics of GAME contributed to the gains achieved in the GAME 
group. 
Limitations 
The study has a small sample size, but despite this we observed between-
group differences. We estimated sample size on an earlier pilot study in which 
no infant had visual impairment. In this study the spread of severity was 
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considerably wider as evidenced by the confidence intervals in the primary 
outcome at follow up. In addition the n=4 dropout, all from the intervention 
group might have influenced the final results. A further limitation is the 
incomplete information about the intervention content of the SC group. As 
expected there was substantial variety in intensity, mode and type of therapy 
offered. Motor task practice and the provision of a home program were common 
elements across both groups. Future studies should endeavour to identify the 
specific elements of GAME that led to the demonstrated benefits. Finally, we 
used a novel severity variable to account for the variation in brain injury in our 
sample. This has not been previously tested however in this study it predicted 
outcome accurately 75% of the time which proved more accurate than the most 
recognised severity tool, GMFCS, which is 58% in this age group38. 
CONCLUSION 
Our study suggests that 6-9 months of GAME, a clinically feasible intervention, 
is more effective than SC to advance the motor function of infants at high risk of 
CP. Furthermore using the GMA to recruit very young infants with CP to clinical 
trials is possible. GAME is a promising new early intervention for infants. We 
therefore recommend a larger and longer well-powered RCT of GAME 
intervention be conducted with more finely tuned exclusion and inclusion criteria 
to establish characteristics of responders and non-responders and to define the 
minimum dose required. 
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Figure 1: Flow of participants 
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TABLE 1. Characteristics of Participants 
 
INFANT CHARACTERISTICS GAME n=15 SC n=15 
AGE Enrolment corrected age (weeks) mean (SD) 15.73 (4.76) 20.07 
(5.08)* 
SEX Male, n (%) 8 (53) 9 (60) 
CP RISK 
FACTORS 
Birth weight (kg), mean (SD) 2.31 (1.02) 2.65 (1.12) 
Multiple births, n (%) 2  (13) 2 (13) 
Hypoxic Ischaemic Encephalopathy, n (%) 4 (27) 2 (13) 
Birth gestational age (weeks), mean (SD) 34.27(5.27) 35.27 (5.09) 
• < 28 weeks, n (%) 1(6) 1(6) 
• 28-31 weeks, n (%) 4(27) 3(20) 
• 32-36 weeks, n (%) 2(13) 2(13) 
• > 36 weeks, n (%) 8(53) 9(60) 
CP 
DETECTION 
 
 
 
 
 
 
 
 
 
 
 
GMs Absent fidgety, n (%) 15 (100) 13(87) 
GMs not assessed, n (%) 0 2 (13) 
Neuroimaging available, n (%) 
MRI 
• CUS only 
• No imaging 
Neuroimaging results, n (%) 
(MRI or CUS – term equivalent age) 
• Normal 
• Unilateral injury 
• Bilateral injury 
 
13 (87) 
1 (6) 
1 (6) 
 
 
0 
1(6) 
     13(87) 
 
12 (80) 
2 (13) 
1 (6) 
 
 
1 (6) 
3(20) 
10(67) 
CP 
SEVERITY 
SCORES 
(predicted by 
blind scoring 
of imaging) 
• 3=non-ambulant CP +VI 
• 2 = non-ambulant CP no VI OR 
     ambulant CP + VI 
4(27) 
4 (27) 
2(13) 
1 (6) 
• 1 = ambulant CP no VI OR VI alone 4 (27) 7 (47) 
• 0 = no CP and no VI 2 (13) 4 (27) 
• Missing (ie no imaging available) 
 
1 (6) 1 (6) 
 
Associated 
impairments 
n (%) 
 
• Severe cerebral vision impairment (CVI) 
• Severe ROP (Grade 3) 
• Epilepsy (uncontrolled) 
• Hearing Impairment 
• Microcephaly (>3 SD below mean) 
4(27) 
0 
1(6) 
0 
5 (33) 
3(20) 
1(6) 
1(6) 
1(6) 
3 (20) 
FAMILY CHARACTERISTICS 
SOCIAL 
RISK 
Maternal age; mean (SD) 33.73 (4.73) 31.07 (7.11) 
Mother’s education beyond secondary school, 
n (%) 
10 (67) 6 (40) 
Primary language not English, n (%) 7 (47) 3 (20) 
High social risk, n (%) 9 (60) 11 (73) 
* p<.05; CP severity score based on neonatal imaging and visual function; VI=vision impairment (either 
severe ROP or diagnosed  severe cerebral vision impairment [CVI]); *=Statistically significant 
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Table 2: Outcomes at baseline, after 16 weeks and at 12 months 
 
Outcome Group Estimate of 
Effect  
(95% CI) 
p-
value Time Point Measure GAME (n=15) 
Mean (SD) 
SC (n=15) 
Mean (SD) 
INFANT MOTOR DEVELOPMENT 
Baseline 
 
16-weeks 
 
12-months 
 
Baseline 
 
16-weeks 
 
12 -months 
PDMS-2  
Raw 
PDMS -2  
Raw 
PDMS-2  
Raw 
PDMS-2  
TMQ 
PDMS-2  
TMQ 
PDMS-2  
TMQ 
 
33.60(13.71) 
 
73.20(36.40) 
 
124.64(55.98) 
 
84.87 (7.89) 
 
79.13(16.11) 
 
72.64(17.75) 
 
41.93 (16.49) 
 
77.20 (44.25) 
 
107.93 (51.11) 
 
82.93 (7.92) 
 
71.93 (16.02) 
 
67.339 (16.12) 
 
- 
 
20.71 (1.66,39.76) 
 
51.58 (26.64,76.52) 
 
- 
 
7.58 (-1.37, 16.52) 
 
8.29 (0.13, 16.45) 
 
.14 
 
  .03* 
 
  .01* 
 
.51 
 
.09 
 
  .05* 
PARENT PERCEPTION OF INFANT MOTOR PERFORMANCE- 
Baseline COPM 
Performance 
3.05 (1.09) 3.19 (0.58) - .41 
16-weeks 
 
16-week 
new 
 
12-months 
COPM 
Performance 
COPM 
Performance 
COPM 
performance 
6.53 (2.08) 
 
3.75 (1.48) 
 
6.64 (2.55) 
5.94 (2.56) 
 
3.45 (1.15) 
 
    4.54 (2.82) 
1.86 (0.58, 3.14) 
 
- 
 
1.61 (0.11, 3.34) 
  .01* 
 
.53 
 
.07 
Baseline COPM 
Satisfaction 
5.18 (2.24) 4.40 (1.64) - .28 
16-weeks 
 
16-week 
new 
 
12-months 
COPM 
Satisfaction 
COPM 
Satisfaction 
COPM 
Satisfaction 
6.80 (2.37) 
 
4.05 (1.89) 
 
7.00 (2.45) 
6.19 (2.80) 
 
4.78 (2.51) 
 
5.18 (2.82) 
0.35 (-1.35, 2.13) 
 
    - 
 
2.14 (0.40, 3.89) 
.08 
 
.53 
 
  .02* 
INFANT MOTOR FUNCTION 
12-months GMFM-66 34.97 (13.42) 32.51 (9.99) 7.96 (0.00, 15.96)   .05* 
INFANT DEVELOPMENT 
12-months BSID-III 
Cognition  
 
6.27 (4.69) 
 
4.40 (4.09) 
 
3.85 (0.39,7.31) 
 
  .03* 
12-months BSID-III 
Fine motor  
 
5.18 (3.66) 
 
3.80 (3.41) 
 
3.01 (0.32,5.71) 
 
  .03* 
12-months BSID-III 
Gross motor 
 
3.36 (3.98) 
 
3.00 (3.05) 5.72 (2.88, 8.56) .12 
HOME ENRICHMENT 
Baseline AHEMD-IS 50.40 (14.08) 55.00 (11.83) - .34 
12-months AHEMD-IS 55.09 (13.90) 53.60 (10.66) 2.30 (-10.88, 6.30) .59 
PDMS-2= Peabody Developmental Motor Scales – Second edition; TMQ= total motor quotient; 
COPM=Canadian Occupational Performance Measure; GMFM-66= Gross Motor Function Measure; BSID-III= 
Bayley Scales of Infant and Toddler Development (expressed as standard scores); AHEMD-IS= Affordances 
in the Home Environment for Motor Development Infant Scale (expressed as percentage of total possible 
score). *=Statistically significant 
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Table 3. Parent mental health at Baseline, after 16 weeks and at 12 months 
Measure GAME Mean 
(SD) 
SC Mean (SD) p-value 
DASS-21 Total Score 
Baseline 
16 weeks 
12 months 
 
29.60(21.26) 
30.80 (24.92) 
22.73 (21.06) 
 
21.47(10.62) 
21.20 (17.95) 
            19.20 (17.38) 
 
.20 
.24 
.64 
Depression Sub-
Scale 
Baseline 
16 weeks 
12 months 
 
10.67 (7.55) 
10.00 (7.67) 
8.18 (7.13) 
 
4.53 (3.89) 
               6.27 (5.70) 
               6.00 (7.13) 
 
  .01* 
.14 
.45 
Stress Sub-Scale 
Baseline 
16 weeks 
12 months 
 
13.33 (9.58) 
14.27 (10.28) 
10.00 (10.51) 
 
13.07 (5.60) 
9.87 (6.65) 
9.07 (6.50) 
 
.93 
.18 
.78 
Anxiety Sub-Scale 
Baseline 
16 weeks 
12 months 
 
5.60 (6.29) 
6.53 (8.57) 
4.55 (5.52) 
 
  3.87 (4.69) 
                5.07 (7.32) 
4.13 (6.07) 
 
.40 
.62 
.86 
*=Statistically significant 
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!!!!!!!!!!!APPENDIX!1:!PARTICIPANTS!and!OUTCOMES!at!12!months!!
Infant 
sex 
Group CP risks 
and 
severity 
coding 
GMs Imaging 
Abnormalities 
(regions 
involved) 
Diagnosis Age 
diagnosed 
Other 
impairments 
1 
 
 
F 
SC Preterm 
<32 weeks 
 
 
Severity 
Code= 3 
U 
F- 
Bilateral GMI  
Bilateral PLIC 
involvement 
Pre-wallerian 
degeneration 
 
CP 
Spastic 
bilateral 
6 months CVI 
Microcephaly 
Cognitive 
delay 
Epilepsy 
Gastrostomy 
2 
 
F 
GAME HIE 
IUGR 
 
 
Severity 
code=2 
PR 
F- 
Extensive WMI 
Bilateral PLIC 
involvement 
Pre-wallerian 
degeneration 
 
CP 
L 
unilateral 
10 months  
3 
 
M 
GAME Preterm 
<26 weeks 
 
Severity 
code=2 
PR 
F- 
Bilateral Grade 
III/IV IVH  
Bilat cerebellar 
haemorrhages 
CP 
R 
unilateral 
8 months CLD 
4 
 
M 
GAME Preterm 
<30 weeks 
Birth defect  
 
Severity 
code=2 
CS 
F- 
Severe 
bilateral cPVL 
CP 
Bilateral 
hypotonic 
4 months Microcephaly 
Cognitive 
delay 
5 
 
M 
GAME Birth defect 
 
Severity  
code = 
missing 
CS 
F- 
No imaging CP 
Mild 
dyskinetic 
unilateral 
12 months Cognitive 
delay 
6 
 
F 
GAME Preterm 
 
Severity 
code=0 
U 
F- 
CUS  
Bilateral 
Periventricular 
echogenicity 
CP 
Mild 
spastic 
bilateral 
12 months  
7 
M 
SC Preterm 
<26 weeks  
 
Severity 
code=1 
PR 
F- 
CUS 
Periventricular 
echogenicity 
CP 
Spastic 
bilateral 
12 months ROP stage 3 
8 
M 
SC CVA 
 
Severity 
code=1 
U 
U 
Bilateral 
thalamic 
haemorrhages 
CP 
Dyskinetic 
bilateral 
10 months Epilepsy 
Cognitive 
delay 
9 
 
M 
SC Birth 
defects 
 
Severity 
code=0 
CS 
F- 
Signal intensity 
abnormalities 
Bilateral PLIC 
involvement 
Global  
delay 
NA Hearing 
impairment 
Cognitive 
delay 
!! 27!
10 
 
M 
 
 
SC HIE 
 
 
Severity 
code=2 
PR 
F- 
BGT injury + 
mild WMI 
Bilateral PLIC 
involvement 
CP 
Bilateral 
Dyskinetic 
8 months  
11 
 
 
F 
GAME HIE 
 
 
Severity 
code=1 
 
PR 
F- 
BGT injury 
Bilateral PLIC 
involvement 
 
Spastic 
catches 
present 
both LLs, 
otherwise 
normal 
Not 
diagnosed 
 
12 
 
 
M 
SC Preterm 
 
 
Severity 
code=0 
PR 
F- 
CUS 
Bilateral Gr III 
IVH 
Bilateral 
ventriculomeg
aly 
 
Mild 
asymmetr
y, 
otherwise 
normal 
Not 
diagnosed 
 
13 
M 
GAME Preterm 
< 30 wks 
 
Severity 
code=1 
U 
F- 
WMI 
Moderate 
bilateral cPVL 
 
CP 
Spastic 
Bilateral 
6 months  
14 
F 
SC NNAS 
 
Severity 
code=0 
U Normal CP 
Mild 
spastic 
bilateral 
5 months Cognitive 
delay 
15 
M 
GAME HIE  
 
Severity 
code=3 
PR 
F- 
Severe 
bilateral BGT 
and WMI 
CP 
Bilateral 
dyskinetic 
5 weeks Epilepsy 
CVI 
Gastrostomy 
16 
 
F 
GAME Birth 
defects 
 
Severity 
code=0 
PR 
F- 
Mild vermian 
hypoplasia 
Enlarged 
fourth ventricle 
Unknown  Microcephaly 
Failure to 
thrive 
17 
 
 
F 
SC Birth 
defects 
 
 
Severity 
code=1 
PR 
F- 
Maldevelopme
nt: 
Reduced 
sulcation 
Abnormal 
ventricular 
shape 
CP 
Bilateral  
12 months CVI 
Microcephaly 
Gastrostomy 
18 
 
M 
SC Hydrocepha
lus 
 
Severity 
code=1 
PR 
F- 
Grade IV L 
IVH 
cPVL (left) 
L PLIC 
involvement 
CP 
R 
unilateral 
12 months R 
hemianopia 
Severe 
feeding 
issues 
 
19 
 
F 
SC Preterm 
(<36 wks) 
NNAS 
Birth 
defects 
PR 
F- 
No imaging CP 
Mild 
bilateral 
12 months  
!! 28!
Severity  
code= 
missing 
20 
 
M 
GAME Preterm 
Multiple 
birth  
 
Severity 
code=1 
CH 
F- 
Bilateral 
arterial 
infarction 
Bilateral PLIC 
involvement 
Pre- wallerian 
degeneration 
CP 
Mild 
bilateral 
12 months  
21 
F 
 
 
GAME NE 
 
Severity 
code=2 
U 
F- 
Bilateral BGT 
+ WMI 
 
CP 
Bilateral 
dyskinetic 
8 months  
22 
 
F 
GAME Nil known  
 
Severity 
code=3 
CS 
F- 
Bilateral GMI + 
BGT 
Bilateral PLIC 
involvement 
CP 
Bilateral  
spastic 
5 months CVI 
Microcephaly 
23 
 
M 
GAME Hydrocepha
lus 
Birth 
defects 
 
Severity 
code=1 
N 
F- 
Bilateral 
ventriculomeg
aly 
Bilateral PLIC 
involvement 
CP 
Bilateral  
spastic 
10 months  
24 
F 
SC HIE 
 
Severity 
code=1 
U 
F- 
BGT + mild 
WMI 
CP 
Mild 
Bilateral 
Spastic 
12 months  
25 
 
 
F 
GAME Preterm 
<30 weeks 
 
Severity 
code=3 
CH 
F- 
Bilat GMI + 
BGT 
Severe 
bilateral cPVL 
Bilateral PLIC 
involvement 
CP 
Bilateral 
dystonic 
4 months CVI 
Microcephaly 
Gastrostomy 
 
26 
 
 
M 
SC CVA 
 
 
Severity 
code=1 
 
U 
F- 
L MCA infarct 
including BGT 
L PLIC 
involvement 
Pre-wallerian 
degeneration 
CP 
Unilateral 
spastic 
12 months  
27 
M 
 
 
SC Seizures 
 
Severity 
code=0 
U 
F- 
WMI + mild 
BGT 
Bilateral PLIC 
involvement 
Global 
delay 
Not 
diagnosed 
by 12 mths 
Cognitive 
delay 
28 
 
 
M 
SC Preterm  
<30 weeks 
Multiple 
birth 
 
Severity 
code=3 
 
CS 
F- 
Bilateral 
extensive WMI 
R IVH grade IV 
R PLIC 
involvement 
Pre-wallerian 
degeneration 
CP 
Bilateral 
4 months CVI 
Microcephaly 
29 SC Preterm CS R GMI + CP 8 months  
!! 29!
 
F 
<30 weeks 
Multiple 
birth 
 
Severity 
code=1 
F- 
 
thalamus 
R PLIC 
involvement 
Pre-wallerian 
degeneration 
L 
unilateral 
30 
 
M 
GAME Preterm 
<36 weeks 
Multiple 
birth 
 
Severity 
code=3 
PR 
F- 
Severe 
bilateral cPVL 
Bilateral PLIC 
involvement 
CP 
Bilateral 
spastic 
4 months CVI 
Microcephaly 
GMs = general movements: U=unknown; PR= poor repertoire; CS= cramped 
synchronised; CH= chaotic; N=normal; F- = absent fidgety. HIE = hypoxic ischaemic 
encephalopathy; NE = neonatal encephalopathy; IUGR= intrauterine growth restriction; 
cPVL = cystic periventricular leukomalacia; NNAS = neonatal abstinence syndrome; 
CVA = cerebrovascular accident; CUS= cranial ultrasound; GMI= grey matter injury; 
WMI=white matter injury; BGT= basal ganglia and thalamus abnormalities; 
PLIC=posterior limb of internal capsule; MCA=middle cerebral artery infarction; 
IVH=intraventricular haemorrhage; CVI=cerebral vision impairment; ROP = retinopathy 
of prematurity; CLD = chronic lung disease !!!!!!!!!!!!!!!!!!!!!!!!
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 w
el
l a
s 
bi
m
an
ua
l p
la
y.
 
b)
 S
it 
to
 s
ta
nd
: a
ll 
in
fa
nt
s 
pr
ac
tic
ed
 s
it 
to
 s
ta
nd
 a
ct
iv
iti
es
 w
ith
 th
ei
r p
ar
en
ts
. I
ni
tia
lly
 th
is
 w
as
 fr
om
 th
e 
pa
re
nt
’s
 la
p 
an
d 
as
/if
 s
itt
in
g 
ba
la
nc
e 
pr
og
re
ss
ed
 fr
om
 a
 s
m
al
l f
oa
m
 b
lo
ck
. T
hi
s 
ac
tiv
ity
 w
as
 in
te
gr
at
ed
 
w
ith
 re
ac
hi
ng
 
c)
 S
itt
in
g:
 s
up
po
rte
d 
si
tti
ng
 b
eg
an
 s
tra
ig
ht
 a
w
ay
 b
ot
h 
us
in
g 
a 
re
cl
in
in
g 
in
fa
nt
 s
ea
t w
ith
 s
up
po
rts
 a
s 
re
qu
ire
d 
A
N
D
 s
up
po
rte
d 
flo
or
 s
itt
in
g.
 T
he
 m
in
im
al
 a
m
ou
nt
 o
f s
up
po
rt 
w
as
 p
ro
vi
de
d 
an
d 
re
du
ce
d 
as
 
so
on
 a
s 
in
fa
nt
 d
em
on
st
ra
te
d 
em
er
gi
ng
 a
bi
lit
y 
to
 m
ai
nt
ai
n 
ba
la
nc
e.
 A
ct
iv
iti
es
 to
 e
nc
ou
ra
ge
 re
ac
hi
ng
 
w
er
e 
in
tro
du
ce
d 
as
 e
ar
ly
 a
s 
pr
ac
tic
ab
le
.  
P
ar
en
t E
du
ca
tio
n:
 G
en
er
al
 in
fo
rm
at
io
n 
ab
ou
t d
ev
el
op
m
en
t, 
fe
ed
in
g,
 s
le
ep
, p
la
y 
an
d 
C
P
 w
er
e 
gi
ve
n 
as
 q
ue
st
io
ns
 a
ro
se
 -d
is
cu
ss
io
ns
 c
ou
ld
 b
e 
in
iti
at
ed
 b
y 
ei
th
er
 p
ar
en
t o
r t
he
ra
pi
st
. P
ar
en
ts
 w
er
e 
co
ac
he
d 
in
 s
im
pl
e 
ta
sk
 a
na
ly
si
s 
an
d 
in
 o
bs
er
va
tio
n 
of
 m
ov
em
en
t p
rin
ci
pl
es
. 
H
om
e 
pr
og
ra
m
m
e:
 C
us
to
m
is
ed
 to
 in
fa
nt
; i
nc
lu
de
d 
ra
ng
e 
of
 a
ct
iv
iti
es
 re
la
te
d 
to
 e
ac
h 
go
al
 P
LU
S
 
ge
ne
ra
l i
nf
or
m
at
io
n.
 A
ct
iv
ity
 id
ea
s 
w
er
e 
ph
ot
og
ra
ph
ed
. P
ro
gr
am
m
e 
up
da
te
d 
as
 re
qu
ire
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5.
 
A
 p
hy
si
ot
he
ra
pi
st
 a
nd
 o
cc
up
at
io
na
l t
he
ra
pi
st
 e
ith
er
 to
ge
th
er
 in
 a
 jo
in
t a
pp
oi
nt
m
en
t o
r i
n 
in
di
vi
du
al
 
se
ss
io
ns
 p
ro
vi
de
d 
G
A
M
E
 in
te
rv
en
tio
n.
 B
ot
h 
th
er
ap
is
ts
 h
ad
 m
or
e 
th
an
 2
0 
ye
ar
s 
ex
pe
rie
nc
e 
in
 
pe
di
at
ric
 re
ha
bi
lit
at
io
n.
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P
ro
to
co
l; 
pi
lo
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H
O
W
 
 
 
6.
 
A
ll 
in
te
rv
en
tio
n 
w
as
 p
ro
vi
de
d 
fa
ce
 to
 fa
ce
 o
n 
an
 in
di
vi
du
al
 b
as
is
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P
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P
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co
l; 
pi
lo
t 
 
W
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7.
 
G
A
M
E
 w
as
 a
lw
ay
s 
pr
ov
id
ed
 a
t t
he
 fa
m
ily
’s
 h
om
e.
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8.
 
G
A
M
E
 w
as
 o
ffe
re
d 
at
 le
as
t f
or
tn
ig
ht
ly
 h
ow
ev
er
 s
om
e 
in
fa
nt
s 
re
ce
iv
ed
 w
ee
kl
y 
se
ss
io
ns
 fo
r a
 p
or
tio
n 
of
 th
e 
st
ud
y 
pe
rio
d.
 G
A
M
E
 d
os
e 
w
as
 d
el
ib
er
at
el
y 
cu
st
om
iz
ed
 to
 th
e 
fa
m
ily
’s
 s
itu
at
io
n 
an
d 
pr
ef
er
en
ce
s 
ho
w
ev
er
 n
o 
in
fa
nt
 w
as
 o
ffe
re
d 
th
er
ap
y 
m
or
e 
th
an
 o
nc
e 
pe
r w
ee
k.
 A
s 
th
er
e 
w
as
 v
ar
ia
tio
n 
in
 le
ng
th
 o
f t
im
e 
in
 th
e 
st
ud
y 
du
e 
to
 a
ge
 o
f e
nr
ol
m
en
t, 
w
e 
ca
lc
ul
at
ed
 b
ot
h 
th
e 
m
ea
n 
an
d 
m
ed
ia
n 
of
 
ho
ur
s 
of
 th
er
ap
y.
 S
es
si
on
s 
w
er
e 
ty
pi
ca
lly
 o
ne
 h
ou
r i
n 
le
ng
th
 b
ut
 w
er
e 
cu
st
om
iz
ed
 to
 th
e 
si
tu
at
io
n 
an
d 
pr
ef
er
en
ce
s 
of
 th
e 
fa
m
ily
. N
um
be
r o
f a
pp
oi
nt
m
en
ts
 ra
ng
ed
 fr
om
 1
8 
to
 3
0 
de
pe
nd
in
g 
on
 a
ge
 a
t 
en
ro
lm
en
t a
nd
 c
om
pl
ex
ity
 o
f c
hi
ld
 a
nd
 fa
m
ily
. L
en
gt
h 
of
 s
es
si
on
s 
ra
ng
ed
 fr
om
 3
0 
m
in
ut
es
 to
 9
0 
m
in
ut
es
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9.
 
A
s 
th
e 
in
fa
nt
 d
ev
el
op
ed
 a
dj
us
tm
en
ts
 w
er
e 
m
ad
e 
to
 th
e 
pr
og
ra
m
m
e 
to
 g
ra
de
 th
e 
ch
al
le
ng
e 
of
 th
e 
ac
tiv
ity
. S
im
ila
rly
 if
 d
iff
ic
ul
tie
s 
ar
os
e 
w
ith
 fe
ed
in
g 
th
e 
in
fa
nt
 w
as
 re
fe
rr
ed
 fo
r f
ur
th
er
 a
ss
es
sm
en
t. 
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.ǂ  
A
 n
um
be
r o
f i
nf
an
ts
 w
er
e 
no
te
d 
to
 h
av
e 
se
ve
re
 v
is
ua
l i
m
pa
irm
en
t. 
W
he
n 
th
is
 o
cc
ur
re
d 
th
e 
in
fa
nt
 w
as
 
re
fe
rr
ed
 fo
r f
ur
th
er
 a
ss
es
sm
en
t. 
Th
e 
en
vi
ro
nm
en
t w
as
 a
da
pt
ed
 to
 in
cl
ud
e 
ta
ct
ile
 a
nd
 a
ud
ito
ry
 to
ys
 
an
d 
im
pl
em
en
ta
tio
n 
of
 a
dv
ic
e 
by
 v
is
io
n 
sp
ec
ia
lis
ts
 w
as
 in
te
gr
at
ed
 in
to
 th
e 
pr
og
ra
m
m
e.
 
 
   
 
 
H
O
W
 W
EL
L 
 
 
11
. 
A
s 
th
e 
sa
m
e 
th
er
ap
is
t p
ro
vi
de
d 
th
e 
in
te
rv
en
tio
n 
to
 a
ll 
in
fa
nt
s 
in
 th
e 
ex
pe
rim
en
ta
l g
ro
up
, f
id
el
ity
  
w
as
 n
ot
 s
ep
ar
at
el
y 
as
se
ss
ed
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O
ne
 in
fa
nt
 in
 G
A
M
E
 w
en
t o
ve
rs
ea
s 
fo
r 8
 w
ee
ks
 fo
r f
am
ily
 re
as
on
s 
du
rin
g 
th
e 
in
te
rv
en
tio
n 
pe
rio
d 
an
d 
di
d 
no
t r
ec
ei
ve
 th
e 
in
te
nd
ed
 d
os
e 
of
 th
er
ap
y.
 F
ou
r i
nf
an
ts
 d
ro
pp
ed
 o
ut
 o
f t
he
 s
tu
dy
 b
et
w
ee
n 
th
e 
16
 
w
ee
k 
an
d 
12
 m
on
th
 ti
m
ep
oi
nt
s 
an
d 
fo
r t
he
se
 in
fa
nt
s 
th
e 
do
se
 w
as
 n
ot
 c
al
cu
la
te
d 
as
 n
o 
lo
gb
oo
ks
 
w
er
e 
co
lle
ct
ed
. P
ar
en
ts
 w
er
e 
no
t i
ns
tru
ct
ed
 h
ow
 m
uc
h 
to
 p
ra
ct
ic
e 
ho
m
e 
pr
og
ra
m
m
e 
ac
tiv
iti
es
 w
ith
 
th
ei
r i
nf
an
ts
 a
t h
om
e 
bu
t w
er
e 
as
ke
d 
to
 d
o 
as
 m
uc
h 
as
 th
ey
 fe
lt 
th
ey
 c
ou
ld
 m
an
ag
e.
 T
he
re
 w
as
 a
 b
ig
 
ra
ng
e 
of
 h
om
e 
pr
ac
tic
e 
re
co
rd
ed
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 A
ut
ho
rs
 - 
us
e 
N
/A
 if
 a
n 
ite
m
 is
 n
ot
 a
pp
lic
ab
le
 fo
r t
he
 in
te
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en
tio
n 
be
in
g 
de
sc
rib
ed
. R
ev
ie
w
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s 
– 
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e 
‘?
’ if
 in
fo
rm
at
io
n 
ab
ou
t t
he
 e
le
m
en
t i
s 
no
t r
ep
or
te
d/
no
t  
 
su
ffi
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en
tly
 re
po
rte
d.
   
   
   
† 
If 
th
e 
in
fo
rm
at
io
n 
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 n
ot
 p
ro
vi
de
d 
in
 th
e 
pr
im
ar
y 
pa
pe
r, 
gi
ve
 d
et
ai
ls
 o
f w
he
re
 th
is
 in
fo
rm
at
io
n 
is
 a
va
ila
bl
e.
 T
hi
s 
m
ay
 in
cl
ud
e 
lo
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tio
ns
 s
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h 
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 a
 p
ub
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he
d 
pr
ot
oc
ol
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 o
th
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 p
ub
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d 
pa
pe
rs
 (p
ro
vi
de
 c
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tio
n 
de
ta
ils
) o
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 w
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si
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 (p
ro
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de
 th
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U
R
L)
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th
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TI
D
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R
 c
he
ck
lis
t f
or
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 p
ro
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l, 
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ite
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o 
th
e 
pr
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 c
an
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t b
e 
de
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 u
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th
e 
st
ud
y 
is
 c
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1.
 
S
ta
nd
ar
d 
C
ar
e 
In
te
rv
en
tio
n 
in
fo
rm
at
io
n 
pr
ov
id
ed
 b
y 
pa
re
nt
 q
ue
st
io
nn
ai
re
 
P
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P
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to
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l; 
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W
H
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2.
 
S
C
 m
ig
ht
 h
av
e 
be
en
 b
as
ed
 o
n 
N
D
T,
 s
en
so
ry
-in
te
gr
at
io
n,
 d
ev
el
op
m
en
ta
l s
ki
ll 
or
 m
ot
or
 le
ar
ni
ng
 
th
eo
ry
.  
 
P
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to
co
l; 
pi
lo
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W
H
A
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3.
 
S
C
 w
as
 v
ar
ia
bl
e 
an
d 
al
l i
nf
or
m
at
io
n 
in
 th
is
 a
pp
en
di
x 
is
 b
as
ed
 o
n 
pa
re
nt
 q
ue
st
io
nn
ai
re
. 
A
ll 
pa
re
nt
s 
w
er
e 
gi
ve
n 
a 
ho
m
e 
pr
og
ra
m
m
e 
an
d 
fo
r 1
/3
 th
is
 w
as
 p
ro
vi
de
d 
in
 w
rit
te
n 
fo
rm
at
. M
os
t 
pa
re
nt
s 
w
er
e 
to
ld
 h
ow
 lo
ng
 a
nd
 h
ow
 o
fte
n 
to
 c
ar
ry
 o
ut
 th
e 
H
P
. S
om
et
im
es
 p
ho
to
gr
ap
hs
 w
er
e 
us
ed
 to
 
de
m
on
st
ra
te
 th
e 
H
P
. S
om
e 
th
er
ap
is
t r
ec
om
m
en
de
d 
eq
ui
pm
en
t s
uc
h 
as
 h
ig
hc
ha
irs
, b
ab
y 
se
at
in
g 
in
cl
ud
in
g 
B
um
bo
 s
ea
ts
 o
r a
n 
in
fa
nt
 s
ea
t w
ith
 tr
ay
. O
ne
 th
ird
 p
re
sc
rib
ed
 s
pe
ci
al
is
ed
 s
ea
tin
g.
 F
ou
r 
in
fa
nt
s 
re
ce
iv
ed
 s
ta
nd
in
g 
fra
m
es
 w
hi
le
 6
 u
se
d 
th
er
ap
y 
ba
lls
 fo
r p
ra
ct
ic
in
g 
se
t a
ct
iv
iti
es
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4.
 
Th
er
ap
y 
se
ss
io
ns
: T
yp
ic
al
ly
 th
er
ap
is
ts
 h
an
dl
ed
 th
e 
in
fa
nt
 fo
r p
ra
ct
ic
in
g 
m
ot
or
 s
ki
lls
 o
r f
ac
ili
ta
tin
g 
m
ov
em
en
t. 
Tw
o 
th
ird
s 
of
 p
ar
en
ts
 re
po
rte
d 
be
in
g 
ac
tiv
e 
in
 th
e 
se
ss
io
n,
 e
g 
pr
ac
tic
in
g 
ac
tiv
iti
es
 a
fte
r 
be
in
g 
sh
ow
n.
 In
 a
 fe
w
 in
st
an
ce
s 
th
e 
pa
re
nt
 w
at
ch
ed
 th
e 
se
ss
io
n 
an
d 
w
as
 n
ot
 in
vo
lv
ed
 in
 h
an
dl
in
g.
 
M
os
t p
ar
en
ts
 re
po
rte
d 
re
ce
iv
in
g 
ad
vi
ce
 re
ga
rd
in
g 
fe
ed
in
g,
 a
nd
 d
ev
el
op
m
en
ta
l s
im
ul
at
io
n.
 A
bo
ut
 4
0%
 
re
po
rte
d 
be
in
g 
ed
uc
at
ed
 in
 s
tre
tc
he
s 
an
d 
ex
er
ci
se
s 
to
 b
e 
do
ne
 d
ur
in
g 
di
ap
er
 c
ha
ng
in
g 
an
d 
ab
ou
t 
on
e 
th
ird
 w
er
e 
ed
uc
at
ed
 in
 o
pt
im
al
 c
ar
ry
in
g 
po
si
tio
ns
. A
ll 
pa
rti
ci
pa
nt
s’
 th
er
ap
y 
w
as
 d
ire
ct
ed
 to
w
ar
ds
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m
ile
st
on
e 
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ta
in
m
en
t s
uc
h 
as
 ro
lli
ng
, h
ea
d 
co
nt
ro
l a
nd
 re
ac
hi
ng
. O
ne
-th
ird
 p
ra
ct
ic
ed
 s
itt
in
g 
an
d 
on
e-
th
ird
 p
ra
ct
ic
e 
st
an
di
ng
 w
ith
in
 th
er
ap
y 
se
ss
io
ns
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5.
 
A
 p
hy
si
ot
he
ra
pi
st
 a
nd
/o
r o
cc
up
at
io
na
l t
he
ra
pi
st
 o
f v
ar
yi
ng
 y
ea
rs
 o
f e
xp
er
ie
nc
e 
pr
ov
id
ed
 th
er
ap
y.
 
Th
er
e 
w
er
e 
ap
pr
ox
im
at
el
y 
18
 d
iff
er
en
t t
he
ra
pi
st
s 
in
vo
lv
ed
 a
lto
ge
th
er
 w
ith
 in
fa
nt
s 
in
 S
C
.  
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6.
 
M
os
t i
nt
er
ve
nt
io
n 
w
as
 p
ro
vi
de
d 
fa
ce
 to
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Checklist of items to include when reporting a randomized trial (56-58) 
 
PAPER SECTION 
And topic  Item Description 
Reported 
on page # 
TITLE & ABSTRACT  1 How participants were allocated to interventions (e.g., "random 
allocation", "randomized", or "randomly assigned").   
INTRODUCTION 
Background 2 Scientific background and explanation of rationale.   
METHODS 
Participants  3 
Eligibility criteria for participants and the settings and locations where the 
data were collected.    
Interventions 4 Precise details of the interventions intended for each group and how and when they were actually administered.   
Objectives 5 Specific objectives and hypotheses.   
Outcomes 6 
Clearly defined primary and secondary outcome measures and, when 
applicable, any methods used to enhance the quality of measurements 
(e.g., multiple observations, training of assessors). 
  
Sample size 7 How sample size was determined and, when applicable, explanation of any interim analyses and stopping rules.   
Randomization -- 
Sequence generation 8 
Method used to generate the random allocation sequence, including 
details of any restriction (e.g., blocking, stratification).    
Randomization -- 
Allocation concealment 9 
Method used to implement the random allocation sequence (e.g., 
numbered containers or central telephone), clarifying whether the 
sequence was concealed until interventions were assigned.  
  
Randomization -- 
Implementation 10 
Who generated the allocation sequence, who enrolled participants, and 
who assigned participants to their groups.    
Blinding (masking)  11 
Whether or not participants, those administering the interventions, and 
those assessing the outcomes were blinded to group assignment. When 
relevant, how the success of blinding was evaluated.  
  
Statistical methods  12 
Statistical methods used to compare groups for primary outcome(s); 
Methods for additional analyses, such as subgroup analyses and 
adjusted analyses.  
  
RESULTS 
Participant flow 13 
Flow of participants through each stage (a diagram is strongly 
recommended). Specifically, for each group report the numbers of 
participants randomly assigned, receiving intended treatment, 
completing the study protocol, and analyzed for the primary outcome. 
Describe protocol deviations from study as planned, together with 
reasons.  
  
Recruitment 14 Dates defining the periods of recruitment and follow-up.    
Baseline data  15 Baseline demographic and clinical characteristics of each group.    
Numbers analyzed 16 
Number of participants (denominator) in each group included in each 
analysis and whether the analysis was by "intention-to-treat" . State the 
results in absolute numbers when feasible (e.g., 10/20, not 50%).  
  
Outcomes and estimation  17 
For each primary and secondary outcome, a summary of results for each 
group, and the estimated effect size and its precision (e.g., 95% 
confidence interval).  
  
Ancillary analyses  18 
Address multiplicity by reporting any other analyses performed, including 
subgroup analyses and adjusted analyses, indicating those pre-specified 
and those exploratory.  
  
Adverse events  19 All important adverse events or side effects in each intervention group.    
DISCUSSION 
Interpretation  20 
Interpretation of the results, taking into account study hypotheses, 
sources of potential bias or imprecision and the dangers associated with 
multiplicity of analyses and outcomes.  
  
Generalizability  21 Generalizability (external validity) of the trial findings.    
Overall evidence  22 General interpretation of the results in the context of current evidence.    
1,2
3
4
5-6
Protocol
6-7
7-8
5
5
4-5
6-7
8
Figure 1
9
Table 1
9
Tables 2 
and 3
NA
NA
12-17
16-18
16-18
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Chapter 8  CONCLUSION 
 
8.1 SUMMARY 
 
The studies of this thesis make an innovative and important contribution to 
the early intervention in CP field. Despite the limitations outlined at the end 
of this chapter, GAME is a promising intervention for infants with CP and 
their families. The results demonstrate the importance of early diagnosis 
using the GMA, and the importance of testing of motor and cognitive 
outcomes of infants with CP in well-powered early intervention trials. 
 
The studies of this thesis have focussed on two problems and investigated 
two solutions: 
1.  PROBLEM: Although the brain injury or lesion associated with CP 
originates in infancy and is non-progressive, a clinical diagnosis of CP is not 
usually given until the second year of life. Not identifying CP in infancy 
delays access to possible neuro-rehabilitative interventions that have the 
potential to harness neuroplastic mechanisms and optimise developmental 
outcomes.  
 
SOLUTION: High quality evidence exists that in fact CP can be detected 
early in high risk infants if the right tools are used, namely the GMA and 
appropriately timed MRI (Study 1). The subsequent research programme 
confirmed that the GMA detects CP in 3-4 month old high-risk infants with 
high levels of sensitivity and specificity in an Australian context, similar to 
those published elsewhere and therefore is feasible (Study 3). 
 
2. PROBLEM: There is a lack of empirical evidence that early intervention for 
infants at high risk of CP has benefits for motor outcomes above that which 
would have been expected from development.  This problem in part flows 
from the historical difficulties in identifying the “right” infants to recruit to 
clinical trials. In addition, goal-oriented motor learning interventions known 
to be effective in older children with CP had not previously been tested in 
infants. 
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SOLUTION: Our systematic review (Study 2) found that interventions that 
include an environmental enrichment component have a small but positive 
effect on motor outcomes in infants at high risk of /with CP. We therefore 
next developed and tested an intervention (”GAME”), based on motor 
learning and environmental enrichment principles, in infants at high risk of 
CP, whom we recruited using the GMA or MRI (Studies 4-6). These two 
small clinical trials demonstrated that GAME is feasible to deliver and can 
advance the motor outcomes of infants with CP. 
 
8.2 SYNTHESIS OF FINDINGS 
 
8.2.1. Early identification of CP - major findings 
 
a) The right infants, the right tools at the right time 
The first two research questions (identified in Chapter 1 p ) asked if it was 
possible to detect CP in the first months of life and if it was, then what the 
most predictive tools were, and what was the feasibility of achieving this in 
our local context (Studies 1 and 3). 
Right infants: The use of the right tools at the right time is the most accurate 
way of identifying those who are specifically at “high risk of CP” from those 
of generic “high-risk”. More specific “high risk of CP” designation will 
enable infants to be offered diagnostic specific intervention rather than 
generalised developmental advice. For example, infants with unilateral 
lesions predictive of hemiplegia might be offered very early CIMT, while 
those with basal ganglia and thalamus lesions and thus at risk of severe 
dyskinetic CP, could be offered very early access to technology.  
 
In Study 1 we summarised the risk profile for CP using data from the 
Australian Cerebral Palsy Register. The mean age of diagnosis of CP was 19 
months. It was found that just over half of all children later diagnosed with 
CP were considered high risk in the neonatal period and were NICU 
patients. In this group a large proportion of infants were preterm, although 
amongst the preterm population 10% or less actually go on to have CP.  
Higher risk for CP exists for infants with neonatal encephalopathy, 
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particularly those with moderate to severe HIE, even with the advent of 
hypothermia (1).  
 
Right tools at the right time: For infants in the high-risk group we have made 
recommendations for finding the right infants using the right tools, based on 
available evidence (Study 1). This includes the routine and systematic use of 
sensitive assessment tools including the GMA, HINE and neuroimaging 
(preferably MRI) within the NICU environment as well as GMA and HINE at 
follow-up. Identified infants should be referred for early intervention to 
promote development. These infants are at high risk of abnormal outcome on 
the basis of abnormal GMs alone. In our sensitivity study (Study 3) only 
three infants with abnormal fidgety movements had not received a definitive 
diagnosis at 12 months but had received early intervention and were being 
closely monitored due to mild neurological signs, such as asymmetry in 
hand function. All of the others had received early intervention and either 
had CP or another developmental disorder. This study confirmed that early 
detection is feasible in our context. 
 
b) Recruiting samples of infants with CP is possible 
Considering that CP is such a heterogeneous condition, and that 15% have 
normal MRIs, and that the GMA can also detect severe cognitive impairment, 
it is unlikely that 100% accuracy in detecting CP is achievable in the first year 
using even the best combination of tools. However, given that 50% of infants 
that will later be diagnosed with CP were treated in NICUs, earlier detection 
is achievable for many of these infants (2). 
 
Prior to the targeted training of clinicians across all NICUs in NSW, only one 
centre was using the GMA routinely.  As a result of our knowledge 
translation project (Study 3) that used tailored site-specific solutions to 
embed the use of the GMA into practice, all centres now have at least two 
trained staff and a number of centres have changed their follow-up schedule 
to take advantage of the optimal window for GMA. This simple shift in 
practice enabled accurate identification of infants suitable for enrolment into 
the RCTs of this research program as well as earlier access to intervention for 
other infants with identified delays. 
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In the two RCTs we conducted (Studies 5 and 6), the GMA was used to 
identify infants for recruitment to the trials. In the pilot study 85%were 
referred from NICUs and 15% from the community. In the 12-week pilot 
(Study 5) 77% of infants had a definitive diagnosis of CP before the primary 
endpoint. The long-term outcome of the others is unknown. In the larger 
RCT (Study 6) 83% had a definitive diagnosis by 12 months, 7% had severe 
developmental delay, 7% had normal outcomes on standardised testing but 
persisting mild asymmetries and 3% had dropped out prior to diagnosis. To 
our knowledge of the published literature, these two studies have recruited 
the highest percentage of infants with CP from such an early age. Future 
studies might be able to improve further on this by adopting inclusion 
criteria that specifies relevant MRI results and absent fidgety GMs at 3-4 
months.  
 
c) Use of clinical imaging in prognosis 
Predicting CP from MRI is possible in many cases if the right timing, 
equipment, sequences and scorers are used (3). In the preterm population, 
MRI at term equivalent age has higher sensitivity for predicting CP than 
earlier scans and is recommended for these infants for risk stratification (4-6). 
For term born infants the picture is less clear, although in recent reviews 
authors have confirmed the sensitivity of early (newborn) MRI post HIE and 
neonatal stroke for predicting neurodevelopmental outcomes, including CP 
(3, 7).  
In our second RCT (Study 6) a pediatric neurologist and radiologist blind 
scored clinical imaging and were 75% accurate in predicting a future 
diagnosis of ambulant or non-ambulant CP (Appendix 1 of chapter 7). Of the 
25% of cases where the outcome was not accurately predicted from imaging 
alone, 7% was a scan quality issue (CUS) and 3% had a normal finding. A 
further 7% were expected from imaging to be non-ambulant due to extensive 
bilateral injuries but were clearly going to be ambulant by the 12-month 
assessment. Only one infant predicted to have ambulant CP was not 
diagnosed by 12 months. In essence, in our study, clinical imaging when 
scored by experts, gave enough information to predict CP and therefore we 
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conclude high quality imaging should be routinely included in the diagnostic 
process. 
 
Implications for policy, practice and research 
 
1). A multidisciplinary approach to the diagnostic process is recommended.  
Imaging experts, neonatologists and allied health practitioners are all 
responsible for aspects of infant care and assessment. Parents of high-risk 
infants need evidence-based information provided compassionately and in a 
timely fashion with which they can begin the process of acceptance of their 
child’s disability. 
2). To most accurately make an early clinical diagnosis of CP both the GMA and 
MRI are recommended to be used. 
The combination of absent fidgety general movements and specific findings 
on MRI are highly predictive of CP and we recommend counselling for 
parents and prompt referral to early intervention programmes that offer 
motor learning and cognitive enrichment approaches. In cases where only 
general movements are abnormal but MRI findings are non-specific we 
recommend a “high-risk of CP” designation be given and an explanation to 
parents that a more formal diagnosis may be established in the future. Early 
intervention should still be offered in this case. 
 
Clinicians responsible for the care of high-risk infants ought to be equipped 
with the most appropriate training to accurately identify the infants in their 
care most in need of intervention post discharge. Currently the use of 
neuroimaging appears “centre dependent”.  MRI is more often used for 
infants with HIE than preterm infants although well equipped centres might 
use MRI in more instances. Cranial ultrasound is the imaging of choice in the 
preterm population due to its clinical utility, however CUS has lower 
sensitivity and when used alone misses a large proportion of infants with CP 
(8-9). Routine use of the GMA within the NICU environment could identify 
those at neurological risk thus enabling closer specific monitoring. In 
particular, a trajectory of cramped synchronized general movements is a 
marker for later diagnosis of spastic CP (10) and could prompt a medical 
practitioner to request MRI. Infants with abnormal general movements ought 
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to be followed up and monitored even if other results such as imaging and 
early developmental testing are within the normal range. Further research to 
establish and implement the use of scoring systems for MRI at an 
international level is vital to further our understanding of causal pathways to 
CP and to ensure researchers and clinicians are using the same “language” 
when reporting neuroimaging findings. 
 
3). Neonatologists, paediatric neurologists, paediatricians and allied health personnel 
working with high-risk infants should receive basic training in the GMA.  
Currently, training in the GMA is not regarded as essential, however given 
the predictive validity of the assessment we recommend it be introduced. 
The human resource burden of GMA scoring might be reduced in the future 
by computerized scoring (13,14) as well as the development of smartphone 
applications to enable parents to record a general movements video and 
upload for scoring by certified assessors. Outcomes of these studies have the 
potential to improve clinical utility of GMA and when these tools are 
available should be seamlessly embedded into NICU and follow up 
environments. 
 
4). Standard neurological testing is an important part of the diagnostic process.  
Standard neonatal follow up includes comprehensive developmental 
assessment, typically using the BSID. Routine use of the HINE at follow up is 
a suitable addition to this procedure. Recent publications regarding the BSID 
have demonstrated poor predictive power for future cognitive and motor 
delays (11-12) and so should not be relied on in isolation to determine an 
infant’s neurodevelopmental status. We recommend the HINE be included 
for the high risk population as cut off scores on this assessment can predict 
CP at different time points with greater accuracy than other available tests. 
No specialized training course is required to be able to use this assessment. 
 
5). Identifying infants who are not regarded “high risk” in the neonatal period will 
prove more difficult.  
The causes of CP in the term born (“low risk”) group are still not well 
understood and lack of knowledge regarding timing of the injuries 
associated with CP is an ongoing problem. The “wait and see” approach is 
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commonly applied in practice, often leading to delay in referral for 
intervention and feelings of unresolved anxiety for parents (15). Another 
problem for this group is that there are very few CP-specific predictive tests. 
In infants older than six weeks an anaesthetic is usually required for MRI so 
in the absence of clear neurological signs, MRI is not typically offered. The 
atypical presence of primitive reflexes and muscle tone are considered basic 
items for infant assessment but are not as sensitive for prediction of 
neurodevelopmental outcome as the “quality and quantity of movement “ 
items in the HINE (16). Assessment of risk factors, neurological exam (HINE) 
and standardized motor assessment and the use of the Ages and Stages 
Questionnaire with three additional questions are recommended, as outlined 
in Study 1. Further research is required to determine what combination of 
these items are the most predictive of a future diagnosis in “low risk” infants 
with motor delay. 
 
In order to translate these recommendations into clinical practice we 
recommend that International Clinical Guidelines for the early detection of 
CP be developed and disseminated as a matter of urgency. 
 
 
8.2.2. Early intervention for infants with CP – major findings 
 
a) Infants with CP are an under-researched group 
The last three research questions (Chapter 1 p ) were focused on the 
effectiveness of using motor learning interventions for infants at high risk of 
CP. In Study 2 we used systematic review methodology to summarise the 
available evidence for the impact of environmental enrichment (EE) on the 
motor outcomes of infants with CP or at high risk of CP. The paucity of trials 
in this population was alarming with only seven RCTs retrieved from all 
published literature. Only the studies that included relatively homogeneous 
groups of infants with CP demonstrated between group differences in favour 
of the EE intervention group. These studies also included child-active motor 
training within the protocol.  
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The search process for this review demonstrated that although there were 
many intervention studies of preterm infants, very few of these studies 
included infants with known brain injuries and studies that included them 
had very low numbers with CP. In addition, interventions commonly 
researched in the “at risk” populations are now shown ineffective (17-18), 
while very few contemporary motor learning interventions have been tested 
in infants. We concluded that very little is known about the effect of early 
therapy intervention on infants at the highest risk of CP because despite 
commonly held beliefs, they are an under-studied population. Our meta-
analysis  (Study 2) was able to demonstrate, however, a small but positive 
effect for interventions that included environmental enrichment even though 
the types of enrichment varied between the studies.  
 
b) A motor-learning intervention, GAME is effective for infants with CP 
The intervention package we developed and labelled GAME (Study 4) was 
built upon published literature relating to goal and activity based therapy, 
motor-learning principles, and environmental enrichment and delivered in 
the context of family centred care. The protocol was first tested in a pilot 
study (Study 5) and we found the intervention was acceptable to parents and 
the recruitment processes were identifying the “right” infants. The second 
larger and longer RCT (Study 6) used slightly expanded inclusion criteria 
and some alternative outcome measures. Both of these studies demonstrated 
that early motor learning interventions, delivered in an enriched home 
environment and jointly applied by trained therapists and parents can 
improve motor outcomes of infants with CP to a greater extent than usual 
care. This is the first trial to demonstrate superior motor outcomes since 
Palmer’s trial (19), and is therefore a new contribution to knowledge about 
early intervention in CP.  
 
Although there were elements of GAME and standard care (SC) that 
overlapped, for example provision of home programmes, GAME was unique 
in mode (100% home visits), content (active motor training focus versus 
milestone attainment focus) and total dose (on average 52 hours more than 
standard care in Study 6).  
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c) Standard early intervention is variable in content and intensity 
Studies 5 and 6 confirmed that early intervention services for infants at high 
risk of CP in Sydney, Australia were extremely variable in mode, content and 
dose. Our earlier survey of a number of NICU staff found that infants in this 
category typically received about 14.2 hours of therapy during the first year 
of life (Appendix 1 of Chapter 1). This figure was very close to the 14.82 
hours of therapy received by infants in standard care in Study 6 but is a vast 
contrast to the rehabilitation that adults with brain injuries receive. The 
National Institute for Health and Care Excellence (NICE) adult stroke 
guidelines (20) recommend a multidisciplinary team conduct assessments 
and provide intervention for every domain affected for at least 45 minutes 
per day, 5 days per week. If these guidelines were followed, an adult stroke 
patient receiving the recommended dose of physiotherapy, occupational 
therapy and speech pathology would receive in seven days the same amount 
as infants with brain injuries typically receive in a whole year. In Study 6 
33% of standard care infants received five hours or less of intervention over 
the entire study period while 13% received more than 38 hours. 
 
As well as variability in intensity, the content of standard care intervention 
was also variable. Parents reported the use of therapy techniques from a 
range of approaches including sensory integration and neurodevelopmental 
therapy as well as motor learning. In general, therapy sessions targeted 
milestone attainment and provided advice about positioning and handling. 
Finally no child in standard care received all of their visits in a natural 
environment. While 33% had some home visits, most therapy sessions were 
conducted in clinical settings.  
 
c) Very little is known about the motor trajectories of infants with CP 
Our clinical trials recruited a heterogeneous group of infants, at various 
levels of risk for CP but who nevertheless most often received a diagnosis of 
CP. Some infants had standard motor scores in the low average or average 
range at three months but were scoring in the “very poor” range at 12 
months even with consistent therapy. Some included infants had very stable 
scores over time, while others showed a slower decline. Since both natural 
history and intervention studies in this age group of infants with CP are so 
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few, an expected average rate of change in raw scores on most tests such as 
the PDMS-2 has not been established nor could it be predicted. In other 
words, Study 6 confirmed that predicting outcomes in infants with CP by 
using norm referenced early motor assessments is imprecise. Criterion 
referenced tests such as the GMFM are important for prognostication but are 
not as useful for this purpose before two years. Suitable criterion referenced 
assessments of the upper limb are available for infants with unilateral CP 
(21) but not yet published for infants with bilateral upper limb involvement.  
 
d) Associated impairments of infants make the first year difficult 
Almost half of the participants in Study 6 had significant associated 
impairments that adversely influenced their participation in therapy. The 
most common associated impairment for infants was severe vision 
impairment. Seven (23%) infants had severe cortical vision impairment and 
one had severe retinopathy of prematurity. In most cases parents were not 
aware at the time of discharge that their baby’s vision was a problem as they 
had seen an ophthalmologist who had assessed the eyes as “normal”.  
Delayed vision assessment meant that appropriate vision stimulation was 
not provided until after six months of age in most cases.  
 
In Study 6, 20% of the infants had severe feeding problems of which 80% 
needed nasogastric or gastrostomy feeding by 12 months. In addition many 
infants in both groups had gastro-oesophageal reflux that interfered with 
sleep, play and required medication and/or specialist intervention. Sleep 
was reported as difficult by almost all families whose baby also had a vision 
impairment or severe reflux.  
 
The cumulative effects of sensory impairment, inadequate nutrition, pain 
and sleep deprivation appeared to further delay the development of these 
infants. Very often these issues were dealt with by a wide range of health 
professionals, across a range of services, resulting in a fragmented approach 
to care.  
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e) Parents are vulnerable, but are essential partners in early intervention 
 The early intervention protocol we used in Studies 5 and 6 involved training 
parents to observe motor development and practice activities with their baby 
to promote improvement in their motor skills.  This was essential to 
achieving an adequate “dose” of therapy as per motor learning principles. 
Concurrently we monitored the mental health of these parents and found 
that a proportion were experiencing higher than average levels of 
depression, stress or anxiety that persisted to their child’s first birthday. 
Managing the balance of educating and involving parents in carrying out 
home programmes, while supporting their own emotional needs is 
important to establish. Parents need information and practical and emotional 
support while at the same time the development of a strong attachment with 
their baby is essential. It is unknown if early intervention expectations help 
or hinder mother-infant attachment, however all parents in our studies 
expressed a desire to “do something” to help their child develop. Since 
depression in mothers is a known contributor to poorer cognition in at-risk 
children (22), taking care of the emotional health and well being of parents of 
high-risk infants seems important.  
 
Implications for policy, practice and research 
1. More high quality research in early intervention for infants with CP is essential to 
move the field forward. 
The lack of early intervention evidence in infants and toddlers with CP is 
alarming and has likely contributed to the high variability in practice evident 
in standard care for these children.  More research funding needs to be 
urgently channelled into this area and researchers must collaborate in order 
to organise well-powered clinical trials that will move the field forward. 
Recruitment streams to early intervention CP trials have previously been 
limited by identification of the “right” participants, but as we have shown 
this does not need to be a problem.  
We recommend a larger, RCT of GAME with a longer intervention period be 
conducted with more finely tuned inclusion and exclusion criteria and longer 
term follow up. 
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2) Best practice clinical guidelines in early intervention are required  
Health practitioners working in early intervention need up to date 
information regarding the suitable content for infants with CP, and how this 
might differ from intervention for children with global delay. Despite the 
small amount of evidence available clinical practice guidelines ought to be 
developed as a matter of urgency. When high level RCT evidence is not 
available, guidelines ought to reflect what is known about motor learning 
and dosing so that infants with brain injuries have the best chance to 
optimise neuroplasticity during the critical period. Such a document would 
give invaluable information to managers and policy makers regarding 
appropriate resource allocation for these children 
3. Prospective longitudinal data is urgently needed 
 In order to predict likely motor outcome earlier, a prospective longitudinal 
study is required. Prospectively collecting data of the emerging motor skills 
and musculoskeletal status of infants with/at high risk of CP will improve 
our understanding of early developmental trajectories and potentially lead to 
strategies to prevent secondary impairments such as contracture from 
occurring.  
 
4. Responsivity of available measurement tools should be established  
Until more is known about the sensitivity to change of commonly used 
assessments in the CP population, researchers will find it difficult to clearly 
demonstrate an intervention effect above that which might solely be due to 
development. Even CP specific assessments such as the GMFM-66 do not 
have data concerning the amount of change that is regarded as “clinically 
significant”. This is an important area requiring further research. 
 
5. Early assessment and intervention for infants with CP should be holistic 
Early intervention services for infants at high risk of CP ought to include 
early and systematic assessment of vision, nutrition and feeding, sleep and 
attend to parental wellbeing. Difficulties in any of these areas should be 
immediately and comprehensively addressed so that infants and families can 
focus on developing healthy attachment and promoting infant motor and 
cognitive development. This holistic service will require a concerted and 
deliberate effort on the part of the Department of Health and their 
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community partners to collaborate more deliberately and effectively to 
streamline waiting times for parents and remove barriers that lead to 
delayed diagnosis and access to appropriate intervention. 
 
The National Disability Insurance Agency currently have a unique 
opportunity in Australia to provide appropriate funding packages to support 
families to receive the right type and dose of therapy for infants at the right 
time. 
 
 
8.2.3 LIMITATIONS OF THE STUDIES 
Our pragmatic trials (Studies 5 and 6) were confounded by the realities of 
variable clinical practice. For example, since early intervention is universally 
accepted as standard of care, conducting RCTs with a pure control group (ie 
no intervention) was understandably regarded as unethical in our context. 
Moreover parents should be free to seek co-interventions for their infant 
according to their preferences, and this was the case in our RCTs (Studies 5 
and 6). The effect of co-interventions was difficult to account for in our 
pragmatic trials, however every effort was made to try and identify the 
essential ingredients within the intervention protocols that differentiated 
them from each other. 
 
In future GAME and early intervention studies, a more detailed description 
of the content of standard care would be ideal, but difficult to obtain as 
clinicians are free to use their preferred approaches to therapy. In Study 6 we 
used the Tidier guidelines to summarise the content of both interventions but 
due to the great variability within the standard care group this had 
limitations. Some overlap in content of standard care and GAME was 
unavoidable. The fidelity of GAME was assured as the same therapists 
delivered GAME intervention to all participants in the GAME group 
however this makes replication of the study difficult. A knowledge 
translation project is now required to train therapists in delivering GAME 
intervention. Future GAME studies ought to involve other therapists trained 
in GAME to minimise the potential bias of “therapist effect”.  
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Studies 5 and 6 were also limited by the size of the samples we recruited. 
Although our sample size was calculated on pilot data (Study 5), the 
heterogeneity of CP meant that infants in the larger RCT (Study 6) were more 
severely affected and therefore perhaps slower to respond to intervention 
than a “typical” CP sample. In addition, since GMFCS level is not 
determined by 12 months, the final motor function of these infants is unclear. 
 
The motor measures we used in the studies are another limitation. As 
previously described there is a paucity of outcome measures with 
demonstrable sensitivity to change for infants with disabilities. We 
attempted to use a known responsive primary outcome measure (Goal 
Attainment Scaling) in the pilot work (Study 5) however found this 
unsatisfactory due to the variability and unpredictability in the rate of 
developmental change between the infants. The PDMS-2 was chosen as there 
was some sensitivity data in CP, albeit in toddlers, and it measured hand 
skills and mobility skills, both of which are commonly targeted in early 
intervention programmes.  
 
8.2.4 CONCLUSION 
 
This unique series of studies has demonstrated that a novel intervention, 
GAME improves the motor and cognitive abilities of infants with cerebral 
palsy. We have shown that by using the right tools at the right time, the right 
infants can be accurately identified and recruited to early intervention trials. 
This programme of research suggests more is possible in the field of early 
intervention for infants with CP and further research is warranted. 
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ABBREVIATIONS
COPM Canadian Occupational Perfor-
mance Measure
GAS Goal Attainment Scaling
MACS Manual Ability Classification
System
NDT Neurodevelopmental therapy
AIM The aim of this study was to describe systematically the best available intervention
evidence for children with cerebral palsy (CP).
METHOD This study was a systematic review of systematic reviews. The following databases
were searched: CINAHL, Cochrane Library, DARE, EMBASE, Google Scholar MEDLINE,
OTSeeker, PEDro, PsycBITE, PsycINFO, and speechBITE. Two independent reviewers
determined whether studies met the inclusion criteria. These were that (1) the study was a
systematic review or the next best available; (2) it was a medical/allied health intervention;
and (3) that more than 25% of participants were children with CP. Interventions were coded
using the Oxford Levels of Evidence; GRADE; Evidence Alert Traffic Light; and the
International Classification of Function, Disability and Health.
RESULTS Overall, 166 articles met the inclusion criteria (74% systematic reviews) across 64
discrete interventions seeking 131 outcomes. Of the outcomes assessed, 16% (21 out of 131)
were graded ‘do it’ (green go); 58% (76 out of 131) ‘probably do it’ (yellow measure); 20% (26
out of 131) ‘probably do not do it’ (yellow measure); and 6% (8 out of 131) ‘do not do it’ (red
stop). Green interventions included anticonvulsants, bimanual training, botulinum toxin,
bisphosphonates, casting, constraint-induced movement therapy, context-focused therapy,
diazepam, fitness training, goal-directed training, hip surveillance, home programmes,
occupational therapy after botulinum toxin, pressure care, and selective dorsal rhizotomy.
Most (70%) evidence for intervention was lower level (yellow) while 6% was ineffective (red).
INTERPRETATION Evidence supports 15 green light interventions. All yellow light
interventions should be accompanied by a sensitive outcome measure to monitor progress
and red light interventions should be discontinued since alternatives exist.
Thirty to 40% of interventions have no reported evidence-
based and, alarmingly, another 20% of interventions pro-
vided are ineffectual, unnecessary, or harmful.1 The gap
between research and practice has been well documented
in systematic reviews1 across multiple diagnoses, special-
ties, and countries. Surveys confirm that, unfortunately, the
research–practice gap occurs within the cerebral palsy (CP)
field to the same degree.2,3 This gap exists despite numer-
ous systematic reviews providing guidance about what does
and does not work for children with CP. When clinicians
want to help, families expect effective interventions, and
the health system depends upon cost-effective services, the
provision of ineffectual interventions is illogical. In view
of this, why is there such variable uptake of best available
evidence within real clinical practice?
In the last decade, the CP evidence base has rapidly
expanded, providing clinicians and families with the
possibility of newer, safer, and more effective interventions.
Orthopaedic surgery and movement normalization were
once the mainstays of intervention, but localized antispas-
ticity medications and motor learning interventions have
gained increased popularity.4,5 Thus, the sheer volume of
research published makes it hard for clinicians to keep up
to date.6 Systematic reviews seek to provide evidence sum-
maries, but, in spite of this, clinicians find it difficult to
interpret review findings and stay abreast of these
syntheses.7 Furthermore, the introduction of new and
sometimes competing effective interventions increases the
complexity of clinical reasoning required by clinicians, who
are primarily motivated to improve outcomes for children.8
In the last 10 years, the field has adopted the World
Health Organization’s International Classification of Func-
tioning, Disability and Health (ICF),9 which has redefined
the way clinicians understand CP and think about inter-
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vention options. From an ICF perspective, CP impacts on
a person’s ‘functioning’, (inclusive of body structures [e.g.
limbs], body functions [e.g. intellectual function], activities
[e.g. walking], and participation [e.g. playing sport]), which
in turn may cause ‘disabilities’, such as impairments, activ-
ity limitations, and participation restrictions. Moreover,
each person with CP lives within a personalized environ-
ment and thus their context also contributes to determin-
ing their independence, comprising personal factors (e.g.
motivation) and environmental factors (e.g. architectural
accessibility).9,10 Thus, there are many potential problems
a child with CP may face and seek intervention for. The
field has chosen a philosophical shift away from almost
exclusively redressing physical impairments underlying
functional problems to adopting an additional focus on
maximizing children’s environment, their independence in
daily activities, and their community participation.11 Fur-
thermore, clinicians applying the recommended goal-based
approach seek to choose interventions guided by what
would best help the family achieve their goals.12–14 Couple
these philosophical preferences with widespread barriers to
research implementation (such as limited time, insufficient
library access, limited research appraisal skills, attitudinal
blocks to research, and differing patient preferences), and
there is no assurance that children with CP will receive
evidence-based interventions.1,15,16
The aim of this paper was to describe systematically the
best available evidence for CP interventions using the
GRADE17 system and to complement these findings with
the Evidence Alert Traffic Light System18 in order to pro-
vide knowledge translation guidance to clinicians about what
to do. The purpose of rating the whole CP intervention evi-
dence base within the one paper was to provide clinicians,
managers, and policy-makers with a ‘helicopter’ view of best
available intervention evidence that could be used to (1)
inform decision-making by succinctly describing current
evidence about CP interventions across the wide span of dis-
ciplines involved in care; (2) rapidly aid comparative clinical
decision-making about similar interventions; and (3) provide
a comprehensive resource that could be used by knowledge
brokers to help prioritize the creation of knowledge transla-
tion tools to promote evidence implementation.19
METHOD
Study design
A systematic review of systematic reviews (i.e. the highest
level of CP intervention research evidence available) was
conducted in order to provide an overview of the current
state of CP intervention evidence. Systematic reviews were
preferentially sought since reviews provide a summary of
large bodies of evidence and reviews help to explain differ-
ences among studies. Moreover, reviews limit bias which
assists clinicians, managers, and policy-makers with deci-
sion-making about current best available evidence.20 How-
ever, for interventions for which no systematic reviews
existed, lower levels of evidence were included to illumi-
nate the current state of the evidence.
Search strategy
Our review was carried out using a protocol based upon
recommendations from the Cochrane Collaboration and
PRISMA statements.21,22 Relevant articles were identified
by searching the CINAHL (1983–2012); Cochrane Data-
base of Systematic Reviews (1993–2013; www.cochra-
ne.org); Database of Reviews of Effectiveness (DARE);
EMBASE (1980–2012); ERIC; Google Scholar; MED-
LINE (1956–2012); OTSeeker (www.otseeker.com); Phys-
iotherapy Evidence Database (PEDro [www.pedro.fhs.usyd.
edu.au]); Psychological database for Brain Impairment
Treatment Efficacy (PsycBITE [www.psycbite.com]); Psy-
cINFO (1935–2012); PubMED; and Speech Pathology
Database for Best Interventions and Treatment Efficacy
(speechBITE [www.speechbite.com]). Searches were sup-
plemented by hand searching. The search of published
studies was performed in July and August 2011 and
updated in December 2012. Interventions and keywords
for investigation were identified using (1) contributing
authors’ knowledge of the field; (2) internationally recog-
nized CP websites such as the American Academy of Cere-
bral Palsy and Developmental Medicine (www.aacpdm.
org), CanChild (www.canchild.ca), the Cerebral Palsy Alli-
ance (www.cerebralpalsy.org.au), Cincinnati Children’s
Hospital (www.cincinnatichildrens.org), Karolinksa Insitu-
tet (www.ki.se), NetChild (www.netchild.nl), NeuroDev-
Net (www.neurodevnet.ca), and Reaching for the Stars
(www.reachingforthestars.org); and (3) the top 20 hits in
Google using the search term ‘cerebral palsy’ as an indica-
tor of popular subject matter.
Electronic databases were searched with EBSCO host
software using PICOs [patient/problem, intervention, com-
parison, and outcome] search terms. The full search strat-
egy is available from the authors on request.
Inclusion criteria
Published studies about intervention for children with CP
fulfilling criteria under the headings below were included.
Type of study
First, studies of level 1 evidence (systematic reviews),
rated using the Oxford 2011 Levels of Evidence were
preferentially sought.23 The Oxford 2011 Levels of
Evidence for treatment benefits include level 1, a system-
atic review of randomized trials or n-of-1 trials; level 2, a
randomized trial or observational study with dramatic
effect; level 3, a non-randomized controlled cohort/
follow-up study; level 4, a case series, case–control study,
or a historically controlled study; and level 5, mechanism-
based reasoning.
What this paper adds
• Of 64 discrete CP interventions, 24% are proven to be effective.
• 70% have uncertain effects and routine outcome measurement is necessary.
• 6% are proven to be ineffective.
• Effective interventions reflect current neuroscience and pharmacological
knowledge.
• All effective interventions worked at only one level of the ICF.
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Evidence of Oxford levels 2 to 4 were included only if
(1) level 1 evidence did not exist on the topic and then the
next best available highest level of evidence was included;
or if (2) level 2 randomized controlled trial(s) had been
published since the latest systematic review, which substan-
tially changed knowledge about the topic.
Second, retrieved bodies of evidence were coded using
the GRADE17 system and Evidence Alert Traffic Light
System18 using two independent raters, with 100%
agreement reached. The GRADE17 system was chosen
because it is a criterion standard evidence-grading tool
and is endorsed by the World Health Organization. Def-
initions of the GRADE terms appear in the notes to
Table I and a full description of panel rating processes
are available from www.gradeworkinggroup.org/publica-
tions/JCE_series (retrieved 8 March 2013). Notably, the
GRADE system rates both (1) the quality of the evi-
dence (randomized trials, high; observational studies, low;
and other levels of evidence, very low, but it is worth
mentioning that high-quality evidence is downgraded if
methodological flaws exist and low-quality evidence is
upgraded if high and certain effect sizes exist [e.g. popu-
lation-based CP register data])17 and (2) the strength of
the recommendation for use, which weighs up trade-offs
between the benefits and harms of using the interven-
tion, whereby a panel considers (a) the methodological
quality of the evidence supporting estimates of likely
benefit and likely risk; (b) inconvenience; (c) the impor-
tance of the outcome that the treatment prevents; (d)
the magnitude of the treatment effect; (e) the precision
of the estimate of the treatment effect; (f) the risks asso-
ciated with therapy; (g) the burdens of therapy; (h) the
costs; and (i) the varying values.17 The GRADE method-
ology means that sometimes bodies of evidence may be
assigned a strong recommendation even when the quality
of the evidence is low. This is either because there is a
high likelihood of harm from no intervention (e.g. anti-
convulsants to prevent seizures or ulcer prevention pres-
sure care) or because the treatment has a low effect size
and is expensive to provide, but a safe, more effective,
cost-comparable alternative exists (e.g. phenol vs botu-
linum toxin A; or neurodevelopmental therapy [NDT] vs
motor learning). The Evidence Alert Traffic Light Sys-
tem18 was chosen because it is a GRADE-complementary
knowledge translation tool, designed to assist clinicians
to obtain easily readable, clinically useful answers within
minutes.6 The Evidence Alert also provides a simple,
common language between clinicians, families, managers,
and funders, based upon three-level colour coding that
recommends a course of action for implementation of
the evidence within clinical practice. The Evidence Alert
System18 has been shown to increase by threefold clini-
cians’ reading habits about CP research.24 Figure 1
describes the GRADE system and the Evidence Alert
System and their relationship to each other. Table I
shows the included studies, best evidence levels grades
and traffic light classification.25–185
Where multiple systematic reviews existed and newer
level 1 to 2 evidence superseded the findings of earlier
level 1 evidence, the grades were assigned based on the
most recent high-quality evidence.
Types of intervention
Studies were included if they involved the provision of and
intervention by either a medical practitioner or allied
health professional.
Types of participants
Studies were included if they explicitly involved human
participants and more than 25% of the participants were
children with CP.
Studies were excluded from the review if (1) they were
diagnostic studies, prognostic studies, or interventions
aimed at preventing CP (e.g. magnesium sulphate186 and
hypothermia187); (2) they provided lower levels of evidence,
unless no systematic review had been published; (3) partici-
pants were adults, although if a study predominantly
(>75%) studied children but included a small proportion of
young adults (<25%) the paper was included; (4) they
reviewed generic prophylaxis interventions (e.g. good par-
enting, standard neonatal care for all infants, i.e. not CP-
specific interventions); (5) they reviewed a whole discipline,
not individual interventions (e.g. physiotherapy, occupa-
tional therapy, speech pathology); (6) they were considered
alternative and complementary interventions with no pub-
lished evidence; (7) a second publication of the same study
published the same results; and (8) they were unpublished
or not peer reviewed.
Data abstraction
A data abstraction sheet based on the Cochrane’s recom-
mendations21 was developed. Abstracts identified from
searches were screened by two independent raters (CP
research experts and knowledge brokers) to determine their
eligibility for further review. Abstracts were retained for
full review if they met the inclusion criteria or if more
information was required from the full text to confirm that
the study met all the eligibility criteria. Two independent
reviewers then reviewed full-text versions of all retained
articles and all additional articles identified by hand search-
ing. Full-text articles were retained if they met inclusion
criteria. Agreement on inclusion and exclusion assignment
of the full-text articles was unanimous. Data extracted from
included studies comprised the authors and date of the
study; the type and purpose of the intervention imple-
mented; the study design; the original authors’ conclusions
about efficacy across study outcomes; and the original
authors’ conclusions on strength of evidence (based on
their assessment of whether there was no evidence of bene-
fit, qualified support, or strong support). For lower level
evidence, risk of bias was assessed using the Cochrane
criteria.
The data extracted from each included study were sum-
marized, tabulated, and assigned a level of evidence rating
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using the Oxford Levels of Evidence; a categorization
using GRADE; a colour coding scheme using the Evidence
Alert Traffic Light system, and an ICF domain (Table I).
More specifically, each intervention outcome sought by
included study authors was assigned an ICF domain based
upon published literature.176 It has been acknowledged in
the literature that ICF coding is notoriously complex to
apply since CP is a disability not a disease, and thus direct
interventions do not ultimately alter underlying disease
processes.10 To overcome this challenge, we applied ICF
codes using CP literature precedents, where the outcome
measure within the included trials had been ICF coded by
other authoritative researchers.10 Of note, ICF linking
rules typically cluster together (1) body structure and func-
tions; and (2) activities and participation. To prevent loss
of findings obscured within aggregated data, we separated
activities from participation because we wanted to illumi-
nate whether or not participation outcomes were being
achieved. All the data required to answer the study ques-
tions were published within the papers, so no contact with
authors was necessary.
Ethics and registration
The study did not involve contact with people, so the need
for ethical approval was waived by the Cerebral Palsy Alli-
ance’s Human Research ethics committee. This systematic
review was not registered.
RESULTS
Using the search strategy, 33 485 citations were identified,
of which 166 articles met the inclusion criteria for review
(Fig. 2).
Participants
For the purpose of this study, participants had CP, which is
a complex and heterogeneous condition. We included stud-
ies about children with CP of any motor subtype (spastic,
dyskinetic, or ataxic), any topography (hemiplegic/unilat-
eral, diplegic/bilateral, or quadriplegic/bilateral), and any
functional ability level (Gross Motor Function Classifica-
tion System [GMFCS]188 levels I to V and Manual Ability
Classification System [MACS]189 levels I to V). There was
substantial emphasis in the medical literature on interven-
tions to reduce spasticity, the most prevalent motor impair-
ment.190 There was also a heavy emphasis in the therapy
literature on interventions designed to improve motor out-
comes consistent with CP being a physical disability. The
higher-quality studies defined the child’s motor function
abilities using the GMFCS and MACS to enable better
interpretation of treatment effects taking into account the
severity of the disability. However, there was insufficient
homogeneity of reporting across studies to enable reporting
by GMFCS level, which was our original intended strategy.
Levels of evidence and ICF
High levels of evidence existed in the literature summariz-
ing interventions for children with CP (Table I). Of theTa
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Review 897
166 included studies, the breakdown by level of evidence
as rated on the Oxford Levels of Evidence was level 1
(n=124), 74%; level 2 (n=30), 18%; level 3 (n=6), 4%; and
level 4 (n=6), 4%.
When the included articles were tallied in 5-year inter-
vals by publication date, it was clear that the number of
systematic reviews published about CP intervention had
exponentially increased in recent years (Fig. 3).
Almost none (2 of 166) of the systematic reviews
retrieved graded the body of evidence summarized using
the GRADE system. We therefore carried out assignment
of GRADEs using the recommended expert panel method-
ology. Using the GRADE system, of the 64 different CP
interventions reviewed across 131 intervention outcomes
16% of outcomes assessed (n=21) were graded ‘do it’ (i.e.
green light, go interventions); 58% (n=76) were graded
‘probably do it’ (i.e. yellow light, measure outcomes); 20%
(n=26) were graded ‘probably do not do it’ (i.e. yellow
light, measure outcomes; see Fig. 1); and 6% (n=8) were
graded ‘do not do it’ (i.e. red light, stop interventions; see
Fig. 1). In line with the appraisal criteria for this review,
occupational therapy, physiotherapy, and medicine were
the disciplines that encompassed the highest number of
proven effective interventions for CP within their evidence
base, which is not surprising given the long historical
research emphasis on redressing the physical aspects of
CP. In the fields of psychology, speech pathology, social
work, and education, the evidence base for all interventions
reviewed was lower level or inconclusive (yellow), but, in
keeping with interdisciplinary care, psychologists and social
Grade of evidence
Quality
Fa
vo
ur
ab
le
Un
fa
vo
ur
ab
le
High Strong + Green: Go
Yellow: Measure
Red: StopStrong –
Weak +
Weak –
High
High = Further research is very unlikely 
to change our confidence in the
estimate of effect
Further research is likely to have
an important impact on our confidence
in the estimate of effect and may 
change the estimate 
Further research is very likely to
have an important impact on our
confidence in the estimate of effect
and is likely to change the estimate 
Any estimate of effect is very uncertain
Moderate
Moderate
Low
Very low
Very low
Very low =
Low
Low =
Recommendation
Traffic alert action
Moderate =
Strong + Do it
Don’t do it
Probably do it
Probably don’t do it
Strong –
Weak +
Weak –
Green = Go: Effective, therefore do it
Yellow = Measure: Uncertain effect,
                               therefore measure
                               outcomes to determine
                               if progress is made
Red = Stop: Ineffective, therefore don’t do it
Figure 1: Relationship between the GRADE and Traffic Light System.
Total no. of
   articles
(n = 33 485)
n = 148
n = 77
n = 118
n = 16
n = 308 000
n = 154
n = 32
n = 72
n = 1
n = 124
n = 25
n = 7
n = 4
n = 66
n = 1996
n = 5
CINAHL
Cochrane
DARE
ERIC
Google scholar
Medline
OT seeker
PEDro
PsychBITE
PsychINFO
PubMED
Systematic reviews
RCTs
Non-randomised
Case series
SpeechBITE
Reasons for deletion included:
Not systematic reviews; not
>25% sample had cerebral
palsy; duplicates; protocols
only; and practice guidelines
      Total no. of
   articles included
         (n = 166)
No. of potential
   articles after
    deletion by
  title (n = 231)
No. of potential
   articles after
    deletion by
       abstract
      (n = 171)
No. of potential
   articles after
deletion by full-
 text (n = 166)
Figure 2: Flow diagram of included articles.
898 Developmental Medicine & Child Neurology 2013, 55: 885–910
workers applied high-level evidence from other diagnostic
groups (e.g. bimanual, cognitive behaviour therapy, coun-
selling, Triple P49). In the field of speech pathology, it is
worth noting that it is difficult to conduct studies of aug-
mentative and alternative communication (AAC) using
conventional rigorous methodologies because included par-
ticipants often have different disability types and, accord-
ingly, differing levels of expressive, receptive, and social
communication abilities. AAC interventions require multi-
factorial measurement because effective device utilization
relies on changes in all of these domains from best-practice
speech, language, and teaching strategies and from chang-
ing the mode of communication. Thus, adequately measur-
ing and attributing interventions effects to each component
of these integrated treatment approaches remains challeng-
ing. Amongst the alternative and complementary medicine
interventions offered by some clinicians, the findings were
of even poorer quality, because an even greater proportion
of the interventions were proven ineffective. However, the
real rate of ineffective alternative and complementary inter-
ventions may be even higher as so many had to be
excluded from this review as a result of the lack of any
published peer-reviewed literature about the approaches
(e.g. advanced biomechanical rehabilitation).
Each intervention was coded using the ICF by the inter-
vention’s desired outcome. Out of the 131 intervention
outcomes for children with CP identified in this study,
n=66 (51%) were aimed at the body structures and func-
tion level; n=39 (30%) were aimed at the activity level; n=7
(5%) were aimed at the participation level; n=8 (6%) were
aimed at the environment level; and the remaining n=11
(8%) were aimed at combinations of ICF levels.
Green light go interventions
In the papers retrieved, the following CP interventions
were shown to be effective: (1) botulinum toxin (BoNT),
diazepam, and selective dorsal rhizotomy for reducing
muscle spasticity; (2) casting for improving and maintain-
ing ankle range of motion; (3) hip surveillance for main-
taining hip joint integrity; (4) constraint-induced
movement therapy, bimanual training, context-focused
therapy, goal-directed/functional training, occupational
therapy following BoNT, and home programmes for
improving motor activity performance and/or self-care;
(5) fitness training for improving fitness; (6) bisphospho-
nates for improving bone density; (7) pressure care for
reducing the risk of pressure ulcers; and (8) anticonvulsants
for managing seizures (despite no CP-specific anticonvul-
sant evidence existing, the panel rated the strength of the
recommendation as strong plus (do it) because good-qual-
ity evidence supports anticonvulsants in non-CP popula-
tions,191 and serious harm, even death, can arise from no
treatment).
Green light effective interventions were mapped against
the ICF by the outcomes that had been measured in the
literature and the corresponding traffic light code was
applied (Table II). First, Table II shows that green-light
effective interventions were all aimed at either the body
structures and function level or the activities levels on the
ICF. The conspicuous finding here was that there were no
proven effective interventions for addressing the participa-
tion, environment, or personal factors levels of the ICF,
even though these are philosophical priorities. Second,
Table II shows that when effective body structures and
functions interventions were measured for an effect at the
activities level (all of the time) evidence of effect was either
lower level or inconclusive and, therefore, was coded yel-
low light. In other words, the positive effects of body
structure interventions did not translate ‘upstream’ to the
activities level. This finding seems to suggest that you ‘get
what you give’. This finding has, however, an alternative
interpretation – we do not yet know if body structures and
functions intervention improves outcomes at the activities
level because of the measurement artefact created by ran-
domized trials only being powered to detect change in one
primary end-point. Third, Table II shows that green light
activity-level interventions were effective at the activities
level of the ICF, but minimal measurement had been
undertaken to illuminate whether or not there was also any
translation of impact ‘downstream’ to the body structures
and functions level.
Yellow light measure outcomes interventions
A high proportion (70%) of the CP interventions within
clinical care had either lower-level evidence supporting
their effectiveness or inconclusive evidence, including acu-
puncture; alcohol (intramuscular injections for spasticity
reduction); AAC; animal-assisted therapy; assistive technol-
ogy; baclofen (oral); behaviour therapy and coaching;
cognitive behaviour therapy; communication training;
conductive education; counselling; oral dantrolene; dyspha-
gia management; early intervention (for motor out-
comes); electrical stimulation; fundoplication; gastrostomy;
hand surgery; hip surgery; hippotherapy; hydrotherapy;
intrathecal baclofen; massage; orthoses; oral–motor
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therapy; orthopaedic surgery; parent training; phenol
(intramuscular injections); play therapy; respite; seating and
positioning; sensory processing; single-event multilevel sur-
gery; social stories; solution-focused brief therapy; strength
training; stretching; therasuits; oral tizanidine; treadmill
training; oral vitamin D; Vojta; and whole-body vibration.
It is important to note that cognitive–behavioural ther-
apy,192–196 early intervention,196–198 parent training,49,50
and solution-focused brief therapy199 all have good-quality
supporting evidence in non-CP populations. It is also
important to note that oral–motor therapy200 and sensory
processing201 have equivocal evidence in non-CP popula-
tions for which they were designed, and so there is no
strong or compelling reason to think either intervention
would work better in CP. Of note, there was great variabil-
ity in the volume and quality of the evidence available at
the yellow-light level. For example, some intervention evi-
dence bases were downgraded to low quality, as per the
GRADE guidelines for dealing with imperfect randomized
controlled trials (e.g. hippotherapy and biofeedback). How-
ever, for some interventions simply next to no evidence has
been published and what has been published involves
very small numbers and is of low quality (e.g. whole-body
vibration).
The yellow-light included reviews that could not dem-
onstrate robust evidence of effectiveness when strict sys-
tematic review criteria about design quality, adequate
sample size, and independent replication were used to
judge the evidence. Yellow-light reviews contained only
marginal amounts of good-quality evidence when criteria
were applied to reduce the possibility of biases explaining
the proposed treatment benefits. Most yellow-light system-
atic review authors commented upon the low quality of the
designs used, serious methodological flaws, the relevance
and sensitivity of the outcomes measures adopted, the diffi-
culty in assembling large homogeneous samples for niche
interventions, and most authors concluded that more rigor-
ous research was needed.
Red light stop interventions
Craniosacral therapy, hip bracing, hyperbaric oxygen,
NDT, and sensory integration have all been shown to be
ineffective in children with CP, and are therefore not rec-
ommended for standard care. Appropriately, effective alter-
natives exist that seek to provide the same clinical outcome
of interest.
To assist with comparative clinical decision-making
amongst intervention options for the same desired out-
come, we mapped the interventions that seek to provide
analogous outcomes using bubble charts. In the bubble
charts, the size of the circle correlated to the volume of
published evidence. The circle size was calculated using
(1) the number of published papers on the topic; and (2)
the total score for the level of evidence (calculated by
reverse coding of the Oxford Levels of Evidence, i.e. expert
opinion=1, randomized controlled trial [RCT]=5). The
location of the circle on the y-axis of the graph corre-
sponds to the GRADE system rating. The colour of the
circle correlates to the Evidence Alert System (Fig. 4).
DISCUSSION
High levels of evidence existed in the literature summarizing
intervention options for children with CP. Akin to other
fields of medicine and allied health, there has been an expo-
nential increase in the number of systematic reviews pub-
lished about CP intervention6 revealing the emergence of
Table II: Green light interventions (and their other indications) by level of ICF
Intervention
ICF level
Body
structures
and
function Activity Participation Environment
Personal
factors
Body structures and function interventions
1. Anticonvulsants G
2. Botulinum toxin G
3. Bisphosphonates G
4. Casting (ankle) G Y
5. Diazepam G
6. Fitness training G Y Y
7. Hip surveillance G
8. Pressure care G
9. Selective dorsal rhizotomy G Y Y
Activities interventions
10. Bimanual training G
11. Constraint-induced movement therapy G
12. Context-focused therapy G
13. Goal-directed training/functional training G
14. Home programmes G Y
15. Occupational therapy post botulinum toxin
(upper limb)
G
G=green intervention when aimed at this level of the International Classification of Functioning, Disability and Health (ICF); Y=yellow
intervention when aimed at this level of the ICF.
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highly effective prevention interventions.186,187 There is no
reason to think that this trend may decline. This finding has
important implications for managers, knowledge brokers,
and clinicians about finding effective and efficient ways for
health professionals to remain up to date with the latest
practice. Best available knowledge translation evidence sug-
gests that managers and senior clinical mentors can help
staff maintain up-to-date knowledge via interactive evi-
dence-based practice continuing education sessions and
journal clubs, but multiple tailored strategies will be
required to change their use of evidence.202 This systematic
review could form the basis of policy, educational, and
knowledge translation material because it is a comprehensive
summary of the evidence base.
Recommendations for practice
Based upon the best available evidence, standard care for
children with CP should include the following suite of
interventions options (where the interventions would
address the family’s goals): (1) casting for improving ankle
range of motion for weight bearing and/or walking; (2) hip
surveillance for maintaining hip joint integrity; (3) biman-
ual training, constraint-induced movement therapy, con-
text-focused therapy, goal-directed/functional training,
and/or home programmes for improving motor activities
or self-care function; (4) BoNT, diazepam, or selective
dorsal rhizotomy for spasticity management; (5) fitness
training for aerobic fitness; (6) pressure care for reducing
the risk of ulcers; (7) bisphosphonates for improving bone
mineral density; and (8) anticonvulsants for managing sei-
zures. When delivering interventions to children with CP,
it is paramount that clinicians choose evidence-based inter-
ventions at the activities and participation level that hone
the child’s strengths and reflect their interests and motiva-
tions, and ultimately seek to help children live an inclusive
and contented life. However, when choosing interventions
at the body structure and functions level, the primary pur-
pose is to mitigate the natural history of CP (such as hip
dislocation) and the probable physical decline from second-
ary impairments,118 rather than trying to fix the condition.
We must also remain mindful that conflicts can arise
between what families hope for and what the evidence sug-
gests will be helpful or is realistically possible.202 Part of
being truly family centred is to act as an information
resource to the family, which will include honest and open
disclosure about prognosis using evidence-based tools to
guide these difficult conversations.203 Similarly, designing
services based upon goals set by the family5,64 is best prac-
tice and can also help to set the scene for discussing what
is realistic and possible from intervention.
   Improved
communication
   Mealtime
management
   Improved
  behaviour
& social skills
   Improved
     parent
     coping
  Improved
     bone
   density
Communication
      training
AAC
 Social
stories
 Oro-
motor
 Oro-
motor
Fundopli
  cation
  Dysphagia
 management
Gastrost
    omy
Behaviour
  therapy
Behaviour
  therapy
Bisphos-
phonates
 Assistive
technology
 standing 
  frames
Vitamin
     D 
 Whole
  body
vibration
Communication
     training
Coach-
   ing
Solut-
  ion
focus
Coun-
selling
Social
stories
   Play
therapy
CBT
c
Figure 4: Contiuned.
902 Developmental Medicine & Child Neurology 2013, 55: 885–910
Going forward, systematic and disciplined use of out-
come measures within all specialties is required for
generating new evidence and confirming treatment effects
of commonly used interventions. Routine outcome
measurement is especially important when yellow-light
interventions are being applied, and could circumnavigate
some of the genuine research barriers including low avail-
ability of research funds and difficulties in assembling large
homogenous samples. This recommendation is particularly
vital for the fields of speech pathology, social work, and
psychology that provide key services to children with CP,
without strong evidence, as of yet, to support their prac-
tice. These professions have been overshadowed in the CP
research arena until recently, when the field stopped solely
redressing physical impairments and started to look further
afield to engendering outcomes in well-being and partici-
pation. In addition, systematic and disciplined use of out-
come measures is also needed when prescribing assistive
technology and assistive devices (such as wheelchairs, walk-
ing frames, and communication devices) for children with
CP, because devices form a large part of standard care. To
date, specialized equipment and technology has been vastly
under-researched, probably because the benefits are easily
observable (such as independent mobility) and the studies
are expensive to conduct; however, in light of device aban-
donment issues and associated costs, extensive efficacy
research is warranted at both an individual and a popula-
tion level. Moreover, prescribing assistive technology with
a specialized appearance (such as orthotics, suits, comput-
erized devices, robotics) may well elevate expectations of
good outcomes and give rise to an overinflated perception
of high-quality expert care. Thus, it is essential to know if
the interventions are working, so as to prevent device
abandonment, false hopes, and unnecessary effort.
When yellow-light interventions are used, it is imperative
that clinicians utilize a sufficiently sensitive outcome mea-
sure to confirm whether or not the intervention is working
and if it is helping the child achieve their family’s goals. The
Canadian Occupational Performance Measure (COPM) and
Goal Attainment Scaling (GAS)5,64,204 have been widely
adopted in the literature for assessing goal achievement
because they are valid, reliable, sensitive to change, and clin-
ically affordable. Moreover, both measures work well within
the family-centred approach because they encourage family-
led goal setting and facilitate individualization, which is
important for such a heterogeneous condition as CP. For
yellow-light interventions, in addition to measuring whether
goals are achieved, it may be desirable to measure if the
intervention is actually achieving what it purports to do for
each individual. Systematic individual outcome measure-
ment, conducted at a population level with data aggregation,
would introduce the possibility of rapidly expanding the
evidence base amongst this heterogeneous population.
Parents, young people, and doctors have identified eight
consensus measurement domains, important for assessing
the impact of a CP intervention, that span the ICF levels.205
We identified systematic reviews that provided measurement
recommendations for evaluating these eight domains in a
way that was sensitive to change. The first of these eight
domains is impairment, which can be subdivided into (1)
spasticity, measured using the Modified Tardieu Scale5,64
and (2) fine motor, measured using the Melbourne Assess-
ment of Unilateral Upper Limb Function11 and the Quality
of Upper Extremity Skills Test.11 The second domain is
general health. Valid and reliable instruments exist regarding
general health in the literature, but less is understood about
whether these measures are sensitive to change in CP, and
therefore no recommendations are made at this juncture.
Third is the gross motor skills domain, measured using the
Gross Motor Function Measure.73,206,207 The fourth domain
is self-care/fine motor skills, which can be subdivided into
(a) self-care, measured using the Paediatric Evaluation of
Disability Inventory206 and the Activities Scale for
Kids207,208 and (b) fine motor, measured using the Assisting
Hand Assessment for activities performance measurement.11
Fifth is the speech/communication domain, measured using
GAS.209 The sixth domain is integration/participation which
can be measured using the COPM or GAS204 (note that
other domain-specific measures exist such as the LIFE-H,
but this does not have adequate sensitivity to detect change).
Finally, regarding both the seventh domain, quality of life,
and the eighth domain, caregiver instruments, valid and reli-
able instruments exist in the literature, but less is understood
about whether these measures are sensitive to change, and
therefore recommendations for use are not made at this
juncture.
In line with the principles of evidence-based care and as
a cost-saving measure, it is highly recommended that cra-
niosacral therapy, hip bracing, hyperbaric oxygen, neurode-
velopmental therapy, and sensory integration should all be
discontinued from CP care. Interestingly, these ineffective
interventions for the most part are founded upon out-dated
neurological theories about CP. For example, hyperbaric
oxygen as a treatment for CP was based on the now dis-
proven assumption that all CP arises from a lack of oxygen
during birth (true for only 5–10% of cases190) and that
increased oxygenation ought to help repair brain function.
Neurodevelopmental therapy sought to reduce hyper-ref-
lexia by repositioning the limb on stretch, providing a local
pattern-breaking effect mimicking spasticity reduction, but
we now know (1) that local effects do not translate to a
reduction in centrally driven spasticity long term210; and
(2) that no substantive evidence exists to support the idea
that inhibition of primitive reflex patterns promotes motor
development.12 Likewise, ‘bottom-up’ approaches, in which
children’s underlying motor deficits are treated with the
aim of preparing them for function (such as neurodevelop-
mental therapy and sensory integration) were commend-
able pursuits when originally invented but disappointingly
have little carryover into functional activities.12
Over a decade ago, CP research experts12 and systematic
review authors called for ‘concerted efforts to investigate
other therapy approaches that may prove more clearly
beneficial’.142 These therapy experts were referring to
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performance-based or ‘top-down’ approaches based on
motor learning theory, in which interventions focus
directly on specific task training in activities of interest and
are not concerned with underlying impairments in body
structures and function.201 This visionary advice, in con-
cert with the researchers who rigorously tested their theo-
ries, has transformed CP rehabilitation in recent years.
The majority of the ‘do it’ or green-light effective CP
therapy evidence generated in the last 10 years are in fact
top-down therapy approaches, aimed at improving activi-
ties performance and inducing neuroplasticity, and include
bimanual training, constraint-induced movement therapy,
context-focused therapy, goal-directed/functional training,
occupational therapy after toxin, and home programmes.
Consistent with the theoretical underpinnings, research has
not focused on whether these top-down approaches had a
positive effect at the body structures and function level of
the ICF (Table II).
Given the sudden increase in new effective treatment
options available, it is essential that the field widely
embraces and implements these interventions in order to
ensure that children with CP achieve the best possible out-
comes. Adoption of evidence-based practice also involves
the difficult task of getting clinicians to stop providing
ineffective treatments that they ‘love’.211 It has been sug-
gested that the field requires professionals ‘who want to do
the best they can for their patients, who are willing to con-
tinually question their own managements, and who have
readily available sources of information about what does
work’.211 Our present systematic review seeks to provide
the CP field with a comprehensive overview about what
works for children with CP and what does not (Fig. 4).
Based on best available evidence, the challenge now is for
the field to stop permissive endorsement of proven ineffec-
tive interventions on the basis of perceived low risk and
clinical expertise. This recommendation includes ceasing
provision of the ever-popular NDT. This is because NDT
has been a mainstay physiotherapy and occupational ther-
apy treatment for many years, but for the most part, the
evidence base is unfavourable. Of note, contemporary
NDT therapists eclectically include additional evidence-
based treatment approaches under the NDT banner (e.g.
motor learning and the philosophy of family-centred prac-
tice), and it is difficult to distil which treatment approaches
are being used with fidelity and what features of the treat-
ment are actually working.
Nevertheless, three systematic reviews have been con-
ducted of traditional NDT,141–143 including 18 discrete
RCTs: 15 measuring efficacy and three measuring optimal
dose. Of the 15 RCTs measuring NDT efficacy, 12 trials
(studying 674 children) found no statistically favourable
benefits from NDT; these trials were of varying quality
(high, moderate, and low), whereas three trials (studying
38 children) showed improvements in body structures and
functions such as gait parameters, spirometry, and mile-
stone acquisition. The three favourable trials were all at
high risk of bias when assessed using the Cochrane criteria,
including small sample sizes (n<16) and extremely low
methodological quality such as a lack of blinding, inten-
tion-to-treat analysis, concealed allocation, etc. In the three
NDT dosing RCTs, two studies (studying n=96 children)
found no difference between intense or regular NDT,
whereas one more recent study, by Tsorlakis212 (n=34),
showed favourable outcomes from higher-intensity NDT
over lower-intensity NDT. The most recent NDT system-
atic review143 cited the Tsorlakis212 RCT as the sole high-
level evidence for NDT being favourable, excluding older
evidence and thus all the unfavourable NDT RCTs. Since
this is not a standard systematic review methodology for
providing proof of efficacy, the results of this systematic
review143 should be interpreted with caution. The differ-
ence in inclusion criteria between the systematic reviews
explains why the newer systematic review143 suggests a
more favourable benefit from NDT than the earlier sys-
tematic reviews that concluded ineffectiveness.141,142
In order to determine the strength of recommendation,
the panel weighed up the balance of benefits and harms from
NDT and concluded that there was strong evidence that
NDT does not improve contracture and tone, along with
weak evidence that NDT does not improve function. This
was because, first, when the methodological quality of the
evidence base was considered, the highest quality evidence
suggested NDT was ineffective, with only low-quality, high
risk of bias studies finding a favourable benefit from NDT.
Second, the importance of the outcome that NDT aims to
prevent was considered: (1) regarding contracture, which is
painful and can limit function, high-quality RCTs showed
that casting was a superior treatment to NDT for contrac-
ture management and therefore the panel favoured casting;
(2) regarding tone reduction, the highest quality evidence
suggested that NDT was ineffective for this indication and
other evidence shows BoNT exists as a highly effective alter-
native and therefore the panel favoured BoNT or other
effective pharmacological agents. Third, the magnitude and
precision of treatment effect was considered: only 3 out of
15 trials found any benefit of NDT, and in these studies the
treatment effects were small with very low precision esti-
mates as a result of methodological flaws. Fourth, the bur-
dens and costs of the therapy were considered: NDT is
time-consuming and expensive for families, and, what is
more, a high-quality RCT shows that substantially better
functional motor gains are achieved from motor learning
than from NDT at equal doses.213 Therefore, despite the
evidence being less well understood for the likelihood of
NDT influencing functional motor gains (yellow light), the
panel favoured motor learning since superior gains were
possible from an equal dose. Furthermore, since no other
body structure and function intervention in this review
showed gains beyond the body structure and function level
up into the activity level, it is hard to imagine why NDT
would be the exception to this trend.
In summary, high-quality evidence demonstrates that
casting is superior to NDT for managing contracture;
BoNT exists as a highly effective alternative to NDT for
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managing tone since NDT is ineffective for this indication;
and despite less being known about whether NDT
improves function, high-quality evidence indicates that
motor leaning is superior to NDT for improving function.
Consequently, there are no circumstances where any of the
aims of NDT could not be achieved by a more effective
treatment. Thus, on the grounds of wanting to do the best
for children with CP, it is hard to rationalize a continued
place for traditional NDT within clinical care.
Recommendations for research
In future, systematic review authors should assign a GRADE
to the body of evidence summarized, to enable clinicians to
more quickly interpret the findings of the review for clinical
practice. For the motor learning interventions that were
‘green light’, researchers have repeatedly called for future
investigations to determine optimal dosing, to better assess
the widely held belief that ‘more is better’. Understanding
optimal intensity of therapy is important for maximizing
outcomes, accurately costing services, and offering family-
friendly, achievable interventions. For all the green-light
interventions, additional studies that evaluate long-term out-
comes are necessary. First, because families of children with
CP have life-long caregiving responsibilities, an understand-
ing the impact of these time-intensive and expensive inter-
ventions would help with expectation management and
planning for lifetime care. Second, it is unknown if some
interventions continue to add an incremental benefit when
used repeatedly over years or whether the gains are one-off
and short term only. Long-term outcome data are essential
for costing and optimizing the outcomes of children with
CP.
For the yellow-light interventions with lower-quality evi-
dence or a paucity of research to support effectiveness, rec-
ommendations for research include the use of individual
patient meta-analyses to accelerate data aggregation; collab-
orations that strategize multicentre data collection to over-
come sample size barriers; and the use of CP registries and
single-system designs if RCTs are deemed impossible or
ethically undesirable to conduct. Use of these research
methodologies is advisable and appropriate across all disci-
plines but would have particular value if applied to the disci-
plines of orthopaedic surgery, speech pathology,214–216 and
social work, in order to better substantiate the important
contributions these clinicians make to CP care. The CP field
would also benefit from social workers and psychologists
confirming the assumed benefits of proven interventions
from non-CP populations amongst children with CP.
When the whole evidence base was viewed from a global
perspective, there was a startling lack of interventions
available to improve children’s participation within their
community. Given that this has been identified by many of
the systematic review authors as a priority area for inter-
vention, more research designed to measure the effects
of participation interventions and funds dedicated to this
end is urgently needed. Furthermore, until participation-
specific measures with sensitivity to change have been
developed, researchers need to measure the effects of par-
ticipation intervention using GAS or the COPM.
Study limitations
All systematic reviews are prone to publication bias from
the included trial data; therefore, this systematic review of
systematic reviews may incorporate this inherent bias.
There is also no guarantee that absolutely all relevant sys-
tematic reviews were retrieved, despite the thorough search
strategy. Publication bias, however, is unlikely to be more
of a problem when identifying systematic reviews than
when identifying clinical trials. Moreover, conducting a
systematic review of systematic reviews is a study limitation
in its own right because the method does not create any
information that was not already available. Furthermore,
using a high-level synthesis helicopter view means that spe-
cific intervention details about how the intervention took
place, who benefitted from the intervention, and for how
long the intervention was carried out for were not
reported; clinicians would need to turn to the included
papers to obtain this information. In its place we hope that
the knowledge synthesis will help to bridge the gap
between research and practice by providing comparisons of
varying interventions to aid decision making.
CONCLUSION
In conclusion, we found compelling evidence from sys-
tematic reviews to suggest that the following interventions
are effective at the body structures and function level
alone: anticonvulsants, ankle casting, BoNT, bisphospho-
nates, diazepam, fitness training, hip surveillance, pressure
care, and selective dorsal rhizotomy. We also found com-
pelling evidence from systematic reviews to suggest that
the following interventions improve function at the activi-
ties level: bimanual training, constraint-induced movement
therapy, context-focused therapy, goal-directed/functional
training, home programmes, and occupational therapy
after BoNT. No interventions were shown to work con-
clusively at more than one level of the ICF. Therefore, if
a body structures and function outcome is desired, the
intervention must be selected from the suite of evidence-
based body structures and function interventions. Con-
versely, if an activities-level outcome is sought, top-down
learning interventions, acting at the activities level, must
be applied.
The lack of certain efficacy evidence for large propor-
tions of the interventions in use within standard care is a
problem for people with CP, healthcare providers, purchas-
ers of healthcare, and funders. More research using rigor-
ous designs is urgently needed as CP is the most common
physical disability of childhood with a life-long impact.190
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• Any fee required for this permission shall be non-refundable after thirty (30) days 
from receipt by the CCC. 
• These terms and conditions together with CCC s Billing and Payment terms and 
conditions (which are incorporated herein) form the entire agreement between you and 
WILEY concerning this licensing transaction and (in the absence of fraud) supersedes 
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all prior agreements and representations of the parties, oral or written. This Agreement 
may not be amended except in writing signed by both parties. This Agreement shall be 
binding upon and inure to the benefit of the parties' successors, legal representatives, 
and authorized assigns. 
• In the event of any conflict between your obligations established by these terms and 
conditions and those established by CCC s Billing and Payment terms and 
conditions, these terms and conditions shall prevail. 
• WILEY expressly reserves all rights not specifically granted in the combination of (i) 
the license details provided by you and accepted in the course of this licensing 
transaction, (ii) these terms and conditions and (iii) CCC s Billing and Payment 
terms and conditions.
• This Agreement will be void if the Type of Use, Format, Circulation, or Requestor 
Type was misrepresented during the licensing process.
• This Agreement shall be governed by and construed in accordance with the laws of 
the State of New York, USA, without regards to such state s conflict of law rules. 
Any legal action, suit or proceeding arising out of or relating to these Terms and 
Conditions or the breach thereof shall be instituted in a court of competent jurisdiction 
in New York County in the State of New York in the United States of America and 
each party hereby consents and submits to the personal jurisdiction of such court, 
waives any objection to venue in such court and consents to service of process by 
registered or certified mail, return receipt requested, at the last known address of such 
party. 
WILEY OPEN ACCESS TERMS AND CONDITIONS
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription 
journals offering Online Open. Although most of the fully Open Access journals publish 
open access articles under the terms of the Creative Commons Attribution (CC BY) License 
only, the subscription journals and a few of the Open Access Journals offer a choice of 
Creative Commons Licenses:: Creative Commons Attribution (CC-BY) license Creative 
Commons Attribution Non-Commercial (CC-BY-NC) license and Creative Commons 
Attribution Non-Commercial-NoDerivs (CC-BY-NC-ND) License. The license type is 
clearly identified on the article.
Copyright in any research article in a journal published as Open Access under a Creative 
Commons License is retained by the author(s). Authors grant Wiley a license to publish the 
article and identify itself as the original publisher. Authors also grant any third party the 
right to use the article freely as long as its integrity is maintained and its original authors, 
citation details and publisher are identified as follows: [Title of Article/Author/Journal Title 
and Volume/Issue. Copyright (c) [year] [copyright owner as specified in the Journal]. Links 
to the final article on Wiley s website are encouraged where applicable. 
The Creative Commons Attribution License
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and 
transmit an article, adapt the article and make commercial use of the article. The CC-BY 
license permits commercial and non-commercial re-use of an open access article, as long as 
the author is properly attributed.
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The Creative Commons Attribution License does not affect the moral rights of authors, 
including without limitation the right not to have their work subjected to derogatory 
treatment. It also does not affect any other rights held by authors or third parties in the 
article, including without limitation the rights of privacy and publicity. Use of the article 
must not assert or imply, whether implicitly or explicitly, any connection with, endorsement 
or sponsorship of such use by the author, publisher or any other party associated with the 
article.
For any reuse or distribution, users must include the copyright notice and make clear to 
others that the article is made available under a Creative Commons Attribution license, 
linking to the relevant Creative Commons web page. 
To the fullest extent permitted by applicable law, the article is made available as is and 
without representation or warranties of any kind whether express, implied, statutory or 
otherwise and including, without limitation, warranties of title, merchantability, fitness for a 
particular purpose, non-infringement, absence of defects, accuracy, or the presence or 
absence of errors.
Creative Commons Attribution Non-Commercial License
The Creative Commons Attribution Non-Commercial (CC-BY-NC) License permits use, 
distribution and reproduction in any medium, provided the original work is properly cited 
and is not used for commercial purposes.(see below) 
Creative Commons Attribution-Non-Commercial-NoDerivs License
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND) 
permits use, distribution and reproduction in any medium, provided the original work is 
properly cited, is not used for commercial purposes and no modifications or adaptations are 
made. (see below)
Use by non-commercial users
For non-commercial and non-promotional purposes, individual users may access, download, 
copy, display and redistribute to colleagues Wiley Open Access articles, as well as adapt, 
translate, text- and data-mine the content subject to the following conditions:
• The authors' moral rights are not compromised. These rights include the right of 
"paternity" (also known as "attribution" - the right for the author to be identified as 
such) and "integrity" (the right for the author not to have the work altered in such a 
way that the author's reputation or integrity may be impugned). 
• Where content in the article is identified as belonging to a third party, it is the 
obligation of the user to ensure that any reuse complies with the copyright policies of 
the owner of that content. 
• If article content is copied, downloaded or otherwise reused for non-commercial 
research and education purposes, a link to the appropriate bibliographic citation 
(authors, journal, article title, volume, issue, page numbers, DOI and the link to the 
definitive published version on Wiley Online Library) should be maintained. 
Copyright notices and disclaimers must not be deleted. 
• Any translations, for which a prior translation agreement with Wiley has not been 
agreed, must prominently display the statement: "This is an unofficial translation of an 
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article that appeared in a Wiley publication. The publisher has not endorsed this 
translation." 
Use by commercial "for-profit" organisations
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes 
requires further explicit permission from Wiley and will be subject to a fee. Commercial 
purposes include:
• Copying or downloading of articles, or linking to such articles for further 
redistribution, sale or licensing; 
• Copying, downloading or posting by a site or service that incorporates advertising 
with such content; 
• The inclusion or incorporation of article content in other works or services (other than 
normal quotations with an appropriate citation) that is then available for sale or 
licensing, for a fee (for example, a compilation produced for marketing purposes, 
inclusion in a sales pack) 
• Use of article content (other than normal quotations with appropriate citation) by for-
profit organisations for promotional purposes 
• Linking to article content in e-mails redistributed for promotional, marketing or 
educational purposes; 
• Use for the purposes of monetary reward by means of sale, resale, licence, loan, 
transfer or other form of commercial exploitation such as marketing products 
• Print reprints of Wiley Open Access articles can be purchased from: 
corporatesales@wiley.com
Further details can be found on Wiley Online Library 
http://olabout.wiley.com/WileyCDA/Section/id-410895.html
Other Terms and Conditions:
v1.9
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or 
+1-978-646-2777.
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AMERICAN ACADEMY OF PEDIATRICS LICENSE
TERMS AND CONDITIONS
Jun 21, 2015
This is a License Agreement between Catherine Morgan ("You") and American Academy of 
Pediatrics ("American Academy of Pediatrics") provided by Copyright Clearance Center 
("CCC"). The license consists of your order details, the terms and conditions provided by 
American Academy of Pediatrics, and the payment terms and conditions.
All payments must be made in full to CCC. For payment instructions, please see 
information listed at the bottom of this form.
License Number 3653870123164
License date Jun 21, 2015
Licensed content publisher American Academy of Pediatrics
Licensed content publication Pediatrics
Licensed content title Enriched Environments and Motor Outcomes in Cerebral Palsy: 
Systematic Review and Meta-analysis
Licensed content author Catherine Morgan, Iona Novak, Nadia Badawi
Licensed content date Sep 1, 2013
Volume number 132
Issue number 3
Start page e735
End page e746
Type of Use Dissertation/Thesis
Requestor type Individual
Format Print and Electronic
Portion Full article
Order reference number None
Billing Type Invoice
Billing Address Catherine Morgan
Cerebral Palsy Alliance
187 Allambie Rd
Allambie Heights
Sydney, Australia 2100
Attn: Catherine Morgan
Total 0.00 USD
Terms and Conditions
AAP TERMS ANDCONDITIONS
The American Academy of Pediatrics grants permission to use the content cited above for 
the purpose stated. This letter shall serve as a receipt for payment of the permissions fee(s) 
and as an approval agreement. 
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1. The following credit line must appear:
Reproduced with permission from Journal <Journal>, Vol. <Vol>, Page(s) 
<Pages>, Copyright © <Year> by the AAP
2. The requester guarantees to reprint the materials exactly as originally published. Obvious 
typographical errors maybe corrected. No deletions, alterations, or other changes may be 
made to the information or statistical data without the written consent of the American 
Academy of Pediatrics. 
3. Rights granted herein are not exclusive and the American Academy of Pediatrics reserves 
the right to grant the same permission to others. Permission is granted for only the 
reproduction media specified.
4. Original artwork or copies of articles cannot be supplied, but PDF files may be downloaded 
from www.aappublications.org . Quantities of reprints and eprints can be obtained by 
contacting Terry Dennsteadt, Reprint Sales Manager – AAP Journals, The Walchli Tauber 
Group, Inc., 2225 Old Emmorton Road, Suite 201, Bel Air, MD 21046. 443.512.8899 x 112 
office, 443.512.8909 fax, terry.dennsteadt@wt-group.com.
5. This permission is granted on a one-time, annual basis only. Reproduction of this material 
is confined to the purpose and/or media for which permission is hereby given. Future use 
of this material is subject to the conditions stated herein. Gratis permissions are not issued 
for use in materials available for commercial sale, even for educational use.
6. If the permission fee for the requested use of our material is waived in this instance, please 
be aware future requests for AAP materials are subject to fees.
7. Reservation of Rights: Publisher reserves all rights not specifically granted in the 
combination of (i) the license details provided by you and accepted in the course of this 
licensing transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment 
terms and conditions.
8. License Contingent Upon Payment. Provided that you have disclosed complete and accurate 
details of your proposed use, no license is effective unless and until full payment is 
received from you(either by publisher or by CCC) as provided in the CCC's Billing and 
Payment terms and conditions. If full payment is not received on a timely basis, then any 
license preliminarily granted shall be deemed automatically revoked and shall be void as if 
never granted. Further, in the event that you breach terms and conditions or any of CCC's 
Billing and Payment terms and conditions, the license is automatically revoked and shall be 
void as if never granted. 
9. Warranties: Publisher makes no representations or warranties of any kind, express or 
implied, including but not limited to, accuracy, timeliness or completeness of the 
information contained in the licensed materials, or merchantability, title or fitness of a use 
for a particular purpose.
10. Indemnity: You hereby indemnify and agree to hold harmless publisher and CCC, and their 
respective officers, directors, employees and agents, from and against any and all claims 
arising out of your use of the licensed material other than specifically authorized pursuant 
to this license.
11. No Transfer of License: This license is personal to you and may not be sublicensed, 
assigned or transferred by you to any other person without publisher's written permission.
12. No Amendment Except in Writing: This license may not be amended except in writing 
signed by both requestor and publisher.
13. This permission, if permission has been granted for use of figures/tables/images, does not 
cover any third party copyrighted work which may appear in the material requested and 
does not apply to materials credited to publications other than American Academy of 
Pediatrics (AAP) journals. For materials credited to non-AAP journal publications, you will 
need to obtain permission from the publication referenced in the material legend or credit 
line before proceeding with usage of the materials. You agree to hold harmless and 
indemnify the AAP against any claims arising from your use of any content in your work 
that is credited to non-AAP sources.
14. This permission does not apply to and is not valid for photographs depicting identifiable 
individuals, including images where individuals' eyes have been blacked out or images 
depicting victims of abuse. 
15. If the requester is translating the material, the following translation disclaimer must be 
included:
The materials reused with permission from the American Academy of Pediatrics 
("AAP") appeared originally in English, published by the AAP. The AAP assumes 
no responsibility for any inaccuracy or error in the contents of these materials, 
including any inaccuracy or error arising from the translation from English.
16. Other Terms and Conditions:
v1.4
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Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or 
+1-978-646-2777.
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JOHN WILEY AND SONS LICENSE
TERMS AND CONDITIONS
Jun 30, 2015
This Agreement between Catherine Morgan ("You") and John Wiley and Sons ("John Wiley
and Sons") consists of your license details and the terms and conditions provided by John
Wiley and Sons and Copyright Clearance Center.
License Number 3659011361092
License date Jun 30, 2015
Licensed Content Publisher John Wiley and Sons
Licensed Content Publication Developmental Medicine & Child Neurology
Licensed Content Title A systematic review of interventions for children with cerebral palsy:
state of the evidence
Licensed Content Author Iona Novak,Sarah Mcintyre,Catherine Morgan,Lanie Campbell,Leigha
Dark,Natalie Morton,Elise Stumbles,Salli-Ann Wilson,Shona
Goldsmith
Licensed Content Date Aug 21, 2013
Pages 26
Type of use Dissertation/Thesis
Requestor type Author of this Wiley article
Format Print and electronic
Portion Full article
Will you be translating? No
Title of your thesis /
dissertation
Optimising motor learning of infants at high risk of cerebral palsy
using environmental and goal oriented interventions
Expected completion date Jun 2015
Expected size (number of
pages)
15
Requestor Location Catherine Morgan
Cerebral Palsy Alliance
187 Allambie Rd
Allambie Heights
Sydney, Australia 2100
Attn: Catherine Morgan
Billing Type Invoice
Billing Address Catherine Morgan
Cerebral Palsy Alliance
187 Allambie Rd
Allambie Heights
Sydney, Australia 2100
Attn: Catherine Morgan
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Total 0.00 AUD
Terms and Conditions
TERMS AND CONDITIONS
This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or
one of its group companies (each a"Wiley Company") or handled on behalf of a society with
which a Wiley Company has exclusive publishing rights in relation to a particular work
(collectively "WILEY"). By clicking �accept� in connection with completing this
licensing transaction, you agree that the following terms and conditions apply to this
transaction (along with the billing and payment terms and conditions established by the
Copyright Clearance Center Inc., ("CCC's Billing and Payment terms and conditions"), at
the time that you opened your Rightslink account (these are available at any time at
http://myaccount.copyright.com).
Terms and Conditions
The materials you have requested permission to reproduce or reuse (the "Wiley
Materials") are protected by copyright. 
You are hereby granted a personal, non-exclusive, non-sub licensable (on a stand-
alone basis), non-transferable, worldwide, limited license to reproduce the Wiley
Materials for the purpose specified in the licensing process. This license is for a one-
time use only and limited to any maximum distribution number specified in the
license. The first instance of republication or reuse granted by this licence must be
completed within two years of the date of the grant of this licence (although copies
prepared before the end date may be distributed thereafter). The Wiley Materials shall
not be used in any other manner or for any other purpose, beyond what is granted in
the license. Permission is granted subject to an appropriate acknowledgement given to
the author, title of the material/book/journal and the publisher. You shall also duplicate
the copyright notice that appears in the Wiley publication in your use of the Wiley
Material. Permission is also granted on the understanding that nowhere in the text is a
previously published source acknowledged for all or part of this Wiley Material. Any
third party content is expressly excluded from this permission.
With respect to the Wiley Materials, all rights are reserved. Except as expressly
granted by the terms of the license, no part of the Wiley Materials may be copied,
modified, adapted (except for minor reformatting required by the new Publication),
translated, reproduced, transferred or distributed, in any form or by any means, and no
derivative works may be made based on the Wiley Materials without the prior
permission of the respective copyright owner. You may not alter, remove or suppress
in any manner any copyright, trademark or other notices displayed by the Wiley
Materials. You may not license, rent, sell, loan, lease, pledge, offer as security, transfer
or assign the Wiley Materials on a stand-alone basis, or any of the rights granted to
you hereunder to any other person.
The Wiley Materials and all of the intellectual property rights therein shall at all times
remain the exclusive property of John Wiley & Sons Inc, the Wiley Companies, or
their respective licensors, and your interest therein is only that of having possession of
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and the right to reproduce the Wiley Materials pursuant to Section 2 herein during the
continuance of this Agreement. You agree that you own no right, title or interest in or
to the Wiley Materials or any of the intellectual property rights therein. You shall have
no rights hereunder other than the license as provided for above in Section 2. No right,
license or interest to any trademark, trade name, service mark or other branding
("Marks") of WILEY or its licensors is granted hereunder, and you agree that you
shall not assert any such right, license or interest with respect thereto. 
NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR
REPRESENTATION OF ANY KIND TO YOU OR ANY THIRD PARTY,
EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT TO THE MATERIALS
OR THE ACCURACY OF ANY INFORMATION CONTAINED IN THE
MATERIALS, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED
WARRANTY OF MERCHANTABILITY, ACCURACY, SATISFACTORY
QUALITY, FITNESS FOR A PARTICULAR PURPOSE, USABILITY,
INTEGRATION OR NON-INFRINGEMENT AND ALL SUCH WARRANTIES
ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND WAIVED
BY YOU
WILEY shall have the right to terminate this Agreement immediately upon breach of
this Agreement by you.
You shall indemnify, defend and hold harmless WILEY, its Licensors and their
respective directors, officers, agents and employees, from and against any actual or
threatened claims, demands, causes of action or proceedings arising from any breach
of this Agreement by you. 
IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR
ANY OTHER PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY
SPECIAL, CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY OR
PUNITIVE DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN
CONNECTION WITH THE DOWNLOADING, PROVISIONING, VIEWING OR
USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION,
WHETHER FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT,
NEGLIGENCE, INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT
LIMITATION, DAMAGES BASED ON LOSS OF PROFITS, DATA, FILES, USE,
BUSINESS OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND WHETHER
OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY
FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED
HEREIN. 
Should any provision of this Agreement be held by a court of competent jurisdiction
to be illegal, invalid, or unenforceable, that provision shall be deemed amended to
achieve as nearly as possible the same economic effect as the original provision, and
the legality, validity and enforceability of the remaining provisions of this Agreement
shall not be affected or impaired thereby. 
The failure of either party to enforce any term or condition of this Agreement shall not
constitute a waiver of either party's right to enforce each and every term and condition
of this Agreement. No breach under this agreement shall be deemed waived or
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excused by either party unless such waiver or consent is in writing signed by the party
granting such waiver or consent. The waiver by or consent of a party to a breach of
any provision of this Agreement shall not operate or be construed as a waiver of or
consent to any other or subsequent breach by such other party. 
This Agreement may not be assigned (including by operation of law or otherwise) by
you without WILEY's prior written consent.
Any fee required for this permission shall be non-refundable after thirty (30) days
from receipt by the CCC. 
These terms and conditions together with CCC�s Billing and Payment terms and
conditions (which are incorporated herein) form the entire agreement between you and
WILEY concerning this licensing transaction and (in the absence of fraud) supersedes
all prior agreements and representations of the parties, oral or written. This Agreement
may not be amended except in writing signed by both parties. This Agreement shall be
binding upon and inure to the benefit of the parties' successors, legal representatives,
and authorized assigns. 
In the event of any conflict between your obligations established by these terms and
conditions and those established by CCC�s Billing and Payment terms and
conditions, these terms and conditions shall prevail. 
WILEY expressly reserves all rights not specifically granted in the combination of (i)
the license details provided by you and accepted in the course of this licensing
transaction, (ii) these terms and conditions and (iii) CCC�s Billing and Payment
terms and conditions.
This Agreement will be void if the Type of Use, Format, Circulation, or Requestor
Type was misrepresented during the licensing process.
This Agreement shall be governed by and construed in accordance with the laws of
the State of New York, USA, without regards to such state�s conflict of law rules.
Any legal action, suit or proceeding arising out of or relating to these Terms and
Conditions or the breach thereof shall be instituted in a court of competent jurisdiction
in New York County in the State of New York in the United States of America and
each party hereby consents and submits to the personal jurisdiction of such court,
waives any objection to venue in such court and consents to service of process by
registered or certified mail, return receipt requested, at the last known address of such
party. 
WILEY OPEN ACCESS TERMS AND CONDITIONS
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription
journals offering Online Open. Although most of the fully Open Access journals publish
open access articles under the terms of the Creative Commons Attribution (CC BY) License
only, the subscription journals and a few of the Open Access Journals offer a choice of
Creative Commons Licenses:: Creative Commons Attribution (CC-BY) license Creative
Commons Attribution Non-Commercial (CC-BY-NC) license and Creative Commons
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Attribution Non-Commercial-NoDerivs (CC-BY-NC-ND) License. The license type is
clearly identified on the article.
Copyright in any research article in a journal published as Open Access under a Creative
Commons License is retained by the author(s). Authors grant Wiley a license to publish the
article and identify itself as the original publisher. Authors also grant any third party the
right to use the article freely as long as its integrity is maintained and its original authors,
citation details and publisher are identified as follows: [Title of Article/Author/Journal Title
and Volume/Issue. Copyright (c) [year] [copyright owner as specified in the Journal]. Links
to the final article on Wiley�s website are encouraged where applicable.
The Creative Commons Attribution License
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and
transmit an article, adapt the article and make commercial use of the article. The CC-BY
license permits commercial and non-commercial re-use of an open access article, as long as
the author is properly attributed.
The Creative Commons Attribution License does not affect the moral rights of authors,
including without limitation the right not to have their work subjected to derogatory
treatment. It also does not affect any other rights held by authors or third parties in the
article, including without limitation the rights of privacy and publicity. Use of the article
must not assert or imply, whether implicitly or explicitly, any connection with, endorsement
or sponsorship of such use by the author, publisher or any other party associated with the
article.
For any reuse or distribution, users must include the copyright notice and make clear to
others that the article is made available under a Creative Commons Attribution license,
linking to the relevant Creative Commons web page.
To the fullest extent permitted by applicable law, the article is made available as is and
without representation or warranties of any kind whether express, implied, statutory or
otherwise and including, without limitation, warranties of title, merchantability, fitness for a
particular purpose, non-infringement, absence of defects, accuracy, or the presence or
absence of errors.
Creative Commons Attribution Non-Commercial License
The Creative Commons Attribution Non-Commercial (CC-BY-NC) License permits use,
distribution and reproduction in any medium, provided the original work is properly cited
and is not used for commercial purposes.(see below)
Creative Commons Attribution-Non-Commercial-NoDerivs License
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND)
permits use, distribution and reproduction in any medium, provided the original work is
properly cited, is not used for commercial purposes and no modifications or adaptations are
made. (see below)
Use by non-commercial users
For non-commercial and non-promotional purposes, individual users may access, download,
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copy, display and redistribute to colleagues Wiley Open Access articles, as well as adapt,
translate, text- and data-mine the content subject to the following conditions:
The authors' moral rights are not compromised. These rights include the right of
"paternity" (also known as "attribution" - the right for the author to be identified as
such) and "integrity" (the right for the author not to have the work altered in such a
way that the author's reputation or integrity may be impugned). 
Where content in the article is identified as belonging to a third party, it is the
obligation of the user to ensure that any reuse complies with the copyright policies of
the owner of that content. 
If article content is copied, downloaded or otherwise reused for non-commercial
research and education purposes, a link to the appropriate bibliographic citation
(authors, journal, article title, volume, issue, page numbers, DOI and the link to the
definitive published version on Wiley Online Library) should be maintained.
Copyright notices and disclaimers must not be deleted. 
Any translations, for which a prior translation agreement with Wiley has not been
agreed, must prominently display the statement: "This is an unofficial translation of an
article that appeared in a Wiley publication. The publisher has not endorsed this
translation." 
Use by commercial "for-profit" organisations
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes
requires further explicit permission from Wiley and will be subject to a fee. Commercial
purposes include:
Copying or downloading of articles, or linking to such articles for further
redistribution, sale or licensing; 
Copying, downloading or posting by a site or service that incorporates advertising
with such content; 
The inclusion or incorporation of article content in other works or services (other than
normal quotations with an appropriate citation) that is then available for sale or
licensing, for a fee (for example, a compilation produced for marketing purposes,
inclusion in a sales pack) 
Use of article content (other than normal quotations with appropriate citation) by for-
profit organisations for promotional purposes 
Linking to article content in e-mails redistributed for promotional, marketing or
educational purposes; 
Use for the purposes of monetary reward by means of sale, resale, licence, loan,
transfer or other form of commercial exploitation such as marketing products 
Print reprints of Wiley Open Access articles can be purchased from:
corporatesales@wiley.com 
